A Practical guide to working with health-care systems on tobacco-use treatment by National Center for Chronic Disease Prevention and Health Promotion (U.S.) Office on Smoking and Health.
A Practical Guide to Working 
with Health-Care Systems 
on Tobacco-Use Treatment 
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Centers for Disease Control and Prevention 
U
.S. D
EPA
R
TM
EN
T O
F H
EA
LTH
 A
N
D
 H
U
M
A
N
 SER
V
IC
ES 
A Practical Guide to W
orking w
ith Health-Care System
s on Tobacco-Use Treatm
ent 
Centers for D
isease Control and
 Prevention 

Ordering Information 
To order a copy of this publication, contact: 
Centers for Disease Control and Prevention

Ofﬁce on Smoking and Health

Mail Stop K-50, Publications

4770 Buford Highway, NE

Atlanta GA 30341-3717

Phone: 1-800-CDC-1311 (800-232-1311)

FAX Information Services: 1-888-CDC-FAXX (888-232-3299)

http://www.cdc.gov/tobacco/pubs.htm

Suggested Citation 
Centers for Disease Control and Prevention. A Practical Guide to Working with Health-Care Systems 
on Tobacco-Use Treatment. Atlanta, GA: U.S. Department of Health and Human Services, Centers for 
Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 
Ofﬁce on Smoking and Health; 2006. 

A Practical Guide to Working
with Health-Care Systems 
on Tobacco-Use Treatment 
 
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Centers for Disease Control and Prevention 
September 2006 

Table of Contents

Acknowledgments......................................................................................................................................... iii

Introduction...................................................................................................................................................... 1

Health-Care Systems Primer ....................................................................................................................... 7

Ambulatory Care ............................................................................................................................................ 7

Government as Health-Care Clinician ........................................................................................................ 8

Hospitals .........................................................................................................................................................11

Health Plans .................................................................................................................................................. 13

Purchasers of Insurance............................................................................................................................... 17

Effective Tobacco-Control Interventions and 

the Health-Care System’s Role................................................................................................................. 21

Individual Treatment.................................................................................................................................... 21

Clinicians........................................................................................................................................................ 25

Systems Changes to Support Clinician Intervention............................................................................... 32

Reducing Patient Out-of-Pocket Costs for Tobacco-Use Treatment ...................................................... 37

Community Policy and Mass Media ......................................................................................................... 40

Building Relationships Within Health-Care Systems ...................................................................... 43

Reasons to Collaborate................................................................................................................................. 43

Keys to Successful Collaboration ............................................................................................................... 43

Beginning a Collaboration........................................................................................................................... 44

Roles Within the Collaboration................................................................................................................... 44

The Public Health Contribution ................................................................................................................. 45

Implementation Strategies....................................................................................................................... 47

Lessons Learned............................................................................................................................................ 47

Measuring Progress...................................................................................................................................... 48

Increasing Systems-Change Effectiveness ................................................................................................ 48

Case Studies................................................................................................................................................... 51

Conclusion ....................................................................................................................................................... 69

References........................................................................................................................................................ 71

Appendixes...................................................................................................................................................... 77

A. Glossary of Terms................................................................................................................................... 78

B. Essential Elements of an Effective Practice-Based Tobacco-Cessation System ............................. 80

C. Essential Elements of an Effective Pediatric Practice-Based Tobacco-Control System ................ 81

A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment | i 
D. Making the Business Case for Tobacco Control................................................................................. 83

E. For More Information............................................................................................................................ 84

F. Practice Assessment Document ........................................................................................................... 90

G. Coverage for Tobacco-Use Cessation Treatments ............................................................................. 95

H. Reducing the Burden of Smoking on Employee Health and Productivity ................................. 101

I. Tobacco Quitlines ................................................................................................................................ 109

J. QuitWorks .............................................................................................................................................113

K. Minimal Data Set Intake Questions....................................................................................................115

L. Medicaid Model Language ................................................................................................................ 125

M. Promotion of Tobacco Cessation in the Health-Care System: Suggested Strategies ................. 127

ii | Table of Contents 
Acknowledgments

Abby C. Rosenthal, M.P.H. 
Cessation Strategic Coordinator 
Ofﬁce on Smoking and Health 
Centers for Disease Control 
and Prevention 
Atlanta, Georgia 
Corinne G. Husten, M.D., M.P.H. 
Acting Director 
Ofﬁce on Smoking and Health 
Centers for Disease Control 
and Prevention 
Atlanta, Georgia 
We thank the following individuals who served as members of the Health-Care Systems Workgroup 
and who contributed their expertise and experience in developing and reviewing this document. 
Marc W. Manley, M.D., M.P.H. 
Workgroup Chair 
Executive Director 
Center for Tobacco Reduction and 
Health Improvement 
BlueCross and BlueShield of Minnesota 
St. Paul, Minnesota 
Anna Berkowitz, M.P.H. 
Program Consultant 
Ofﬁce on Smoking and Health 
Centers for Disease Control and Prevention 
Atlanta, Georgia 
Wendy Bjornson, M.P.H. 
Smoking Cessation Center 
Oregon Health & Science University 
Portland, Oregon 
Nancy G. Clarke 
Health System Liaison

Oregon Department of Human Services,

Health Promotion, and Chronic 
Disease Prevention 
Portland, Oregon 
Jack F. Hollis, Ph.D. 
Associate Director 
Kaiser Permanente Center for Health Research 
Portland, Oregon 
Carolyn C. Link, M.P.H. 
Workgroup Lead Writer 
Center for Tobacco Reduction and 
Health Improvement 
BlueCross and BlueShield of Minnesota 
St. Paul, Minnesota 
Nicola Majchrzak, M.P.H., M.S.W. 
Project Director 
Massachusetts General Hospital Tobacco  
Research and Treatment Center 
Boston, Massachusetts 
Tim McAfee, M.D., M.P.H. 
Chief Medical Ofﬁcer 
Free and Clear, Inc. 
Seattle, Washington 
Cathy Melvin, Ph.D., M.P.H. 
Director, Smoke-Free Families 
National Dissemination Ofﬁce 
Cecil G. Sheps Center for Health 
Services Research 
University of North Carolina at Chapel Hill 
Chapel Hill, North Carolina 
Nancy Rigotti, M.D. 
Director,Tobacco Research and 
Treatment Center 
Massachusetts General Hospital 
Boston, Massachusetts 
A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment | iii 
Leif Solberg, M.D. 
Associate Medical Director for 
Care Improvement Research 
Health Partners Research Foundation 
Minneapolis, Minnesota 
Jessica Spraggins, M.P.H. 
ORISE Fellow 
Ofﬁce on Smoking and Health 
Centers for Disease Control and Prevention 
Atlanta, Georgia 
Tracey Strader, M.S.W. 
Executive Director 
Oklahoma Tobacco Settlement
 Endowment Trust Fund 
Oklahoma City, Oklahoma 
Susan Swartz, M.D. 
Medical Director 
Center for Tobacco Independence 
Maine Medical Center 
Portland, Maine 
Jonathan P. Winickoff, M.D., M.P.H. 
Chair, American Academy of Pediatrics 
Tobacco Consortium 
Assistant Professor of Pediatrics 
Harvard Medical School 
Boston, Massachusetts 
Reviewers 
Christopher M. Anderson, B.A. 
Program Director 
California Smoker’s Helpline 
Dept. of Family and Preventive Medicine 
University of California, San Diego 
La Jolla, California 
Scott Sherman, M.D., M.P.H. 
Smoking Cessation Coordinator 
VA Greater Los Angeles Health-
Care System 
Professor of Medicine 
UCLA/San Fernando Valley Program 
Sepulveda, California 
Donna Warner, M.B.A., M.A., C.A.C. 
Director, Planning and Program 
Development 
Massachusetts Tobacco Control Program 
Massachusetts Department of Public Health 
Boston, Massachusetts 
Case Study Contributors 
Charles J. Bentz, M.D., F.A.C.P. 

Wendy Bjornson, M.P.H.

Nancy Clarke

Sally Carter, M.S.W. 

D’Anne Gilmore 

Joy L. Leuthard, M.S., L.S.W.A.

Nicola Majchrzak, M.P.H., M.S.W.

Tim McAfee, M.D., M.P.H.

Lynn Mitchell, M.D., M.P.H. 

Lezli Redmond, M.P.H.

Dawn Robbins

Tracey Strader, M.S.W. 

Susan Swartz, M.D.

Judith Van Osdol, B.S.N., R.N., M.H.S.A.

Donna Warner, M.B.A., M.A., C.A.C.

We also acknowledge the contributions of the following Northrop Grumman IT contractor staff: 
Maxine Forrest, Technical Writer; Jody Gan, Research Associate; Samantha Helfert, Medical 
Librarian; and Jeffrey Roussel and Catherine Ignacio, Graphic Designers. 
iv | Acknowledgments 
Introduction 
T
Treating Tobacco Use and Dependence: 
Clinical Practice Guideline 
Promoting widespread use of treatment for tobacco dependence is one of 
the primary goals in improving public health (U.S. Department of Health 
and Human Services, 2000). Tobacco use, and smoking in particular, causes 
many of the chronic and debilitating diseases that affect the population 
and stress the health-care system. Such diseases include heart disease, 
stroke, multiple cancers, and respiratory diseases, as well as complications 
of pregnancy such as preterm delivery and low infant birth weight (U.S. 
Department of Health and Human Services, 1989, 2001, and 2004; National 
Cancer Institute, 1999). 
State health departments 
and businesses are uniquely 
positioned to expand 
the provision of tobacco-
dependence treatment 
through partnerships and 
purchasing strategies. Insur-
ance coverage can be expanded 
for state employees and 
Medicaid recipients. Business 
partnerships can be developed 
to initiate or expand coverage 
for self-insured or indemnity 
populations. Comprehensive 
beneﬁts must be appropriately 
promoted, and their use should 
be monitored. 
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obacco dependence shows many features of a chronic disease. Although a 
minority of tobacco users achieves permanent abstinence in an initial quit 
attempt, the majority persist in tobacco use for many years and typically 
cycle through multiple periods of relapse and remission. A failure to appreciate the 
chronic nature of tobacco dependence may undercut clinicians’ motivation to treat 
tobacco use consistently (Fiore et al., 2000). 
This guide will review what is known about implementing comprehensive 
tobacco-control and treatment strategies within health-care systems. 
Provided within are examples of effective partnerships between public 
health agencies, health-care systems, and the business community. Also 
included is a primer designed to promote a better understanding of 
health care for those not familiar with systems operations. The reader 
should be aware that this guide uses the term “patient” in the broadest 
sense—therefore, users of this guide should not exclude opportunities 
for providers to treat tobacco use among relatives, such as parents of 
infant, child, and adolescent patients; other patient family members; 
and any other individuals with whom providers have contact through 
interactions with patients. 
Approximately 28% of adolescents in this county currently use tobacco, 
22% of whom are smokers (Centers for Disease Control and Prevention 
[CDC], 2005a). Additionally, more than one in ﬁve adults in this country 
currently smoke (CDC, 2004b), but most want to quit. In 2002, 70% of 
smokers reported that they wanted to quit, and 41% attempted to quit 
for at least 24 hours in the past year. However, only about 5% of smokers 
maintained abstinence for 3 to 12 months (CDC, 2005b). 
Safe and effective tobacco-use treatments that greatly enhance success in 
quitting are available, but many smokers do not or cannot access these 
treatments (Fiore et al., 2000). Most who try to quit may not be successful 
because they do not use effective treatments (American Cancer Society, 
2003; Zhu et al., 2000). 
In terms of efﬁcacy, cost effectiveness, and impact, tobacco-use treatment 
has been ranked in the top three preventive services and has been speciﬁed 
as cost saving (Maciosek et al., 2006). Experts agree that reducing the 
number of new smokers and helping current smokers quit plays a critical 
role in improving public health (Peto et al., 2000). Reducing tobacco use 
is a key component of Healthy People 2010—the nation’s action plan for 
improving public health in the ﬁrst decade of the 21st century. This plan 
includes 21 objectives related to tobacco and a goal to reduce smoking 
prevalence by more than half (to 12%) by 2010. Current smoking prevalence 
in the United States is 20.8% (CDC, 2005b). 
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Source: Henningfield JE, Slade J. Tobacco-dependence medications: public health and regulatory issues. 
Food and Drug Law Journal 1998;53(suppl):75–114. 
The chart below illustrates the importance of including cessation in primary 
tobacco-control efforts. 
Promoting quitting among tobacco users is one of the key recommenda-
tions in several recent major reports. The CDC recommends the following 
comprehensive tobacco-control strategies: 
U.S. Public Health Service (PHS) Guideline for 
Treating Tobacco Use and Dependence 
■	 Ensure that all smokers are offered effective tobacco-use treatment at all 
clinical encounters. 
■	 Increase access to and participation in effective tobacco-use counseling. 
■	 Increase access to and appropriate use of effective tobacco-treatment 
medications. 
■	 Reduce patient out-of-pocket costs for tobacco-use treatment. 
■	 Create a social and economic environment that promotes quitting 
(Fiore et al., 2000). 
Guide to Community Preventive Services 
■	 Increase the unit price for tobacco products. 
■	 Implement sustained mass media campaigns. 
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■	 Implement provider reminder systems in health-care settings. 
■	 Reduce patient out-of-pocket costs for tobacco-use treatment. 
■	 Initiate multicomponent interventions that include patient telephone 
support (Hopkins et al., 2001). 
Interagency Committee on Smoking and Health, 
Cessation Subcommittee Goals, 2003 
■	 Mobilize health insurers, employers, and others to foster evidence-based 
tobacco-dependence coverage for all covered lives. 
■	 Mobilize health systems to implement system-level changes to foster 
effective utilization of tobacco-dependence treatments. 
■	 Mobilize national quality assurance and accreditation organizations, 
clinicians, health systems, and others to establish and measure the 
treatment of tobacco dependence as part of the standard of care 
(www.cdc.gov/tobacco/ICHS). 
■	 Mobilize communities to ensure that policies and programs are in place 
to increase demand for services and to ensure access to such services, 
especially for underserved populations (Fiore et al., 2004). 
The Cochrane Collaboration, 2005 
■	 Health insurance that pays the full cost of smoking-cessation treatments 
can increase quit rates compared to beneﬁt plans that only partially 
cover cessation treatment or that offer no cessation beneﬁts (Cochrane 
Collaboration, 2005). 
■	 Programs to stop smoking delivered during hospitalization that include 
a 1-month follow-up are most effective (Cochrane Collaboration, 2005). 
■	 Proactive telephone counseling can be effective compared to an 
intervention without personal contact. Successful interventions generally 
involve multiple contacts timed around a quit attempt (Cochrane 
Collaboration, 2005). 
■	 All of the commercially available forms of nicotine replacement therapy 
(gum, transdermal patch, nasal spray, inhaler, and sublingual tablets/ 
lozenges) are effective as part of a strategy to promote smoking cessation 
(Cochrane Collaboration, 2005). 
■	 Standard self-help materials may increase quit rates compared to 
no intervention, but the effect is likely to be small (Cochrane 
Collaboration, 2005). 
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Establishing new relationships, particularly with people in health-care 
systems and the business community, is essential to achieving success. 
By themselves, public health agencies have insufﬁcient funding and 
capacity to deliver tobacco-use treatment services, create an environment 
that supports tobacco-use treatment, and manage other aspects of a 
comprehensive tobacco-use treatment program. These tobacco-use 
treatment objectives may be best achieved by developing new partnerships. 
The primary purpose of this guide is to increase public health professionals’ 
(in state and local health departments) comfort with and skill in establishing 
collaborative relationships with leaders in health-care systems and working 
with these partners on activities to promote effective system-wide tobacco-
use treatment. The goal is to provide key information and practical advice 
that will help public health professionals improve their understanding of 
health-care systems and develop better skills in building relationships and 
working with health-care professionals. 
This guide is also intended as a vehicle for public health agencies to assist 
health-care systems in increasing their use of effective tobacco-dependence 
treatments. The guide can also serve as a resource for the business/ 
employer sector, which is adversely affected by tobacco use through 
absenteeism, loss of productivity, and higher health-care costs. Businesses 
and employers also have a vested interest in encouraging and supporting 
health-care systems to promote and implement effective tobacco-
dependence treatment and cessation services. 
Two primary sources of evidence inform this guide: the PHS clinical 
practice guidelines, Treating Tobacco Use and Dependence, and the CDC’s 
Guide to Community Preventive Services (the Community Guide). The evidence 
base from those resources is supplemented by the opinions and experiences 
of a national panel of experts who contributed to this effort and served as 
technical reviewers. 
This guide includes four major sections: 
■	 Health-Care Systems Primer provides an overview of the major 
organizations that make up the health-care system and summarizes 
the challenges that each component faces for implementing effective 
tobacco-cessation initiatives. As noted above, public health professionals 
and members of the business/employer sector who are less familiar 
with these organizations should review this section before reading the 
next sections. 
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■	 Effective Tobacco-Control Interventions and the Health-Care System’s 
Role discusses effective tobacco-use treatments and strategies for 
increasing access to these treatments. Professionals from each part 
of the public and private health-care system—clinics, hospitals, 
health plans, insurers, insurance purchasers, and the public health 
community—have roles to play in implementing these strategies. 
Some of their key roles are described in this section. Because the section 
presumes a working knowledge of health-care systems, readers who 
are less familiar with these organizations should ﬁrst review the Health-
Care Systems Primer, which begins on page 7. Case studies of successful 
partnerships between public health agencies and health-care systems are 
integrated throughout the document. 
■	 Building Relationships Within Health-Care Systems describes 
strategies for collaboration on achieving tobacco-treatment–related 
objectives and how different agencies have used collaborative efforts 
to achieve speciﬁc goals. 
■	 Implementation Strategies describes initiatives for incorporating 
recommended evidence-based strategies into practice. 
The appendixes provide additional resources, such as detailed information 
on selected topics and sample materials that can be adapted or duplicated 
by clinics and clinicians. A listing of additional sources of information 
(e.g., publications, Web sites) is also included. 
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Health-Care Systems Primer 

The inﬂuence of health-care system administrators, insurers, and purchasers could, in theory, be used to encourage and support the consistent and effective identiﬁcation and treatment of tobacco users. These agents could 
craft and implement supportive systems, policies, and environmental prompts that 
render tobacco-use treatment an integral part of the health-care system. Indeed, 
research clearly shows that systems-level change can reduce smoking prevalence 
among enrollees of managed health-care plans (Fiore et al., 2000). 
Treating Tobacco Use and Dependence: 
Clinical Practice Guideline 
In a very simpliﬁed view of the health-care system, there are four major 
components: 
■	 Service delivery (inpatient through hospitals and outpatient/ambulatory 
through clinics or providers’ ofﬁces). 
■	 Administration (via health plans or insurers). 
■	 Finance (through commercial and governmental purchasers). 
■	 Quality care (compliance with quality-assurance standards). 
It is useful to understand the basic organizational forms and concerns of 
ambulatory care, hospitals, health plans, and purchasers before approaching 
these organizations with a tobacco-use treatment agenda. This knowledge 
can increase conﬁdence, help identify opportunities, and demonstrate 
a commitment to understanding potential partners’ capabilities and 
constraints. 
Ambulatory Care 
Providers’ ofﬁces are the main point of contact between tobacco users and 
the health-care system because 70% of smokers visit a clinician each year 
(Tomar et al., 1996). (In this document we use the term clinic to describe all 
sites where patients receive outpatient ambulatory care. We use the term 
clinician to refer to all health-care providers, including physicians; nurses; 
physical, occupational, and respiratory therapists; pharmacists; etc.) Clinics 
range in size and focus, from solo practices to small- and large-group 
practices or medical groups, and from specialty to multispecialty clinics 
and outpatient surgery centers. 
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Increasingly, clinics and practices are joining together to form larger medical 
groups. An organization that includes services like home health care or 
physical therapy as well as clinic and hospital services is referred to as 
an integrated delivery system. In some communities these large systems 
also are major employers that play a signiﬁcant role in the local business 
community. 
While autonomy has always been important to clinicians, aggregation 
provides certain advantages, such as greater leverage when negotiating 
contracts with health plans, joint marketing opportunities, resource sharing, 
and ﬁnancial stability for smaller practices. 
Tobacco-use treatment efforts have traditionally targeted primary care 
clinics, but in recent years these efforts have been expanded to reach 
specialty clinics and inpatient settings. 
Government as Health-Care Clinician 
Government-funded and -operated clinics are an important part of the 
health-care safety net. These include county health departments, clinics, 
and hospitals; Women, Infants, and Children (WIC) clinics; Federally 
Qualiﬁed Health Centers (FQHC); the Veterans’ Administration hospitals 
and clinics; and the Department of Defense and Indian Health Service 
community health clinics and centers. In each of these settings, clinicians 
should be encouraged to deliver treatments that are recommended in the 
Public Health Service (PHS) guidelines. Strategies described in the Guide 
to Community Preventive Services should be supported as systems-change 
initiatives (Hopkins et al., 2001). These clinical settings provide an excellent 
opportunity for reaching low-income populations, which have the highest 
smoking rates. 
Challenges Clinics Face 
Public health professionals should be aware of typical concerns affecting 
the energy, interest, and capacity of clinicians in integrating tobacco-use 
treatment strategies into regular practice. 
Change pressures 
In one study of clinical quality improvement in the mid-1990s, researchers 
noted that during a single year, 64% of 44 participating clinics underwent 
a change in ownership or afﬁliation, 77% experienced a major change in 
internal systems, and almost every clinic experienced personnel turnover 
among managers or key clinicians (Magnan et al., 1997). While clinicians 
may value tobacco-use treatment, such turmoil makes it difﬁcult for clinic 
staff and management to focus on new or non-acute issues. 
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Economic pressures 
Health plan or Medicaid reimbursement may be absent or insufﬁcient to 
adequately reimburse providers for services, which can be a disincentive 
for providing “free service.” This adds to time pressures. Health plan cost 
increases have also added economic pressures. 
Clinician time and stress 
A standard 12- to 15-minute ofﬁce visit actually involves about 10 minutes 
of clinician–patient time. The priority for clinicians is to address patient 
concerns as well as potential acute medical needs during this limited time. 
Clinicians are also under pressure to provide patients with a wide range 
of preventive services and comprehensive care for an increasing number 
of chronic medical conditions. So although clinicians generally want their 
patients to stop smoking, they often believe that they do not have the time 
or expertise to address this issue, or they may not consider tobacco-use 
treatment to be a top priority for the time-limited ofﬁce visit. Patients 
rarely make an appointment speciﬁcally for or request assistance with 
quitting smoking. To address the time constraints, referrals can be made 
to telephone counseling/quitlines, which are present in almost every state, 
or to community-based cessation programs to provide ongoing counseling 
and support for quitting. 
Reimbursement 
Although there are effective evidence-based treatments for smokers, 
clinicians usually are not reimbursed for providing these services. The 
lack of reimbursement, while not the main driver of care delivery, may 
negatively affect treatment patterns (Fiore et al., 2000; Manley et al., 2003). 
Payment methods are shifting back 
to fee-for-service arrangements and 
away from capitation. Under fee-
for-service reimbursement systems, 
the incentives point more toward 
procedures and tests and away from 
services that are harder to quantify 
(and bill), such as intensive tobacco-
use treatment counseling (Fiore et al., 
2000; Manley et al., 2003). 
Stafﬁng 
Clinic staffs vary widely in their 
number, capacity, skill level, and 
expertise. However, clinics can 
A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment | 9 
2002 HEDIS 
measures related 
to smoking report 
three rates: 
■	 Advising smokers 
to quit (as in 
prior years). 
■	 Offer of smoking 
cessation 
medications. 
■	 Offer of strategies 
for support and 
assistance with 
quitting. 
improve their tobacco-cessation efforts for patients who use tobacco. 
The important factors in successfully implementing interventions are 
(a) any staff member can be involved, (b) assigning speciﬁc roles and 
tasks makes it happen, and (c) making referrals to state quitlines may 
reduce the counseling burden. 
Quality of care 
Clinicians in all settings are concerned with delivering high-quality care, 
and many employ quality improvement (QI) techniques to plan, implement, 
measure, and improve care strategies. Many clinics emphasize the use of 
evidence-based care guidelines, which are readily available for tobacco-use 
treatment (Fiore et al., 2000). This may be a challenge if the PHS guideline 
was not used to develop the QI measures or if the measures are not being 
monitored. 
Clinicians who have limited access to information technology may use a 
paper-based system, which limits system-wide data collection and affects 
their ability to measure quality improvement. A number of health systems 
have or are moving toward electronic medical records, which will enable 
them to collect more comprehensive information. 
About 90% of the nation’s health plans use the Health Employer Data 
Information Set (HEDIS) measures to assess their performance. HEDIS 
is sponsored, supported, and maintained by the National Committee for 
Quality Assurance (NCQA), a nonproﬁt organization that assesses and 
measures the quality of health plans. NCQA assesses health plans in 
three ways: 
1. Accreditation through an on-site review of key clinical and 
administrative processes. 
2. Use of HEDIS to measure performance in key areas. 
3. A comprehensive satisfaction survey of plan members. 
Prior to 2002, the HEDIS measure related to tobacco use was called 
“Advising Smokers to Quit” and one rate was reported: the percentage 
of health plan members 18 and older who were continuously enrolled 
during the measurement year, were either current smokers or recent 
quitters, were seen by a managed care organization (MCO) practitioner 
during the measurement year, and received advice to quit smoking. 
In 2002, rates were added for discussion or recommendation of tobacco-use 
treatment medications and support or assistance with quitting. The measure 
was renamed “Medical Assistance with Smoking Cessation” (NCQA, 2003a). 
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HEDIS data are collected using a mailed patient-satisfaction survey 
developed by the Consumer Assessment of Health Plans (CAHPS®), a 
5-year project funded by the Agency for Healthcare Research and Quality 
(AHRQ) to help consumers identify the best health plans and services to 
meet their needs (AHRQ, 1998). Information on tobacco use is collected as 
part of a general patient-satisfaction survey of randomly selected health 
plan members. Respondents who report recent smoking and a visit to the 
doctor during the previous year are asked whether their clinician advised 
them to quit, offered medication, or provided assistance with quitting 
during the visit. The most recent survey found the mean for medication 
and assistance to be 35%. Plans in the top 90th percentile were providing 
medications and assistance in the 46% range. 
HEDIS data can be used as a rough estimate of smoking prevalence 
in the health plan population. If a health plan mails 1,500 surveys and 
receives 500 returned surveys, and 100 respondents report being smokers, 
it is reasonable to estimate a 20% smoking prevalence rate among plan 
members. However, because smokers are somewhat less likely to respond 
to surveys, the estimate may be somewhat low (Solberg et al., 2003). These 
data can be compared to state prevalence data to validate the estimate. 
Hospitals 
Like clinics, hospitals can operate as independent entities, as part of a 
system, or as part of a network of hospitals. Also like clinics, the trend 
is toward greater integration and afﬁliation with other parts of the health-
care system. 
There are four major types of hospitals: 
■	 General medical and surgical. 
■	 Specialty (specialty hospitals treat a speciﬁc population like children 
or mothers or specialize in the treatment of certain conditions, such as 
heart disease). 
■	 Psychiatric. 
■	 Rehabilitation and chronic disease. 
Each of the major types of hospitals also can be characterized by their 
tax status (for-proﬁt or not-for-proﬁt), afﬁliation with a health professional 
training school or teaching hospital, and the range of services provided 
(Paciﬁc Business Group on Health, 2004). Teaching hospitals and those 
receiving public funding may be more willing to initiate tobacco-control 
programming (Conroy et al., 2005). 
Some hospitals 
are interested in 
providing tobacco-
use treatment 
services and 
education to the 
community. Others 
may engage in 
tobacco-control 
activities, such as 
clean indoor air 
campaigns. Still 
others may be 
interested in doing 
all of the above. 
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JCAHO’s tobacco-
related measures: 
■	 Acute myocardial 
infarction. 
■	 Congestive 
heart failure. 
■	 Pneumonia 
(formerly 
community-
acquired 
pneumonia). 
The measure 
assesses the 
percentage of 
smokers with these 
conditions who are 
given tobacco-use 
treatment advice 
and treatment 
during their 
hospital stay. 
Hospitalized patients may be particularly motivated to try to quit smoking 
for two reasons. First, the illness resulting in hospitalization may have been 
caused or exacerbated by tobacco use, highlighting the patient’s personal 
vulnerability to the health risks of smoking. Second, every hospital in the 
United States must now be smoke-free to gain accreditation by the Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO). As 
a result, every hospitalized smoker is temporarily housed in a smoke-free 
environment. For both these reasons, clinicians should use hospitalization 
as an opportunity to promote tobacco-use treatment among their patients 
who smoke (Fiore et al., 2000; Cochrane Collaboration, 2005). 
Challenges Hospitals Face 
Like clinics, hospitals are faced with complex and competing pressures 
that can inﬂuence their tobacco-use treatment activities. 
Length of stay 
The average length of stay (i.e., number of days that patients remain in the 
hospital) is growing shorter, and the inpatient population is increasingly 
acutely ill (Hall and DeFrances, 2003). These acutely ill patients require 
complex medical care that affords little time or attention for chronic issues, 
including tobacco-use treatment. The new JCAHO requirements are 
beginning to change this picture (see below). 
Stafﬁng 
Many hospitals experience shortages of skilled nursing staff. Professional 
nurses have less time to spend with individual patients who are increasingly 
acutely ill. 
Accreditation 
Hospitals are accredited by JCAHO, which evaluates the quality and safety 
of care for more than 16,000 health-care organizations. To maintain and 
earn accreditation, organizations must have an extensive on-site review at 
least once every 3 years. Tobacco-related measures are included in three of 
JCAHO’s core measures (see left sidebar) (JCAHO, 2003). Hospital staff may 
be more interested in tobacco-use treatment activities for selected patients 
who are covered by the standards. 
Hospitals are also assessed by Quality Improvement Organizations (QIOs) 
that are under contract with the federal government to assess and improve 
the hospital-based care provided to Medicare patients. Quality measures 
are used to identify areas with the greatest potential for improvement. Like 
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JCAHO, QIOs use three measures that pertain to tobacco. These measures 
assess the percentage of smokers (patients who have smoked in the year 
prior to hospital admission) with acute myocardial infarction, congestive 
heart failure, and pneumonia who are provided tobacco-use treatment 
advice and offered counseling and medication, if appropriate (Medicare 
Quality Improvement Clearinghouse, 2005). 
Quality of care 
Hospitals are concerned with quality of care and patient safety—both 
of which can be affected by the patient’s tobacco use. To improve both 
elements, evidence-based guidelines exist for the treatment of tobacco 
use among hospitalized smokers (Fiore et al., 2000). 
Health Plans 
Health plans provide and manage administrative services for the health-
care system. For the purposes of this document, a health plan is the 
organization that offers a variety of health insurance products and may 
take responsibility for coordinating and improving the delivery of care. 
The insurance product is the insurance policy or beneﬁt coverage offered 
to a group or individual by the health plan. 
Health plans vary substantially in their approaches to managing health care, 
the types of insurance products offered, and the populations served. Today 
it is common for health plans to offer both indemnity and managed care 
plans, to serve both fully insured and self-insured customers, and to serve 
both government and commercial purchasers. 
To work effectively with health plans of all types, it is not necessary for 
public health professionals to understand the numerous variations. Instead, 
they can focus on the major points outlined below. 
Assignment of Risk 
The concept of ﬁnancial risk is central to understanding insurance. The 
entity that bears the risk for a population is ﬁnancially responsible for 
paying the cost of health-care claims incurred by that population. 
A fully funded or fully insured product is one under which the health 
plan bears the ﬁnancial responsibility (American’s Health Insurance Plans, 
2003). Most small employers are fully insured. Health plans typically offer 
a deﬁned set of beneﬁts, sometimes with different options and potential 
“a la carte” additions, for these subscribers. 
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Health plans have 
greater control 
over tobacco-
use treatment 
medication and 
counseling beneﬁts 
for their fully 
insured members. 
State and federal 
legislation 
mandating 
standards and 
beneﬁts for fully 
insured plans and 
members often do 
not apply to self-
insured plans. 
A self-funded or self-insured product is one under which an employer or 
other group sponsor, rather than the health plan, is ﬁnancially responsible 
for paying expenses, including claims (America’s Health Insurance Plans, 
2003). Large employers (over 500 employees) are frequently self-insured, 
and they select a beneﬁts package for their employees. Self-insured 
companies usually contract with a health plan or independent company 
(known as third-party administrators) to process claims and handle other 
administrative needs. 
If a health department wants to increase the percentage of people with 
insurance coverage for effective tobacco-use treatment medications and 
counseling, they must work with health plans, large self-insured employers, 
and broader government agencies (e.g., county, city) to structure beneﬁts 
appropriate for supporting cessation (see Appendix G). 
Reimbursement System 
Under a fee-for-service payment system, a health plan (indemnity) 
reimburses the member or pays the health-care clinician directly for each 
covered medical expense after the expense has been incurred (America’s 
Health Insurance Plans, 2003). By contrast, under capitation (managed 
care), the clinician is paid a ﬁxed amount for each patient served, regardless 
of the actual number or nature of services provided. 
Types of Health Plans 
Health plans can be categorized by whether they offer indemnity or 
managed care insurance products to their customers. It is common for 
health plans to offer multiple insurance products, and the differences 
between the various products are becoming less clear over time, as more 
hybrid options become available. 
Indemnity 
Sometimes called “traditional” health insurance policies, indemnity 
products provide coverage for health-care services on a fee-for-service 
basis. These policies typically include a deductible, which is an amount 
that a member must pay out of pocket each year. Most also charge a 
co-payment for covered services and have maximum overall beneﬁt 
limitation or limitations on speciﬁc services. 
Unlike managed care plans, members of an indemnity plan can generally 
receive care from any licensed health-care clinician at any location and 
time they choose. But these broader choices are typically accompanied by 
increased out-of-pocket expenses and more administrative procedures for 
the members. 
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Managed care 
Managed care plans and products typically involve a network of clinicians 
from whom a subscriber can receive care, some type of limitation on beneﬁts 
to subscribers who choose to use clinicians outside of that network, and 
some type of authorization or approval system (Essentials of Managed 
Care). There are three major types of managed care plans: Preferred 
Provider Organizations (PPOs); Point of Service (POS) plans; and 
Health Maintenance Organizations (HMOs). 
PPOs are companies that arrange for lower fees with a network of health-
care clinicians, giving policyholders a ﬁnancial incentive to seek care within 
that network. Members pay higher rates for services obtained from a 
clinician who is not part of their network. 
POS refers to a type of coverage that allows plan members to choose a 
clinician within the plan’s network or one outside the network at the time 
that the care is needed. Choosing an out-of-network clinician usually 
involves higher costs. 
HMOs are the oldest form of managed care (AHRQ, 2002; Health Insurance 
Association of America, 2002). They offer members a range of health 
beneﬁts, including preventive care, for a set monthly fee. The health plan 
pays for services for members in advance, rather than as they are provided 
(AHRQ, 2002). There are many kinds of HMOs, distinguished in large part 
by their different relationships 
with clinicians. 
Public health professionals 
have tended to assume that 
managed care organizations, 
especially HMOs, are more 
likely to be receptive to efforts 
to decrease tobacco use. The 
theory is that because they 
use capitation, HMOs have 
a clearer incentive to control 
costs and provide preventive 
care. This has proven to be 
partially true, with surveys 
of insurers ﬁnding that 
HMOs are more likely than 
other insurance plans to 
cover tobacco-use treatment 
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counseling and medication and to systematically identify tobacco users 
(Rigotti et al., 2002). However, some traditional indemnity plans have 
proven to be very interested in and effective at addressing tobacco-use 
treatment, while some HMOs have virtually ignored it (Manley et al., 2003). 
Indemnity plans may actually be able to document savings from decreases 
in utilization that result from tobacco-use treatment more easily than HMOs. 
Challenges Health Plans Face 
Health plans face several challenges that may negatively or positively 
affect their capacity and interest in working on tobacco-use treatment. 
Public health professionals will be more effective in working with health 
plans on tobacco control if they understand these pressures. 
Rising health-care costs 
Nationally, private health insurance premiums increased 13.9% in 2003 
and 11.2% in 2002 (Kaiser Family Foundation, 2004). Health plans are 
increasingly being challenged by purchasers to control rising costs result-
ing from expensive new drugs and medical technologies. Tobacco-use 
treatment is cost-effective; although it results in higher short-term expenses, 
it will yield long-term beneﬁts in lower overall costs (Winer, 1994). (See 
Appendix H for a detailed discussion of reimbursement issues.) 
Competition and purchaser demand 
In many markets, health plans are concerned for their economic survival. 
In response to rising health-care costs and purchaser demand, low-cost 
insurance options are being offered by new companies that are entering 
the market as well as by existing companies. These options may cover 
only major medical expenses, not routine clinic visits. They are attractive 
to employers who are faced with annual premium increases that are often 
in the double digits, but these low-cost plans may also result in fewer 
reimbursed opportunities for tobacco treatment. New products such as 
“medical savings accounts” and “consumer-directed health policies” are 
also emerging. Their effect on tobacco-use treatment is still unknown. 
Quality of care and accountability 
Many health plans see achievement of accredited status from the NCQA 
as a necessity for attracting employer/purchaser business in a competitive 
environment. In 2002, the focus of the HEDIS tobacco measures expanded 
from providing documentation of smoking status and giving advice to quit 
to providing medications and support and assistance with quitting. JCAHO 
has implemented an additional measure for hospitals that assesses the 
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provision of tobacco-dependence treatment for heart disease and 
pneumonia. Establishing goals and monitoring service provision within 
health plans and hospitals is important for creating change over time. 
Purchasers of Insurance 
Purchasers are important and often-overlooked players in the health-care 
system. Purchasers include companies, government agencies, or other 
consortia that purchase health-care beneﬁts for a group of individuals 
(U.S. Department of Health and Human Services, 2005). 
As the major purchasers of health insurance plans for the U.S. workforce, 
employers determine whether their employees and the employees’ 
dependents have access to tobacco-use treatment beneﬁts. More than 
60% of Americans receive their health coverage through their employer 
(Partnership for Prevention, 2002). Of employers who provide coverage, 
currently only 24% provide any coverage for tobacco-use treatment and 
only 5% provide coverage for both medication and counseling (Partnership 
for Prevention, 2002). 
Government Purchasers 
Local, state, and federal governments ﬁnance health insurance coverage 
for groups such as seniors (Medicare), the poor and disabled (Medicaid), 
veterans (Veterans Administration or VA), government employees, and 
others. Government purchasers pay for plans that cover 25% of all insured 
people (Mills and Bhandari, 2003). Public health professionals can make 
substantial gains in reducing out-of-pocket costs for tobacco-cessation 
treatments by focusing on changing the purchasing behavior of state 
governments and working with larger employers or business–health 
coalitions. State and county ofﬁcials should ensure that tobacco-dependence 
treatment is covered by the insurance they provide. The provision of 
comprehensive coverage is a ﬁrst step in reducing tobacco dependence 
among government employees at the state and county levels. If prevalence 
is high in this group, initiating coverage, along with creating tobacco-free 
campuses and ties to the state quitline, will help reduce tobacco-use rates 
(Cochrane Collaboration, 2005). 
In 2000, approximately 32 million people in the United States received 
health insurance coverage through a state Medicaid program (Kaiser Family 
Foundation, 2000). Of these, about 11.5 million—or 36%—were smokers 
(CDC, 2004a), making smoking prevalence in this population much 
Medicare currently 
covers tobacco-
dependence 
counseling and 
prescription 
medications. 
Over-the-counter 
medications are 
not covered at 
this time. 
Counseling: 
■	 Medicare will 
cover two 
cessation 
attempts per 
year. 
■	 Each attempt 
may include a 
maximum of four 
intermediate or 
intensive sessions. 
■	 Total annual 
beneﬁts cover up 
to eight counseling 
sessions in a 
12-month period. 
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Medicare 
reimbursement 
for eligible 
providers: 
■	 Physicians/ 
dentists. 
■	 Physician 
assistants. 
■	 Nurse 
practitioners. 
■	 Clinical nurse 
specialists. 
■	 Nurse midwives. 
■	 Other Medicare-
recognized 
practitioners. 
Larger companies, 
particularly those 
with dedicated 
employee health 
staff and lower 
employee turnover 
rates, may be 
more interested 
in and capable of 
offering tobacco-
use treatment 
interventions. 
higher than that in the general population. In 2002, a total of 36 Medicaid 
programs (71%) reported offering coverage for at least one form of tobacco-
dependence treatment for all Medicaid recipients. Of these, 12 states offered 
some form of tobacco-use treatment counseling services, and 36 covered 
pharmacotherapy treatments (CDC, 2004a). One of the national health 
objectives for 2010 is for all 50 states and the District of Columbia to provide 
Medicaid coverage for nicotine-dependence treatments. 
In 2003, only three states’ Medicaid beneﬁts packages included compre-
hensive coverage for tobacco-use treatment medications and counseling 
(Halpin, Bellows, and McMenamin, 2006). Public health professionals 
should become aware of the current level of coverage and programming 
provided through state-administered programs like Medicaid and work 
to move toward the provision of comprehensive coverage where it does 
not exist. 
Extending tobacco-treatment insurance coverage to all federally 
covered lives would ensure that a large proportion of the U.S. population 
(approximately 100 million people and their families) has effective and 
comprehensive insurance coverage for the treatment of tobacco dependence. 
Covered lives would include Medicaid and Medicare beneﬁciaries, 
Department of Defense beneﬁciaries, persons covered by the Department 
of Veterans Affairs, federal employees enrolled in the Federal Employee 
Health Beneﬁts Program, and individuals receiving health care at federally 
funded clinics (Fiore et al., 2004). 
To encourage implementation of more comprehensive Medicaid coverage, 
Medicaid purchasing speciﬁcations were developed by CDC’s Ofﬁce on 
Smoking and Health in conjunction with George Washington University. 
These provide contract language based on the PHS guideline and the 
Community Guide to assist states in purchasing coverage for tobacco-
dependence treatment (George Washington University, 2002; Hopkins 
et al., 2001). 
Commercial Purchasers 
Both large and small employer groups purchase health-care beneﬁts. As 
discussed earlier, many large employers are self-insured and design their 
own beneﬁts and manage their own ﬁnancial risk, while smaller employer 
groups are typically fully insured. Some groups engage brokers who act 
as agents licensed by the state to sell and service contracts for multiple 
health plans. 
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Purchasing Groups 
These groups usually offer affordable group health coverage to businesses 
with fewer than 100 employees. They are also known as health insurance 
purchasing co-ops, employer-purchasing coalitions, and purchasing 
coalitions. Most are locally or regionally based and funded through 
voluntary agencies, grants, and membership dues (America’s Health 
Insurance Plans, 2003). Public health professionals can be more efﬁcient 
by educating the leaders of purchasing groups on tobacco-use treatment 
issues than by working one on one with small employers. 
Union Trust Funds 
Union trust funds (sometimes referred to as Taft-Hartley funds after the 
1947 Labor Management Relations Act, which governs relations between 
employers and labor unions) may be used to provide health insurance to 
union members (American Federation of State, County, and Municipal 
Employees, 2000; Barbeau et al., 2001). Union trust funds typically insure 
members for their entire working career, even when a member changes 
employers. Therefore, the union may have a longer-term perspective in 
considering their return on investment for tobacco-use treatment. 
Challenges Purchasers Face 
Cost 
As described in Section 3, health-
care costs are rapidly increasing. 
Cost is a leading barrier to providing 
comprehensive health insurance 
coverage (Partnership for Prevention, 
2002); however, concerns about cost 
due to tobacco-related disease may also 
help convince employers to provide 
tobacco-use treatment coverage. 
Employers and insurers sometimes 
neglect to assess the extent of the cost 
of tobacco-related diseases. It may be 
valuable to assist them in determining 
these costs in relation to the cost of 
expanded beneﬁts (Paciﬁc Center on 
Health and Tobacco, 2002 ). 
Brokers can be 
a key audience 
for public health 
professionals 
seeking to 
inﬂuence 
purchasing 
decisions and 
inﬂuence the 
products offered 
by health plans 
and businesses 
(Paciﬁc Center 
on Health and 
Tobacco, 2003a). 
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Quality 
A focus group study of employers revealed multiple factors inﬂuencing 
purchasers’ health plan selection. These include cost, quality and breadth 
of beneﬁts, reputation, and level of customer service (Partnership for 
Prevention, 2002). 
Productivity 
Employers/purchasers are concerned about their workforce’s health and 
productivity. Employers with less employee turnover may have greater 
interest in the longer-term payoff that investing in reducing tobacco use 
provides. See Issues Brief in Appendix H. 
Insurance mandates 
Not all insured individuals are affected by state health mandates because 
Medicare and self-insured employer health plans may not be subject to 
state regulation. Even so, in 1997 health mandates inﬂuenced coverage for 
more than 60 million insured people. From the employer and health plan 
perspective, there are strong arguments both in favor of and in opposition 
to health mandates. Some mandates may improve worker productivity and 
protect small businesses, but at the same time mandates can increase costs to 
health plans, consumers, and employers (Partnership for Prevention, 2002). 
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Effective Tobacco-Control Interventions 
and the Health-Care System’s Role 
Over the years the harmful effects of smoking have been well documented. Although great progress has been made, a challenging struggle remains. We all need to strengthen our efforts to prevent young people from ever 
starting to smoke and to encourage smokers of all ages to quit (U.S. Department of 
Health and Human Services, 2004). 
Richard Carmona, M.D., M.P.H., F.A.C.S., U.S. Surgeon General 
The Health Consequences of Smoking: A Report of the 
Surgeon General, Executive Summary 
The scientiﬁc literature shows broad agreement that tobacco-use treat-
ment interventions are effective as well as cost-effective (Fiore et al., 
2000; Warner et al., 1996; Cofﬁeld et al., 2001; Maciosek et al. 2006). Tobacco-
use treatment interventions that have been proven to be effective can be 
categorized in a number of different ways. In this section, we describe four 
categories of effective interventions: 
■	 Individual treatment, including behavioral counseling and 
pharmacotherapy. 
■	 Health-systems changes that support clinician intervention. 
■	 Reducing patient out-of-pocket costs for tobacco-use treatment. 
■	 Community policy changes and mass media campaigns. 
We also present speciﬁc tobacco-use treatment objectives for each of these 
categories, ways to achieve those objectives (strategies), and examples 
of tactics for implementation (service delivery, coordinated initiatives, 
administration) and speciﬁc roles that professionals from each component 
of public and private health-care systems (health plan administrators, 
purchasers, etc.) can play in achieving the tobacco-use treatment objectives. 
Individual Treatment 
The U.S. Public Health Service (PHS) clinical practice guideline, Treating 
Tobacco Use and Dependence, found counseling and medication to be safe 
and effective in increasing a person’s chances of quitting smoking 
(Fiore et al., 2000). Studies show that tobacco-use treatment counseling 
and pharmacotherapy treatment each double quit rates (Cochrane 
Collaboration, 2005; Fiore et al., 2000). 
Objective: 
Increase the delivery 
of effective tobacco-
use treatment 
counseling and 
FDA-approved 
medications. 
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Case Study #1 
QuitWorks: Linking Hospitals in 
Massachusetts to the Quitline 
Objective: 
Illustrate how public health ofﬁcials can collaborate with health plan 
managers to promote institutional adoption of the PHS guidelines and 
use of the state’s Quitline. 
In 2002, the Massachusetts Department of Public Health, in collaboration with all 
major health plans, launched QuitWorks, a cessation service for all Massachusetts 
residents operated by the Try to STOP Tobacco Resources Center (Quitline) in 
Boston. QuitWorks is a program for use by any provider with any patient regardless 
of health insurance status. 
At the heart of QuitWorks is a simple fax enrollment form. Upon receipt (by fax) 
of a completed form, the quitline calls the patient and offers free conﬁdential 
tobacco-treatment counseling by telephone and describes the full range of the 
state’s evidence-based treatment programs. Referring providers receive a fax-back 
status report on each patient enrolled and, at 6 months, an outcome report on the 
patient’s quit attempts and quit status. 
The initiative was initially introduced to more than 4,000 physician practices 
statewide. In 2003, hospitals in Massachusetts began expressing a need for 
the program, in part to meet Joint Commission on Accreditation of Health 
Organizations (JCAHO) core measures. In response, QuitWorks for Hospitals 
was launched, creating a continuum of effective treatment interventions from 
admission to post-discharge or post-outpatient visit. More than 22 of 62 hospitals 
in Massachusetts have adopted the QuitWorks program or are in the process of 
doing so. 
More than 20 hospitals have implemented the PHS guidelines and many have 
purchased training for their staff. Hundreds of clinicians have received training in 
QuitWorks or brief interventions. Some hospitals have added in-house tobacco- 
treatment specialists and have sent them to the University of Massachusetts Medical 
School (UMMS) certiﬁcation training or participated in obtaining online training 
in basic cessation-treatment skills. Several hospitals have initiated a system-wide 
program to screen for tobacco-use status, including in the emergency room. 
It takes a dedicated team of hospital executives and clinic managers from 3 to 
6 months to integrate QuitWorks into patient care. A QuitWorks Guide for Hospitals 
and Health Centers directs the hospital team to consider the systems-level changes 
needed and to create and sustain tobacco-free campuses and provide counseling 
and nicotine replacement therapy (NRT) for patients and staff members. 
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Case Study #1, continued 
QuitWorks for Hospitals has had important partners: Massachusetts General 
Hospital, Tobacco Research and Treatment Center, and Tufts New England Medical 
Center helped design QuitWorks for Hospitals, while Massachusetts’s health plans 
and the Massachusetts Peer Review Organization contributed training and ﬁnancial 
support. Opening a new and important arena for QuitWorks, BlueCross/BlueShield 
of Massachusetts recently awarded a grant to the UMMS to adapt QuitWorks for 
community health centers serving cultural and linguistic minorities. 
Lessons Learned: 
■	 Effective relationships can be developed between quitlines and hospitals. 
■	 Hospitals and health-care systems may be willing to pay for staff training in 
using the system and receiving data feedback from the quitline. 
■	 Quitlines cannot implement a system of this magnitude alone. Public health 
department involvement is needed in convening all partners. 
■	 Endorsement by all major health plans, and any funding they provide, has 
helped QuitWorks achieve legitimacy, credibility, effectiveness, and a sense of 
permanence. 
■	 Follow-up and reporting of client outcomes also adds to program credibility. 
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Recommendations 
related to 
pregnancy: 
■ Although quitting in 
the ﬁrst trimester is 
preferred, quitting at 
any time during the 
pregnancy will yield 
beneﬁts. Clinicians 
should offer effective 
interventions at the 
ﬁrst prenatal visit 
and throughout the 
pregnancy. 
■ Pregnant smokers 
should be offered 
extended or 
augmented psycho-
social interventions 
that exceed minimal 
advice to quit. 
■ Many pregnant 
women are reluctant 
to admit they smoke. 
Careful and supportive 
questioning may be 
needed. 
■ Pharmacotherapy 
should be considered 
when a pregnant 
woman is otherwise 
unable to quit. In such 
cases, the clinician 
and the pregnant 
smoker must contrast 
the risks and beneﬁts 
of the medication 
against the risk 
of continued 
tobacco use. 
(Fiore et al., 2000) 
Counseling can be provided in a number of different venues, including 
face to face (individual or in a group) or by telephone. The effectiveness of 
counseling services increases as their intensity (i.e., the number and length 
of sessions) increases. Counseling can be provided effectively by many 
different kinds of health-care clinicians. Even brief counseling for tobacco 
cessation (i.e., 1–3 minutes) can be beneﬁcial (Fiore et al., 2000). 
The U.S. Food and Drug Administration (FDA) has approved six medi-
cations to help smokers quit (see medications chart in Appendix G). 
Five are nicotine replacement therapies that relieve withdrawal 
symptoms. These include nicotine gum, patches, inhalers, nasal sprays, 
and lozenges (CDC, 2004a). The sixth medication, which is not a nicotine 
replacement product, is the oral medication bupropion. Bupropion is an 
antidepressant that is thought to reduce the urge to smoke by affecting 
the same chemical messengers in the brain that are affected by nicotine 
(Fiore et al., 2000). Except in the presence of identiﬁed contraindications, 
all patients attempting to quit should be encouraged to use FDA-approved 
pharmacotherapies. Long-term tobacco-use treatment pharmacotherapy 
should be considered as a strategy to reduce the likelihood of relapse (Fiore 
et al., 2000). Most people use these medications for a period of 4–6 weeks. 
Speciﬁc Populations 
Although smoking prevalence is higher among men than women, the PHS 
guideline indicates that the same tobacco-use treatments are effective for 
both sexes, with the exception of pregnant women (Fiore et al., 2000). The 
guideline outlines speciﬁc recommendations for pregnant women because 
of the serious risk of smoking to these women and their unborn children 
(see sidebar). 
There are well-documented differences between racial and ethnic groups 
in the United States in terms of smoking prevalence, smoking patterns, 
and quitting behaviors (CDC, 2005b). The PHS guideline concludes that 
treatments identiﬁed in the scientiﬁc literature as safe and effective should 
be offered to patients across all racial and ethnic groups and states that it is 
essential for the treatments to be conveyed in a language that is understood 
by the smoker. Using culturally appropriate models and examples may 
also increase the smoker’s acceptance of treatment. Clinicians also should 
remain sensitive to individual differences and health beliefs that may affect 
treatment acceptance and success (Fiore et al., 2000). 
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Clinicians 
Strategies 
A number of strategies have been shown to increase clinicians’ delivery of 
effective tobacco-use treatment counseling and appropriate medication. 
These include 
■	 Using clinician prompts and reminder systems (Hopkins et al., 2001). 
■	 Providing education, resources, and feedback to promote clinician 
intervention in conjunction with provider reminder systems 
(Hopkins et al., 2001; Fiore et al., 2000). 
■	 Dedicating staff to provide tobacco-dependence treatment and 
assessing the delivery of this treatment in staff performance evaluations 
(Fiore et al., 2000). 
■	 Providing telephone counseling support as an adjunct to other 
interventions by using health plan or state-based quitlines 
(Hopkins et al., 2001; Cochrane Collaboration, 2005). 
■	 Coding for tobacco dependence (305.1) in both inpatient and out-
patient settings (Fiore et al., 2000). 
Tactics 
There are many ways in which a variety of people in the health-care system 
can promote access to effective tobacco-dependence treatment. Examples 
of effective actions for clinicians, hospital staff members, administrators, 
insurance purchasers, and public health professionals are presented below. 
Service delivery (clinicians) 
■	 Provide brief counseling to 
patients who use tobacco or 
have recently quit and refer 
patients to quitlines and other 
available cessation resources 
(Revell, 2005). 
■	 Offer FDA-approved ﬁrst-
line tobacco-dependence 
pharmacotherapies to all 
tobacco users who are trying 
to quit (Fiore et al., 2000). 
■	 Provide intensive counseling 
or refer to telephone quitlines 
(Fiore et al., 2000; Revell, 2005; 
Cochrane Collaboration, 2005). 
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■	 Recommend pharmacotherapy if appropriate for pregnant smokers 
(Fiore et al., 2000). 
■	 If hospital-based, provide inpatient tobacco-dependence consultation 
services and medication and ensure that discharged patients are referred 
to a quitline or other services for ongoing counseling and follow-up 
(Solberg et al., 2004). 
Administration (insurance providers) 
■	 Provide annual coverage for at least two courses of all ﬁrst-line FDA-
approved pharmacotherapies (including over-the-counter medications) 
and two courses of counseling (George Washington University, 2002). 
■	 Collaborate with public health professionals in establishing quitlines as 
an adjunct to treatment services. 
■	 Ensure access to comprehensive cessation coverage beneﬁts and monitor 
beneﬁt utilization. 
■	 Integrate tobacco-use treatment counseling into all case management 
services, including those for pregnancy as well as chronic disease. 
■	 Participate in quitline oversight to ensure quality service and promote 
collaboration between the health plan and the quitline. 
■	 Assess and report on Health Employer Data and Information Set 
(HEDIS) Consumer Assessment of Health Plans (CAHPS) measures for 
the provision of medication and the provision of support and assistance 
in quitting; set targets to improve to 90th percentile rates (National 
Committee for Quality Assurance [NCQA], 2003b). 
■	 Eliminate or minimize co-pays or deductibles for counseling and 
medications. 
■	 Advocate for sustained state quitline funding. 
Health plans/hospitals/quality assurance 
■	 Develop procedures to identify smokers at health plan or at hospital 
admission and refer them to tobacco-use treatment services. 
■	 Expand formularies to include ﬁrst-line FDA-approved tobacco-
dependence pharmacotherapies. 
■	 Encourage clinicians to prescribe ﬁrst-line medications to reduce a 
patient’s nicotine withdrawal symptoms, even if the patient is not 
intending to quit following his or her hospital stay. 
■	 Monitor adherence to JCAHO tobacco-treatment standards and consider 
broadening these to all tobacco users admitted to the hospital. 
■	 Communicate results of tobacco-use treatment interventions to clinicians 
and health-care staff and primary care providers following discharge. 
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■	 At discharge, refer patients who smoke to a quitline or other local 
services for follow-up. 
■	 Include tobacco-use treatment in community wellness programs. 
■	 Promote hospital and clinic policies that support tobacco-use treatment 
and provide for in- and outpatient tobacco-dependence services and 
post-discharge follow-up (Fiore et al., 2000). 
■	 Review HEDIS scores on tobacco measures, set targets, and monitor 
progress. 
Quality promotion (public health) 
■	 Work with quality improvement organizations (QIOs) to support and 
monitor existing tobacco-control standards (e.g., Medicaid standards). 
■	 Ensure that the state quitline represents the needs of the community 
and health-care systems (hospitals, clinics, health plans, etc.). Public 
health professionals could invite a representative of the quitline to talk 
with health-care systems and could offer feedback from the service to a 
business or health plan (Tobacco Technical Assistance Consortium, 2003). 
■	 Act as a neutral convening body for collaborative tobacco-centered 
quality improvement initiatives between state health plans or clinics. 
■	 Consider clinical and health plan quality measures related to tobacco 
use when selecting networks, health insurance products, and health 
plans (George Washington University, 2002; NCQA, 2003a; JCAHO, 
2003). 
■	 Ensure that all public health programs such as Title V (Maternal and 
Child Health Block Grant), Title X (The National Family Planning 
Program), and others address tobacco cessation. 
Public health 
■	 Actively promote tobacco-use treatment interventions to health-care 
employers and health insurers. 
■	 Coordinate with employers to contract with quitlines to provide tobacco-
use treatment counseling for employees. (This strategy would apply 
primarily to larger employers.) 
■	 Fund, promote, or administer a statewide quitline. 
■	 Promote or support tobacco-use treatment services for uninsured and 
underinsured people in public clinics. 
■	 Proactively seek health system participation in quitline promotion and 
referral systems as well as implementing quality improvement efforts to 
ensure that the quitline is meeting health-care system needs. 
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■	 Promote implementation of tobacco-free campuses for health-care 
systems and employers. 
■	 Serve as an advocate for funding (e.g., advocate for monies received 
from a tobacco tax to be dedicated for tobacco-use treatment) (Tobacco 
Technical Assistance Consortium, 2003). 
■	 Encourage health-care systems and employers to provide funding to 
state quitlines or funding for promotional initiatives. 
■	 Promote tobacco-use treatment counseling and medication coverage to 
self-insured groups. 
Health-Care Systems Strategies 
Individual 
Treatment 
Service Delivery 
Administration Quality Assurance 
(Health Plans/ 
Hospitals) 
Quality Promotion 
(Public Health) 
Public Health 
Provide brief counseling 
to patients who smoke 
or have recently quit 
and refer patients to 
quitlines and other 
available resources 
for more intense 
counseling. 
Provide annual 
coverage for at least 
two courses of all ﬁrst-
line FDA-approved 
pharmacotherapies 
(including over-the-
counter medications) 
and two courses of 
counseling. 
Develop procedures 
to identify smokers 
at health plan or at 
hospital admission 
and refer them to 
tobacco-use treatment 
services. 
Work with quality 
improvement 
organizations (QIOs) 
to support and monitor 
existing tobacco control 
standards. 
Actively promote 
tobacco-use treatment 
services to health-care 
employers and health 
insurers. 
Offer FDA-approved 
ﬁrst-line tobacco-
dependence 
pharmacotherapies to 
all tobacco users who 
are trying to quit. 
Collaborate with public 
health professionals in 
establishing quitlines 
as an adjunct to 
treatment services. 
Expand formularies 
to include ﬁrst-
line FDA-approved 
tobacco-dependence 
pharmacotherapies. 
Ensure that the state 
quitline represents 
the needs of the 
community and 
health-care systems 
(hospitals, clinics, 
health plans, etc.). 
Coordinate with 
employers to contract 
with quitlines to 
provide tobacco-use 
treatment counseling 
for employees. 
Provide intensive 
counseling or refer to 
telephone quitlines. 
Ensure access to 
cessation coverage 
beneﬁts and monitor 
beneﬁt utilization. 
Encourage clinicians 
to prescribe ﬁrst-line 
medications to reduce 
a patient’s nicotine 
withdrawal symptoms, 
even if the patient is 
not intending to quit 
following his or her 
hospital stay. 
Act as a neutral 
convening body for 
collaborative tobacco-
centered quality 
improvement initiatives 
between state, health 
plans, or clinics. 
Fund, promote, and/or 
administer a statewide 
quitline. 
Recommend 
pharmacotherapy 
if appropriate for 
pregnant smokers. 
Integrate tobacco-
use treatment 
counseling into all 
case management 
services, including 
those for pregnancy 
as well as chronic 
disease. 
Monitor adherence 
to JCAHO tobacco-
treatment standards 
and consider broaden-
ing these to all tobacco 
users admitted to the 
hospital. 
. 
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Health-Care Systems Strategies, continued 
Individual 
Treatment 
Service Delivery 
Administration Quality Assurance 
(Health Plans/ 
Hospitals) 
Quality Promotion 
(Public Health) 
Public Health 
If hospital-based, 
provide inpatient 
tobacco-dependence 
consultation services 
and medication and 
ensure that discharged 
patients are referred 
to a quitline or other 
services for ongoing 
counseling and 
follow-up. 
Participate in quitline 
oversight to ensure 
quality service and 
promote collaboration 
between the health 
plan and the quitline. 
Communicate results 
of tobacco-use 
treatment interventions 
to clinicians and health-
care staff and primary 
care providers following 
discharge. 
Consider clinical and 
health plan quality 
measures related to 
tobacco use when 
selecting networks, 
health insurance 
products, and 
health plans. 
Promote or support 
tobacco-use treatment 
services for uninsured 
and underinsured 
people in public 
clinics. 
Assess and report on 
Health Employer Data 
and Information Set 
(HEDIS) Consumer 
Assessment of Health 
Plans (CAHPS) measures 
for the provision of 
medication and of 
support and assistance; 
set targets to improve 
to 90th percentile rates. 
At discharge, refer 
patients who smoke to 
a quitline or other local 
services for follow-up. 
Ensure that all public 
health programs such 
as Title V (Maternal 
and Child Health 
Block Grant), Title X 
(The National Family 
Planning Program), and 
others address tobacco 
cessation. 
Proactively seek health 
system participation in 
quitline promotion and 
referral systems as well 
as implementing quality 
improvement efforts to 
assure that the quitline 
is meeting health-care 
systems needs. 
Eliminate or minimize 
co-pays or deductibles 
for counseling and 
medications. 
Include tobacco-
use treatment in 
community wellness 
programs. 
Promote 
implementation of 
tobacco-free campuses 
for health-care systems 
and employers. 
Advocate for quitline 
funding. 
Promote hospital and 
clinic policies that 
support tobacco-use 
treatment and provide 
for in- and outpatient 
tobacco-dependence 
services and post-
discharge follow-up. 
Serve as an advocate 
for funding. 
Review HEDIS and 
JCAHO scores on 
tobacco measures, set 
targets, and monitor 
progress. 
Encourage health-
care systems and 
employers to provide 
funding to state 
quitlines or funding for 
promotional initiatives. 
Promote coverage of 
tobacco-use treatment 
counseling and 
medication coverage 
to self-insured groups. 
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Case Study #2 
Use of Outreach in Tobacco-Control 
Training and Assistance 
Objective: 
To increase understanding of tobacco dependence and the use of effective 
tobacco-dependence treatments through a collaborative outreach program. 
The Wisconsin Department of Health has closely partnered with the Center 
for Tobacco Research and Intervention, University of Wisconsin–Madison 
(UW-CTRI), which focuses on improving the understanding of tobacco 
dependence and increasing the use of effective treatments to help smokers 
quit for good. Partnerships with health-care systems, insurers, and employers 
have increased tobacco-use treatment coverage in the state. 
The CTRI outreach program provides academic detailing to ofﬁce practices. 
Academic detailing* supports providers in implementing effective tobacco-
dependence treatment by providing training to health-care providers, clinics, 
and health-care delivery systems. The six Wisconsin outreach specialists conduct 
on-site trainings with a CME credit option, provide guides and materials, and 
conduct specialized technical assistance for integrating tobacco-dependence 
treatment within each clinic’s unique care-delivery system. The outreach program 
has reached more than 10,000 clinicians in at least 500 different organizations 
through trainings, materials, and consultative services. 
The outreach staff members offer health-care providers direct access to the 
Wisconsin Tobacco Quit Line, a proactive, individualized counseling service that 
has helped approximately 40,000 callers from its inception in 2001 until June 2005. 
The Quit Line and UW-CTRI recently began the “Fax to Quit” program, which has 
increased the number of clients served by the quitline by faxing a referral to the 
quitline and having the quitline make a proactive call to the client. Health-care 
providers generate a steady stream of referrals to the Quit Line—approximately 
500 each month. 
UW-CTRI coordinates with 45 federally funded clinics, health departments, and 
other organizations that treat low-income patients on training for clinic staff, 
linkages to the Quit Line, and the provision of free nicotine patches to uninsured or 
underinsured smokers. In addition, UW-CTRI partners with First Breath, a program 
of the Wisconsin Women’s Health Foundation, to promote smoking cessation 
among pregnant women. 
* Academic detailing is similar to detailing used by the pharmaceutical industry, but 
it brings a training/systems-change message to ofﬁce practices. 
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Case Study #2, continued 
UW-CTRI also partnered with the Wisconsin Hospital Association to disseminate 
a recently developed “hospital packet.” This effort provides on-site technical 
assistance to help hospitals implement key tobacco-dependence treatment 
recommendations. 
Supporting strategies for change is difﬁcult. Quality standards such as HEDIS, 
JCAHO, coding systems, and organizing elements (e.g., electronic medical 
records) can be used to support integration of tobacco-dependence treatment 
within health-care systems. Tracking and evaluation should be used to monitor 
the implementation and delivery process and provide feedback to clinicians. 
Lessons Learned: 
■	 Outreach staff can be effective in promoting integration of tobacco-control 
strategies within the practice setting. 
■	 Encouraging providers to fax referrals to the quitline improves care outcomes. 
■	 Partnering with key health-care and business organizations can improve 
coverage for tobacco-dependence treatment. 
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Objective: 
Ensure that all 
tobacco users are 
offered effective 
tobacco-use 
treatment at all 
clinical encounters. 
Systems Changes to Support Clinician Intervention 
Clinicians and health-care systems play an important role in encouraging 
patients who use tobacco products to attempt to quit and in helping 
ensure the success of these attempts. The PHS guideline indicates that 
even minimal intervention by a clinician (i.e., as little as 3 minutes of face-
to-face counseling) can increase overall abstinence rates, and both the PHS 
guideline and the Community Guide recommend strategies to encourage 
health-care clinicians to assume an active role in helping patients quit. 
Working with systems to incorporate the range of effective strategies will 
promote improved treatment. The guidelines advocate ﬁve key steps to 
intervention in the primary care setting that are collectively known as the 
5A’s (Fiore et al., 2000). They involve 
■	 Asking if patients smoke. 
■	 Advising them to quit. 
■	 Assessing readiness to quit. 
■	 Assisting with counseling and pharmacological treatments. 
■	 Arranging for follow-up. 
An alternative to the 5 A’s has been proposed by Dr. Steven Schroeder and 
the Smoking Cessation Leadership Center at the University of California, 
San Francisco. One of their central strategies is Ask-Advise-Refer (i.e., to a 
quitline or other effective program) (Schroeder, 2003). 
Not every patient who is identiﬁed as a smoker or other tobacco user will 
be ready to make a quit attempt. Therefore, after asking about tobacco use, 
advising the smoker to quit, and assessing his or her current readiness to 
quit, it is important to provide a motivational intervention known as the 
5R’s for those not currently ready to quit. Its steps emphasize 
■	 Relevance—Encourage the patient to consider how quitting or not 
quitting speciﬁcally affects them and their loved ones. 
■	 Risks—Suggest and highlight relevant risks of continued tobacco use. 
■	 Rewards—Help the patient identify potential beneﬁts of stopping 
tobacco use. 
■	 Roadblocks—Identify barriers or impediments to quitting and ways 
these can be addressed. 
■	 Repetition—Repeat this intervention each time the patient visits 
the clinic. 
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Strategies 
Strategies to promote clinician intervention could include 
■	 Adopting a clinical system that identiﬁes smoking or other tobacco-use 
status in conjunction with the collection of vital signs (Fiore et al., 2000). 
■	 Using a centralized system that features clinician reminder elements 
and a clinician education component to encourage clinicians to address 
tobacco use and to assist them in helping their patients quit (Hopkins, 
2001). 
■	 Implementing ofﬁce-wide systems to support delivery of the 5A’s to 
patients who are willing to quit, followed by documentation of the 
treatment services provided, and encouraging follow-up with the 5R’s 
motivational intervention for patients who are currently unwilling to 
quit smoking (Fiore et al., 2000). 
■	 Including tobacco-dependence treatment in the deﬁned duties of 
clinicians (Fiore et al., 2000). 
■	 Using electronic medical records to support and document tobacco- 
dependence treatment (Bentz, Davis, and Bayley, 2002). 
■	 Coding for tobacco dependence 
using the 305.1 ICD-10 code 
(Fiore et al., 2000).* 
■	 Providing quitline linkages to 
support treatment intervention 
and follow-up (Paciﬁc Center on 
Health and Tobacco, 2003b). 
■	 Reimbursing for treatment of 
tobacco use as a chronic disease 
(Fiore et al., 2000). 
■	 Implementing a centralized system 
to identify and treat tobacco users 
who are hospitalized for any 
reason (Rigotti et al., 2002). 
* Some systems are also using the following CPT codes: 0002F: Tobacco use, 
smoking assessed; 0003F: Tobacco use, nonsmoking assessed; G0375: Smoking 
and tobacco use cessation counseling visit, Intermediate, greater than 3 minutes 
up to 10 minutes; G0367: Smoking and tobacco use cessation counseling 
visit, Intensive, greater than 10 minutes; 99383–99387: Preventive Medicine 
Examination; 99393–99397: Established Patient Periodic preventive medicine 
evaluation; 99401–99412: Preventive Medicine, Individual Counseling; 90804– 
90809: Ofﬁce or other outpatient facility—behavior modiﬁcation; 90816–90822: 
Inpatient hospital, partial hospital or residential care facility; 01320: Dental code. 
A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment | 33 
Tactics 
Examples of effective roles that each component of the health-care system 
plays in promoting use of the 5A’s and the 5R’s and achieving a greater level 
of clinician intervention are described below. 
Service delivery 
■	 Promote state-run or other quitline services to clinicians, health plans, 
and insurers (Fiore et al., 2000). 
■	 Coordinate with quitlines to provide post-discharge follow-up (Paciﬁc 
Center on Health and Tobacco, 2003b). 
■	 Integrate tobacco-use treatment in programs administered by health 
departments, including services for children with special health-care 
needs; Maternal and Child Health Block Grant (Title V) programs; 
family planning grants (Title X); Medicaid; and Special Supplemental 
Nutrition Program for Women, Infants, and Children (WIC) programs 
(Fiore et al., 2000). 
Quality assurance/quality improvement 
Quality assurance/quality improvement staff or other designated 
individuals within the health-care system should coordinate the following: 
■	 Provide feedback to individual clinicians and groups on their 
effectiveness in delivering medications and referrals to counseling 
or quitline services (Hopkins et al., 2001). 
■	 Become champions and, along with committed team members 
(physicians, nurses, medical assistants, and others), provide training 
for clinicians in evidence-based treatment. 
■	 Initiate a system where tobacco users can be referred to state or health 
plan tobacco-cessation quitlines. 
■	 Ask health plans for NCQA HEDIS data that report rates of clinician 
advice to quit, provision of medication, and support and assistance 
with quitting. (Information on HEDIS measures related to tobacco 
use is provided on page 10 of this document [NCQA, 2003a].) 
■	 Monitor beneﬁt utilization and feed results back to health-care systems 
and clinicians providing services and use to determine if quality 
indicators are being met. 
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Administration 
■	 Implement ofﬁce-based reminder systems that trigger clinical staff to 
ask all patients about tobacco use, provide chart documentation of 
tobacco-use status, and offer and document quitting assistance to 
users (Fiore et al., 2000). 
■	 Encourage ofﬁce practices to deﬁne roles among clinical staff to ensure 
that counseling and medications are systematically provided and their 
provision documented in medical charts or electronic records.  
■	 Implement a system to identify and document the tobacco-use status 
of all clinic and hospitalized patients. 
■	 Develop inpatient treatment systems, referral networks, and quality 
assurance mechanisms to support such systems. 
■	 Provide incentives and support to clinician groups that want to set up 
systems for implementing the PHS guidelines and increase treatment 
rates (America’s Health Insurance Plans, 2003). 
Finance 
■	 Provide annual coverage for at least two courses of both counseling and 
FDA-approved medications with minimal or no co-payments (George 
Washington University, 2002). 
■	 Coordinate with state Medicaid programs to ensure comprehensive 
coverage of counseling and medication (George Washington University, 
2002). 
■	 Collaborate with the business sector to promote comprehensive coverage 
and quitline services. 
Quality care 
■	 Assess JCAHO scores relating to tobacco-use treatment and set targets 
for improvement. 
■	 Provide “quality surveillance” by sharing data within and between 
clinician groups that allow comparisons of their own performance on 
tobacco-related indicators with others (e.g., provision of medication 
by assessing pharmacy data, referral to telephone counseling through 
feedback from the quitline service). 
■	 Assess HEDIS scores for provision of medication and support and 
assistance with quitting (counseling). 
■	 Identify “best practices” for tobacco-use cessation interventions within 
health systems and promote successful models and structures. 
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Systems Changes to Support Clinician Intervention 
Service Delivery Quality 
Assurance/Quality 
Improvement 
Administration Finance Public Health 
Provide feedback to 
individual clinicians 
and groups on their 
effectiveness in 
delivering medications 
and referrals to 
counseling and/or 
quitline services. 
Assess JCAHO/HEDIS 
scores relating to 
tobacco-use treatment 
and set targets for 
improvement. 
Implement ofﬁce-based 
reminder systems that 
trigger clinical staff to 
ask all patients about 
tobacco use, provide 
chart documentation of 
tobacco-use status, and 
offer and document 
quitting assistance to 
users. 
Provide annual 
coverage for at least 
two courses of both 
counseling and FDA-
approved medication 
with minimal or no 
co-payments. 
Coordinate with 
quitlines to provide 
post-discharge 
follow-up. 
Provide “quality 
surveillance” by 
sharing data within 
and between clinician 
groups that allow 
comparisons of their 
own performance 
on tobacco-related 
indicators with others. 
Deﬁne roles among 
clinical staff to ensure 
that counseling and 
medications are 
systematically provided 
and their provision 
documented. 
Coordinate with state 
Medicaid programs to 
ensure comprehensive 
coverage of counseling 
and medication. 
Promote state-run or 
other quitline services 
to clinicians, health 
plans, and insurers. 
Become champions 
and, along with 
committed team 
members (physicians, 
nurses, medical 
assistants, etc.), provide 
training for clinicians 
in evidence-based 
treatment. 
Implement a system to 
identify and document 
the tobacco-use status 
of all hospitalized 
patients. 
Initiate a system where 
tobacco users can 
be referred to state 
tobacco cessation 
quitlines. 
Assess HEDIS scores for 
provision of medication 
and support and 
assistance with quitting 
(counseling). 
Collaborate with 
the business 
sector to promote 
comprehensive 
coverage and quitline 
services. 
Integrate tobacco-use 
treatment in programs 
administered by 
health departments, 
including services for 
children with special 
health-care needs; 
Maternal and Child 
Health Block Grant 
(Title V) programs; 
family planning grants 
(Title X); Medicaid; and 
Special Supplemental 
Nutrition Program 
for Women, Infants, 
and Children (WIC) 
programs. 
Develop inpatient 
treatment systems, 
referral networks, 
and quality assurance 
mechanisms to support 
such systems. 
Identify “best practices” 
for tobacco-use 
cessation interventions 
within health systems 
and promote successful 
models and structures. 
Ask health plans for 
NCQA HEDIS data that 
report rates of clinician 
advice to quit, provision 
of medication, and 
support and assistance 
with quitting. 
Provide incentives and 
support to clinician 
groups that want to 
set up systems for 
implementing the PHS 
guidelines and increase 
treatment rates. 
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Reducing Patient Out-of-Pocket Costs 
for Tobacco-Use Treatment 
As previously noted, smoking cessation treatments are not only clinically 
effective, but also are extremely cost-effective relative to other commonly 
used disease prevention interventions and medical treatments (e.g., treat-
ment of elevated cholesterol, mammography screening) (Fiore et al., 2000). 
Reducing or eliminating patient out-of-pocket costs for tobacco-dependence 
treatments increases treatment rates (CDC, 2000; Curry et al., 1998; 
Cochrane Collaboration, 2005). 
Strategies 
Approaches for increasing tobacco-use treatment by reducing patient costs 
include 
■	 Providing effective tobacco-dependence treatments (both counseling 
and pharmacotherapy) as paid or covered services for all subscribers 
or members of public and private health insurance packages (Fiore et 
al., 2000; George Washington University, 2002; Cochrane Collaboration, 
2005).* 
■	 Encouraging initiation of reimbursement mechanisms to compensate 
clinicians for delivery of effective tobacco-dependence treatments 
and including these interventions in the deﬁned duties of clinicians 
(Fiore et al., 2000). 
Tactics 
There are a variety of tactics that health plan administrators, purchasers, 
and public health professionals can employ to promote implementation of 
these strategies. 
Service delivery 
■	 Provide medication and counseling (e.g., state-run quitlines or other 
counseling services) for uninsured or underinsured populations (George 
Washington University, 2002). 
■	 Promote quitline services and collaborate with Medicaid, health-care 
systems, and employers to provide low- or no-cost services (George 
Washington University, 2002).  
■	 Ensure maximal utilization of services (George Washington University, 
2002). 
* As of March 2005, Medicare began reimbursing physicians for tobacco-
dependence treatment counseling. Medicare also began providing coverage 
for prescription tobacco treatment medications in January 2006. 
Objective: 
Reduce or eliminate 
patient out-of-pocket 
costs for tobacco-use 
treatment. 
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Public health 
State public health and/or large public health agencies need to coordinate 
the following: 
■	 Work with insurance agents and brokers, health consultants, sales 
staff, and purchasing coalitions to promote the inclusion of tobacco-use 
treatment services, including counseling and medication coverage, in 
beneﬁt contracts. 
■	 Ensure that purchasers understand the ﬁnancial beneﬁts of tobacco-use 
treatment interventions. 
■	 Negotiate tobacco-use treatment beneﬁts as part of union contracts. 
■	 Provide and promote tobacco-use treatment beneﬁts for employees 
through insurance contracts, self-insurance, and work-site programs. 
■	 Consult with federal, state, and local government decision makers to 
provide and promote tobacco-use treatment beneﬁts for government 
employees and people who receive health-care beneﬁts through 
Medicare, Medicaid, the Indian Health Service, Community Health 
Centers, the Veterans Administration, the Department of Defense, and 
the Bureau of Prisons. 
■	 Encourage employers to learn how beneﬁts they already have can be 
used for tobacco-use treatment and to promote their use by employees 
(Tobacco Technical Assistance Consortium, 2003; Paciﬁc Center on Health 
and Tobacco, 2002). 
■	 Demonstrate to employers that coverage of tobacco-use treatment is 
cost effective and cost saving (Cofﬁeld et al., 2001; Tobacco Technical 
Assistance Consortium, 2003; Cochrane Collaboration, 2005; Maciosek 
et al., 2006). 
Administration 
■	 Support coding for tobacco dependence (ICD-10, Code 305.1) within the 
health-care system to assist in identifying tobacco users and to assess 
costs of tobacco-related diseases. 
■	 Remove or minimize barriers to accessing tobacco-use treatment beneﬁts 
by decreasing or eliminating co-pays and removing utilization caps 
(Hopkins et al., 2001). 
■	 Inform clinicians and ofﬁce managers of coverage availability. 
■	 Understand current coverage levels. Ask insurers about all products 
or services (e.g., beneﬁts, riders, discounts) that address tobacco-use 
treatment (Paciﬁc Center on Health and Tobacco, 2003a). 
■	 Promote coverage of tobacco-use treatment counseling and medication 
coverage to self-insured groups. 
■	 Provide disease management and treatment for tobacco-related diseases 
and conditions. 
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Reducing Patient Out-of-Pocket Costs for Tobacco-Use Treatment 
Service Delivery Quality 
Assurance/Quality 
Improvement 
Administration Finance Public Health 
Provide medication 
and counseling for 
insured, uninsured, 
or underinsured 
populations. 
Monitor beneﬁt 
utilization and feed 
results back to health-
care systems providing 
services. 
Support coding for 
tobacco-dependence 
(ICD-10, Code 305.1) 
within the health-care 
system to assist in 
identifying tobacco users 
and to assess costs of 
tobacco-related diseases. 
Include tobacco-use 
treatment counseling 
and medications as a 
standard part of all fully 
insured contracts. 
Work with insurance 
agents and brokers, health 
consultants, sales staff, 
Medicaid, and purchasing 
coalitions to promote 
the inclusion of tobacco-
use treatment services, 
including counseling and 
medication coverage, in 
beneﬁt contracts. 
Promote quitline 
services and collabor-
ate with Medicaid, 
health-care systems, 
and employers to 
provide low- or no-
cost services. 
Remove or minimize 
barriers to accessing 
tobacco-use treatment 
beneﬁts by decreasing 
or eliminating co-pays 
and removing utilization 
caps. 
Reimburse for tobacco 
use treatment in the 
same way that clinicians 
are reimbursed for other 
chronic diseases. 
Ensure that purchasers 
understand the ﬁnancial 
beneﬁts of tobacco-use 
treatment interventions. 
Ensure maximal 
utilization of services 
by reducing or 
eliminating co-pays. 
Inform clinicians and 
ofﬁce managers of 
coverage availability. 
Include coverage for 
ofﬁce visits to treat 
“tobacco-use disorder” 
as a standard beneﬁt. 
Negotiate tobacco-use 
treatment beneﬁts as part 
of union contracts. 
Understand current 
coverage levels. Ask 
insurers about all 
products or services 
(e.g., beneﬁts, riders, 
discounts) that address 
tobacco-use treatment. 
Cover at least two 
courses of counseling 
and medication per year 
to support the quitting 
process. 
Provide and promote 
tobacco-use treatment 
beneﬁts for employees 
through insurance 
contracts, self-insurance, 
and work-site programs. 
Promote coverage of 
tobacco-use treatment 
counseling and 
medication to self-
insured groups. 
Offer health 
beneﬁts that include 
comprehensive 
counseling and 
medications for 
employees. 
Consult with federal, state, 
and local government 
decision makers to provide 
and promote tobacco-use 
treatment beneﬁts for 
government employees and 
people who receive health-
care beneﬁts through 
Medicare, Medicaid, the 
Indian Health Service, 
Community Health Centers, 
the Veterans Administration, 
the Department of Defense, 
and the Bureau of Prisons. 
Provide disease 
management and 
treatment for tobacco-
related diseases and 
conditions. 
Work with self-insured 
employers (including 
states) to ensure that 
their health plans 
provide coverage for 
both tobacco-use 
treatment counseling 
and pharmacotherapies. 
Encourage employers to 
learn how beneﬁts they 
already have can be used 
for tobacco-use treatment 
and to promote their use 
by employees. 
Demonstrate to employers 
that coverage of tobacco-
use treatment is cost-
effective. 
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Objective: 
Create social 
and economic 
environments that 
promote tobacco-
use treatment. 
Finance 
■	 Include tobacco-use treatment counseling and medications as a standard 
part of all fully insured contracts. 
■	 Reimburse for tobacco-use treatment in the same way that clinicians are 
reimbursed for treatment of other chronic diseases. 
■	 Include coverage for ofﬁce visits to treat “tobacco-use disorder” as a 
standard beneﬁt (305.1 IDC-10 code). 
■	 Cover at least two courses of counseling and medication per year to 
support the quitting process (George Washington University, 2002). 
■	 Offer health beneﬁts that include counseling and medications for 
employees. 
■	 Work with self-insured employers (including states) to ensure that their 
health plans provide coverage for both tobacco-use treatment counseling 
and pharmacotherapies (Tobacco Technical Assistance Consortium, 2003). 
Community Policy and Mass Media 
Mass media campaigns, when part of multicomponent interventions, 
also are effective in increasing the number of tobacco users who seek 
treatment. Such campaigns do not necessarily have to be focused on 
tobacco-use treatment (CDC, 2000). Increasing the unit price of tobacco, 
primarily through an increase in excise tax, also helps people seek treatment 
and decreases smoking prevalence and tobacco consumption (Hopkins 
et al., 2001). Data show that a 10% increase in the price of tobacco products 
generally results in a 4% decrease in the amount of tobacco used by the 
general population (Hopkins et al., 2001). Research ﬁndings also show 
that legislation that bans smoking in the workplace creates an environment 
favorable to tobacco cessation (Cochrane Collaboration, 2005). Workplace 
smoking bans decrease daily tobacco consumption while increasing 
quit attempts and the success of these attempts (Center for Tobacco 
Cessation, 2004). 
Like the general population, pregnant women and racial and ethnic 
minority groups beneﬁt from a comprehensive approach to tobacco-
use treatment that includes increases in the price of tobacco and the 
establishment of smoke-free workplace policies. Tax increases are 
especially helpful in promoting cessation among pregnant women, 
adolescents, and low-income individuals, thereby increasing the need 
for adequate coverage for and access to cessation services for these 
groups (CDC, 2000; Hopkins et al., 2001). 
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Strategies 
Effective methods for using policy changes and the media to promote 
tobacco-use treatment include the following: 
■	 Implementing smoking bans and restrictions to reduce exposure to 
environmental tobacco smoke (Hopkins et al., 2001). 
■	 Increasing the unit price for tobacco products to reduce the initiation of 
tobacco use and prevalence, increase cessation attempts, and increase the 
use of tobacco-use treatment (Hopkins et al., 2001). 
■	 Combining mass media education (campaigns) with other interventions 
to reduce tobacco-use initiation and prevalence, increase cessation, and 
increase tobacco-use treatment (Hopkins et al., 2001). 
■	 Marketing quitlines to encourage their use (and unaided quit attempts as 
well) (Zhu et al., 2000). 
Stakeholders 
In the policy and media categories, the roles of the various health system 
players are similar. A willing organization could play one or more of the 
roles identiﬁed below. 
■	 Coalition member: Representatives of clinics, hospitals, and health plans 
can be powerful members of coalitions that promote policy change and 
the maintenance of funding for tobacco-control programs, including 
quitlines. 
■	 Bridge to employers: Health plans and large clinic or hospital systems 
are businesses as well as health-care organizations. They can provide 
a link to the business sector that public health professionals and 
advocacy organizations may lack. Senior executives of large health-care 
organizations can reach out to other business leaders and involve them 
in policy changes. 
■	 Effective lobbyist: Health system lobbyists with key legislative 
relationships may be able to open doors previously closed to traditional 
tobacco-control advocates. 
■	 Funder: Health systems can be dues-paying members of organizations or 
coalitions that promote policy change or work-site health initiatives and 
may be able to ﬁnancially support media campaigns. 
■	 Champion: Clinicians are trusted sources of health-care advice and 
credible tobacco policy messengers at the state and local levels. Rural 
health-system organizations and leaders often have even greater 
inﬂuence than their metropolitan peers because they may have more 
direct relationships with legislators, or their organizations may carry 
substantial clout as employers. 
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■	 Defender: Effective media campaigns and policy initiatives are 
vulnerable to attack from opponents of tobacco control. Health 
systems leaders can support a program under attack—or better yet, 
proactively educate decision makers about the importance of tobacco-
dependence treatment and the key role media campaigns and public 
policies play in encouraging and supporting quitting. 
■	 Business health coalition: A number of larger communities have 
business health coalitions with valuable relationships in both the 
health-care and business communities that may be an asset in moving 
an agenda forward. A business health coalition typically comprises 
health-care system and business members who collaborate to address 
key health issues in the community. 
Business health coalitions can 
•	 Encourage members to initiate or expand coverage for tobacco-

dependence treatment.

•	 Increase members’ awareness of the state quitlines and promote 
ﬁnancial support. 
•	 Support smoke-free policies among businesses and in the community. 
For additional information on effective coalitions and campaigns, 
refer to the following Paciﬁc Center on Health and Tobacco documents: 
Health Insurance Beneﬁts for Treatment of Tobacco Dependence: Summary and 
Invest in Tobacco Cessation for a Healthy, Productive Workforce, available at 
www.ttac.org/leadership/resources.html. Also, please visit the Centers 
for Disease Control and Prevention’s Media Campaign Resource Center at 
www.cdc.gov/tobacco/mcrc and the Tobacco-Free Coalition of Oregon’s 
site at www.tobaccofreeoregon.org. The Make It Your Business campaign 
(available at www.tobaccofreeoregon.org) is another valuable resource. 
(See Case Study #6 on page 56.) 
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Building Relationships 
Within Health-Care Systems 
Tobacco control seeks to end the death and disease caused by tobacco use and by exposure to secondhand smoke. But, unlike diphtheria, pertussis, or tetanus, there is no vaccine to inoculate people against tobacco’s harmful 
effects. Instead, individuals, agencies, and organizations must work together to 
take on a complex mix of social, cultural, economic, and political issues which 
encourage tobacco use (Tobacco Technical Assistance Consortium, 2004). 
Communities of Excellence Plus in Tobacco Control: 
Training and Resource Manual 
Informed by a basic understanding of the structure and concerns of 
health-care system organizations, public health professionals can more 
knowledgeably approach potential partners and begin the important 
process of building relationships. The challenge is to move beyond 
simple cooperation and coordination to create a spirit of collaboration 
and partnership to address tobacco as a community issue (Winer and 
Ray, 1994). 
When a comprehensive and complex set of goals will be pursued over a 
longer period of time, the more intensive approach of collaboration may be 
the best investment. This can result in systems change to impact tobacco-
dependence treatment and thereby reduce rates of illness and death. 
Reasons to Collaborate 
Organizations collaborate to achieve some result or results that one 
organization cannot achieve alone (Ray, 2002). Whether your goal is to 
increase access to effective tobacco-use treatment counseling or to create 
smoke-free environments that support tobacco-use treatment, it is unlikely 
that a single organization can achieve that objective alone. 
Keys to Successful Collaboration 
Several factors support successful collaborations, including mutual trust, 
shared decision making, open communication, and having a skilled 
convener (Winer and Ray, 1994). In addition, having committed leaders, 
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Getting Started: 
Selecting Appropriate 
Public Health Staff 
The “right” person to 
initiate contact with a 
health system organization 
depends on your 
objectives. If you are 
trying to increase clinician 
referrals to a quitline, you 
may need to work with 
someone other than your 
community policy contact. 
You should be prepared to 
talk to a number of people 
before ﬁnding the right 
person. 
Health department staff 
members who have 
previous experience with 
community organizing 
or coalition development 
may be a good choice to 
assist in building a new 
tobacco-use treatment 
coalition and anticipating 
and addressing potential 
problems. 
a common purpose, dedicated resources, external accountability, and clear 
time lines increases the chances for success (Solberg, 2000). 
Tobacco-control collaborations are prone to experiencing the same barriers 
as other collaborations: disparate visions, ﬂawed communications, lack 
of role deﬁnition, and unclear responsibilities. In addition, tobacco-use 
treatment collaborations are often challenged by competition over tobacco-
control resources and attempts by outside forces to divide health coalitions. 
Beginning a Collaboration 
Collaboration between public health systems and the nongovernmental 
health-care system involves the coming together of distinct cultures. Early 
on, participants must develop trust, and to do so, they must rely on each 
other’s honesty, integrity, and fairness. Developing relationships takes 
time, effort, and persistence. It is also very helpful at the beginning to take 
the time to develop a common vocabulary so everyone is communicating 
effectively. 
In addition to having potentially different educational backgrounds and 
work experience, public health professionals and health-care systems 
professionals work for organizations with different missions and cultures. 
Experienced collaborators emphasize the primacy of personal relationships. 
Successful development is more likely to grow out of individual contacts 
and relationships that turn eventually into a small cooperative project over 
time. Only then is there sufﬁcient trust to start thinking about shared values 
and mission. 
An interagency collaboration works best if there is sponsorship by senior 
leaders in participating organizations. If the health department director 
contacts the health-care system CEO and obtains buy-in, the initiative 
frequently begins with a solid base. 
Roles Within the Collaboration 
In any given state, there may be multiple collaborations that are relevant 
to tobacco control—a purchasers’ coalition, a Medicaid beneﬁts task force, 
a clinical guideline-focused collaborative, and others. In each, certain 
roles must be ﬁlled. These include convenor, facilitator, funder, technical 
assistance provider, and active participant. The right organizations to 
perform each of those roles depends on the speciﬁc situation. 
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The Public Health Contribution 
To be effective collaborators, public health professionals must identify what 
they can contribute to the collaboration. Skills and resources that public 
health professionals can contribute might include 
■	 Knowledge of effective tobacco-control strategies. 
■	 Common ground and the ability to foster cooperation and agreement 
among competitors for shared efforts. 
■	 Group facilitation and management skills. 
■	 Technical support. 
■	 Leadership in tobacco-control policy advocacy, if appropriate. 
■	 Experience in reaching speciﬁc populations (e.g., pregnant smokers, 
low-income populations, populations with health disparities). 
■	 Data collection, analysis, and reporting. 
■	 Funding to support the collaboration and its work; recognition of the 
skills and resources that health-care systems and professionals bring and 
the importance of focusing on tobacco control as a strategy for improving 
quality of care. 
■	 A clear mission. Public health groups can be more mission-driven and 
help keep the work going. 
■	 Relationships with existing programs in the voluntary sector (American 
Heart Association, American Lung Association, American Cancer Society, 
pregnancy programs, etc.) that may be of assistance in supporting 
tobacco-control initiatives. 
Health-care systems may have a different culture than that of public health. 
Using the contacts discussed on the previous page, the health-care systems 
may appreciate public health support in establishing internal committees 
within the system. Having representation from management, nursing, 
beneﬁts, respiratory therapy, pharmacy, quality improvement, legal, and 
other departments will be helpful in planning the initiative and ensuring 
that key departments integrate tobacco-control strategies into their system 
components (see Health-Care Systems Primer, pp. 7–20, for additional 
details.) 
Next Steps: 
Finding a Health-Care 
Systems Contact 
Differing program needs 
will require contact with 
different health-care 
systems contacts. The 
following are suggestions 
for developing contacts 
to meet speciﬁc program 
needs: 
Some clinics, hospitals, 
and health plans employ 
medical and nursing 
staff with speciﬁc quality 
improvement (QI) 
accountabilities. Look for 
a “QI medical director” 
or “Director of QI” when 
searching for a contact for 
clinical systems or individual 
treatment efforts. 
In the policy and media 
arenas, key contacts include 
health system lobbyists, 
communications directors, 
market researchers, 
and medical directors 
who might serve as 
spokespeople. If the health 
system has a philanthropic 
arm, such as a foundation 
or community relations 
department, you might 
want to try that area, too. 
Try contacting the hospital’s 
community relations 
department or marketing 
departments about offering 
tobacco-use treatment 
services at the hospital or 
work sites or developing 
relationships that will 
provide quitline referrals. 
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Implementation Strategies 

Results from community-based interventions and statewide programs show that a comprehensive approach to tobacco control is needed to curtail the epidemic (U.S. Department of Health and Human Services, 2000). 
Donna E. Shalala, former Secretary of Health and Human Services 
In beginning to work with health-care systems, selecting appropriate staff 
and developing initial relationships between the leaders of all organizations 
lays the foundation in which the collaboration can be developed to improve 
tobacco-use cessation. Changing systems is a long-term process that requires 
working with health-care systems to determine perceived problems, gaps 
in care, and willingness to change. Identifying a champion’s willingness to 
commit resources and develop opportunities for systems change is a good 
starting point. Potential opportunities include the following: 
■	 Is a health-care system looking to create a tobacco-free campus before 
insurance coverage for tobacco cessation is expanded? 
■	 Are there practices or components of the system that have effectively 
implemented Public Health Service (PHS) guidelines for treating tobacco 
dependence? 
■	 Would these providers or health-care practices be willing to provide 
leadership? 
■	 What are the barriers to effective implementation of provider reminders? 
■	 What current programming is in place that could potentially be used as a 
model for tobacco-use treatment (e.g., diabetes, hypertension)? 
Lessons Learned 
The most progressive health plans have used a number of strategies and 
components in successful tobacco-control initiatives (Rigotti et al., 2002). 
Some of their lessons learned include the following: 
■	 Establish evaluation mechanisms up front. This is important for 
demonstrating the effectiveness of the initiative. 
■	 Work with partners to establish an internal committee, which is critical 
for developing reasonable time lines, setting feasible goals and objectives, 
and obtaining buy-in and support for the implementation process. Key 
players might include 
•	 Medical director. 
•	 Beneﬁts manager. 
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• Health promotion representative. 
• Pharmacists. 
• Nurses. 
• Quality assurance personnel. 
Measuring Progress 
The plan may be willing to share its Health Employer Data Information 
Set (HEDIS) and JCAHO scores on these measures, or the state insurance 
commissioner’s ofﬁce may have the scores. Because insurers make multiple 
coverage plans available to purchasers, determine the extent of tobacco-
dependence treatment coverage provided within the more popular plans. 
Public health staff can view the coverage and provide feedback comparing 
coverage to PHS and Community Guide recommendations. (See Coverage 
document, Appendix G.) If current coverage for tobacco-dependence 
treatment is not in line with the PHS guidelines, recommendations as 
to what steps might be taken to increase coverage for medication and 
counseling could be provided. Establishing baselines in tobacco cessation 
facilitates goal setting. One baseline measure could be the current level of 
medications being provided to treat tobacco dependence. Health systems 
often closely track the provision of pharmacotherapy. 
The HEDIS measures have three components. The “advice to quit” measure 
is the ﬁrst indicator. Plans at the highest levels in the country are scoring in 
the 70% range. Second, the HEDIS scores relate to the provision of support 
and assistance in quitting, which is a proxy for counseling. The highest rate 
in 2004 was 45%. The HEDIS “offer of medication” question is a third source 
of information (NCQA, 2003a), also with the highest rate around 45%. 
Increasing Systems-Change Effectiveness 
A plan identifying implementation components, time lines, and evaluation 
criteria should be developed.* Data collection and analyses are also 
integral parts of effective systems change. If health-care systems are 
interested, public health staff could share practice assessments, which 
assists in identifying strengths and opportunities at the practice level and 
provides support for implementing evidence-based practices. (See Practice 
Assessment document, Appendix F.) 
*The National Business Coalition on Health (NBCH) also conducts an annual 
assessment of health plans—eValue8. This tool requests treatment information 
from plans that is compared to national data and fed back to the plans in terms 
of strengths and opportunities. Tobacco-use treatment information is collected in 
the prevention section of the tool. 
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Public health departments could also assist health-care systems in 
identifying and using baseline data to develop implementation targets. 
If medication prescriptions are at the 20% level, this is in line with current 
practice. A 10 percentage point increase (to 30%) over the next 1 to 2 years 
might be a reasonable target. System pharmacies usually have excellent data 
systems for tracking medication dispensing. These data can then be used to 
show change over time. 
One example of work in this area is from Oregon. The Oregon Department 
of Health assessed which health plans were most likely to have a high 
percentage of tobacco users and then worked closely with the plans to 
enhance coverage and treatment strategies. 
Other questions to consider when addressing these issues include: Can a 
mechanism be instituted with the quitline vendor to provide feedback to 
the health plan and individual providers on patient enrollment progress, 
and can a system of fax referrals to the quitline be established? For example, 
Wisconsin has developed a mechanism for providers to fax referrals to the 
quitline, which accounts for 35% of all referrals. What additional strategies 
can be developed to integrate tobacco control into existing systems? If 
electronic medical records are in use, tobacco-use status should be logged 
into the system and any treatment provided should be documented. These 
data should then be collected, analyzed, and fed back to providers on a 
regular basis as a means to measure progress toward reaching treatment 
targets set by the system. 
Another strategy is to develop coordination between health plans. Health 
plans within a geographic area are frequently staffed by the same clinicians. 
If health plans promote the same message across plans, providers may be 
more likely to implement effective tobacco-control treatment. The state 
health department could assist in supporting health plan implementation 
of strategies coordination in tobacco control, including 
■ Identiﬁcation of tobacco-use status. 
■ Advice to quit. 
■ Offer of medication. 
■ Referral to a quitline or other counseling services. 
State Examples 
In Minnesota, health plans were encouraged to improve medication 
coverage and alleviate the quitline burden of providing medications to 
otherwise insured individuals, thus assuring state funding to provide 
medications for the underinsured and uninsured. 
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The California Next Generation Alliance developed an ofﬁce practice guide, 
the Health Care Provider’s Tool Kit for Delivering Smoking Cessation Services, that 
is designed to promote effective ofﬁce-based tobacco-cessation practices 
(Next Generation California Tobacco Control Alliance, 2003). 
The Paciﬁc Center on Health and Tobacco in Oregon developed a Linking 
Health Care Systems and Quitlines document that contains a number of case 
studies illustrating successful strategies (Paciﬁc Center on Health and 
Tobacco, 2003b). 
In Michigan, the Michigan Association of Health Plans took a leadership 
role in coordinating health plan change efforts, establishing minimum 
suggested standards for coverage of tobacco-use treatment and bringing 
implementation staff together to share strategies and materials to improve 
treatment. The states of Oregon, Maine, and Wisconsin and the Columbia 
University Dental School have provided academic detailing to ofﬁce 
practices promoting science-based tobacco-control activities within the 
ofﬁce setting (Swartz et al., 2002). 
Educating purchasers about the importance of coverage and enlisting their 
assistance in implementing comprehensive coverage for their employees 
has also been an effective strategy. For example, the Tobacco-Free Coalition 
of Oregon (TOFCO) has developed a business health document, Make It Your 
Business, which provides examples of working with businesses to improve 
coverage of tobacco-use treatment (TOFCO, 2003). 
Several tactics for systems change are as follows: 
■	 The Arizona Health Department works with WIC clinics to support 
faxed referrals to the quitline. 
■	 Prescription pads listing the quitline telephone number can be 
distributed to promote referrals.  
■	 A video could be shown for providers and their patients to familiarize 
them with the quitline service. 
■	 Quality-assurance strategies can be developed that will assess the 
extent of 
•	 Provision of medication. 
•	 Referrals to the quitline or other counseling services. 
•	 Coding for tobacco dependence (305.1). 
The next section provides case studies to more fully illustrate effective 
implementation strategies. 
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Case Studies 

Case Study #3 
Connecting Private Clinics 
to State-Level Quitlines 
Providence Health System, Oregon 
Objective: 
To increase compliance with the PHS guidelines on clinician–quitline 
collaboration, updated tobacco-use tracking systems, and efﬁcient 
clinician feedback methods. 
Providence Health System in Portland, Oregon, implemented a project to increase 
compliance with the Public Health Service (PHS) guidelines for the 5 A’s intervention 
in 20 local primary care clinics. This project featured three unique health-care 
delivery components designed to increase clinicians’ ability to consistently deliver 
tobacco-cessation and other preventive health services: 1) a direct link from the clinic 
to a statewide tobacco-cessation quitline; 2) an electronic medical record (EMR) 
charting system that prompted providers to consistently screen for tobacco users 
and manage them appropriately; and 3) a provider feedback system that motivated 
providers to increase compliance with the PHS tobacco-cessation guidelines. 
In a 1-year study, 100,000 unique outpatient visits were documented in the 
20 Providence clinics (Bentz, 2002). Fifteen percent of patients (15,000) were 
identiﬁed as tobacco users, and 4.3% of tobacco users (643) were referred to 
the quitline either through direct fax referral from the clinic or via self-referral 
after receiving a brochure. The effect of provider performance feedback had a 
signiﬁcant, positive inﬂuence on the documentation of Asking, Advising, Assessing, 
and Assisting in the EMR. The total Assistance rate (referrals to the quitline or to a 
Providence tobacco program, provision of written cessation materials by clinic staff, 
prescriptions for and counseling on medications, etc.) in clinics receiving feedback 
was almost double that of the clinics that received no feedback (controls). 
The costs per quitline connection were very reasonable (between $21 and 
$35 per patient) during the ﬁrst year of the study. After the start-up costs 
were paid, the cost per quitline connection dropped signiﬁcantly (down to less 
than $6 per patient) during the second year. This compares favorably to the costs 
that are typically incurred when using media connections to drive quitline uses 
($100 to $400 per patient connected). 
Lessons Learned: 
Connecting smoking patients in physicians’ ofﬁces directly to state-level quitlines 
is feasible, effective, and well accepted by clinicians and patients. This method 
may prove to be an economical way for public health advocates to promote 
quitline usage. 
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Case Study #4 
Involving Health Systems Promotes 
Public Health Programs’ Success 
Oklahoma State Medical Association 
Objective: 
To form a partnership that will meet public health needs by promoting 
relationships with clinicians. 
The partnership between the Oklahoma State Department of Health (OSDH) and 
the Oklahoma State Medical Association (OSMA) resulted in a successful bid for a 
3-year grant to develop a best-practice prenatal smoking-cessation intervention. 
OSMA served as the lead agency on the grant application. Traditionally, the health 
department would have assumed the role of lead agency and sought OSMA 
endorsement, but OSDH staff understood that clinicians would be more likely 
to welcome the best-practice intervention if it were introduced and promoted 
by other clinicians. 
To date, the program has reached 26 private-practice sites, including private 
physician practices, residency programs, and Native American tribal clinics, 
and is coordinating the provision of technical assistance, grant-writing support, 
training, and consultation by OSDH staff with expertise in prenatal tobacco-use 
treatment. OSMA, representing nearly 5,000 providers, contributed its credibility 
among clinicians, access to a signiﬁcant number of doctors and various health 
systems statewide, and the strong infrastructure of the clinician-developed and 
-led Physician’s Campaign for a Healthier Oklahoma. The purpose was to improve 
tobacco-dependence treatment for prenatal smokers in the state. 
To date, the program has reached 17 private practices and is coordinating with 
two health-care systems. Providers and staff are encouraged to 
■	 Assess prenatal cessation practices using a modiﬁed chronic disease assessment 
tool. (See assessment tool, Appendix F.) 
■	 Identify areas of tobacco-dependence treatment needing improvement. 
■	 Establish strategies to move toward more effective practice over time. 
The OSDH found that when it takes advantage of opportunities to involve health 
system leadership in public health initiatives, the health system responds by 
leveraging resources, strengthening partnerships, extending the reach of public 
health initiatives, and further investing in public health outcomes. Although these 
opportunities may place health systems in new roles or unfamiliar territory, their 
success can be considerable if the initiatives build on the health system’s strengths. 
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Case Study #4, continued 
Results: 
The following preliminary results have been identiﬁed through independent 
evaluation of the project. Comprehensive data will not be available until late 2006. 
■	 Familiarity with the 5 A’s in practice sites showed an overall increase. 
■	 Self-reported advice to quit, assessing willingness to quit, and assisting patients 
to quit all increased. 
■	 More resources became available within practices to assist women in quitting. 
■	 Use of the statewide cessation HelpLine has increased dramatically. 
■	 Conﬁdence, on the part of providers and their staff, in implementing the 
5 A’s intervention increased from the baseline data to the post-implementation 
survey. 
■	 Practices indicated more awareness of important factors related to 
comprehensive tobacco-cessation program implementation. 
■	 Self-reported ability to implement the program was high. 
■	 All tasks related to the program implementation were reported as “easy.” 
■	 Satisfaction with the Practice Enhancement Assistants (PEAs) was rated 
very high. 
■	 100% of practice sites said that they would recommend the PEA implementation 
process and participation in the Smoke Free Beginnings program to other 
practices. 
■	 One limitation of the project evaluation: when the baseline and post-
implementation surveys were completed by the providers, the same 
person did not complete the survey in all cases.  
Lessons Learned: 
■	 Medical society involvement was invaluable in reaching health-care providers. 
■	 A peer-to-peer approach proved effective in reaching clinicians. 
■	 Using a practice assessment tool helped identify areas of strength and 
opportunity and provided a guide for selecting targets for change. 
■	 Many practices were able to show changes in ofﬁce practice as a result of the 
intervention. However, this will be better quantiﬁed as time progresses. 
Funding for this project was provided by the Smokefree Families Dissemination 
Program, Robert Wood Johnson Foundation. 
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Case Study #5 
Public–Private Quitline Collaboration 
Oregon Medicaid 
Objective: 
To build an effective partnership to support a broad-based quitline. 
The state of Oregon created a successful public–private partnership for telephone-
based quitting assistance as a way to support the tobacco-use treatment efforts of 
health plans. This partnership is a collaboration of three public agencies operating 
at the state level: 
■ The Public-Health Tobacco Prevention and Education Program (TPEP). 
■ The Tobacco-Free Coalition of Oregon (TOFCO). 
■ The Ofﬁce of Medical Assistance Program (OMAP). 
TPEP selected a vendor for its statewide telephone-based (single-call) tobacco-
use treatment support program that could also provide a proactive multiple-call 
program to health plans at a reasonable cost. Participation by health plans is 
voluntary, and advantages include proactive enrollment, free promotion, volume 
price discounts, and free evaluation. 
OMAP modeled the partnership by contracting with the vendor for its fee-for-
service members. It also used its managed care contracting mechanisms and 
quality improvement forum to encourage its health plans to use this program 
or a comparable one. 
Five of OMAP’s (Medicaid) 14 health plans elected to participate in the shared 
program. Through a Health Systems Task Force, TOFCO convened the plans’ 
tobacco-use treatment staffs to create common guidelines, provide outreach to 
clinicians and clinics, promote the program to members, and monitor results. 
The TPEP policy decision to make the telephone support program a shared 
public–private responsibility ensured that area health plans would continue their 
existing ﬁnancial contributions to tobacco-use treatment programs. But voluntary 
participation has its limits. Although the combined resources and inﬂuence of the 
prevention program, the Medicaid agency (OMAP), and the advocacy group made 
it easy for health plans to participate, only the state Medicaid plans expanded 
their tobacco-treatment offerings as a result of this effort. Prior to the initiative, 
one Medicaid health plan and three commercial plans provided their members 
with telephone counseling for quitting tobacco use. Afterwards, four additional 
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Case Study #5, continued 
Medicaid plans added telephone counseling as a beneﬁt. Now, half of all callers to 
the Oregon quitline are Medicaid clients.* No additional commercial plans added 
telephone counseling as a beneﬁt; however, two of the three plans that already 
offered telephone counseling switched to the common carrier. 
Data show that a “help is here” campaign to promote the quitline generated 
700 calls within a 3-week period. Quit rates, though lower than those published 
in clinical trials, are comparable to those reported in published literature for 
“real world” applications. 
Lessons Learned: 
■	 Coordination with Medicaid is an effective strategy for reaching low-income 
populations. 
■	 Medicaid enrollees may be harder to reach at follow-up for determination 
of quit rates. 
* El-Bastawissi A, McAfee T, Zbikowski SM, et al. The uninsured and Medicaid 
Oregon tobacco user experience in a real world, phone based tobacco use 
treatment programme. Tobacco Control 2003;12(1):45–51. 
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Building Business Champions 
Tobacco-Free Coalition of Oregon, 
Make It Your Business Campaign 
Objective: 
Develop business partnerships to support comprehensive coverage 
for tobacco-dependence treatment. 
In Oregon, about 40% of tobacco users get health-care beneﬁts from their 
employers, but only about one-third of them are covered for tobacco-dependence 
treatment. A key to increasing beneﬁt coverage is getting access to large health-
care purchasers to make a strong business case for adding these beneﬁts. 
Through a series of surveys and focus groups, the Tobacco-Free Coalition of Oregon 
(TOFCO) identiﬁed key audiences needing information about the cost-effectiveness 
of providing reimbursement for tobacco-use treatment. At the top of the list were 
the large purchasers as well as insurers and consultants who broker contracts 
between the purchasers and insurers. To help gather information and gain access 
to these key groups, staff with the Oregon Department of Human Services Tobacco 
Prevention and Education Program assisted TOFCO in developing a partnership 
with the Oregon Coalition of Health Care Purchasers (OCHCP). OCHCP, which 
prefers system-wide rather than single health issue projects, allowed TOFCO to 
conduct a survey of its members about tobacco-addiction treatment resources 
and to assist with member follow-up. 
The director of the OCHCP subsequently agreed to serve on a high-level 
advisory committee for the “Make It Your Business” campaign, a statewide 
campaign sponsored by TOFCO to involve businesses in providing tobacco-
use treatment services for employees. The chairman of the advisory committee 
is the Oregon Health and Science University (OHSU) medical school president, 
and other members include representatives from health insurers, businesses, and 
labor unions. The advisory committee developed a strategic outreach plan and 
successfully generated earned media through editorials and press releases of survey 
information. In the process, advisory committee members became advocates for 
expanding coverage for tobacco-dependence treatment in their own organizations. 
The medical school president reviewed beneﬁt coverage for the more than 10,000 
employees of the university’s hospital, clinics, and research departments. He also 
met with the executives of the largest health plans in the area to advocate for 
inclusion of tobacco-dependence treatment as a standard beneﬁt in these health 
plans. OHSU now provides coverage for employees. 
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Projects that challenge businesses and insurers to examine their beneﬁt packages 
for tobacco-use treatment coverage and make the business case for adding these 
beneﬁts can result in signiﬁcant progress. The Make It Your Business Campaign tools 
to help approach businesses and insurers are available at www.tobaccofreeoregon. 
org. Getting access to the decision makers, while difﬁcult, can be facilitated by 
recruiting high-level advisors and using targeted media channels such as popular 
business journals. To build the momentum needed for this change to occur, 
campaigns to increase consumer demand are also needed. 
Lessons Learned: 
■	 Purchasers, employers, and the media were more receptive to providing and 
promoting beneﬁts for tobacco-use treatment than assumed. 
■	 Businesses often do not know if their health plans cover tobacco-use treatment. 
They may assume their plans provide this coverage when they do not. 
■	 Though many businesses may see the beneﬁts to providing coverage for 
tobacco-use treatment, there may still be resistance to adding coverage 
because of the added costs and perceived low demand for these services. 
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Health Systems Contribute Support 
in the Face of Funding Cuts 
Oregon Tobacco Prevention and Education Program 
Objective: 
To build an effective partnership to support a broad-based quitline. 
Because of limited funds, the tobacco-use treatment component of Oregon’s 
Tobacco Prevention and Education Program (TPEP) was designed as a public– 
private partnership. The state quitline is a cornerstone of this partnership. Successful 
relationships between the state program and the health plans’ and health systems’ 
tobacco coordinators, quality improvement coordinators, health promotion staff, 
and clinician champions have been created as a result of this collaboration. 
When funding for TPEP was cut by the legislature because of a severe state budget 
shortfall, the day-to-day partners were quick to react. Several of the health systems’ 
medical directors testiﬁed at legislative hearings to explain the delivery systems’ 
interconnected dependence on the state program for tobacco-use treatment 
services. But when sustained funding for the tobacco program was pitted against 
the need to fund low-income health care, allegiances were split. The primary 
mission of those with the most inﬂuence—that is, the top executives and lobbyists 
for the health plans and health systems—is health care. So in this situation, the 
executives and lobbyists’ case in favor of protecting health care won over the 
medical directors’ concern about the loss of the state quitline. 
Lessons Learned: 
■	 The political positions of health systems are quite complex, which makes it very 
important for tobacco-control programs to work at multiple levels within the 
insurer and clinician organizations. 
■	 To better withstand state budget crises, a separate strategy is needed to build 
stronger alliances with leaders at the highest levels of the health systems that 
exert the strongest political clout. 
A strong coalition effort was able to gain renewed reimbursement for the quitline 
following a short period of extremely limited service. 
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Partnership Extends and Improves Tobacco-Use 
Treatment in Oklahoma 
Oklahoma Health Care Authority, Oklahoma State Department 
of Health, Oklahoma Tobacco Settlement Endowment Trust, 
Oklahoma Medicaid 
Objective: 
Build partnerships with professional organizations to increase provider 
provision of tobacco-use treatment. 
A 4-year strategic partnership brought improved access to tobacco-use treatments 
to the state of Oklahoma. The Oklahoma State Department of Health (OSDH), the 
Oklahoma Health Care Authority (OHCA), Medicaid, and the Oklahoma Tobacco 
Settlement Endowment Trust (TSET) created a formula for success that resulted in 
better information exchange, stronger interagency relationships, a convincing case 
for improved access to tobacco-use treatment medications based on health and 
economic data, and leverage of Master Settlement Agreement (MSA) resources 
that helped create a statewide helpline for tobacco users. 
From 1999 to the present, each partner has contributed resources and support. 
OSDH staff provided technical assistance to OHCA by 
■	 Presenting the Public Health Service’s Clinical Practice Guideline: Treating Tobacco 
Use and Dependence to health plan medical directors. 
■	 Providing model Medicaid contract language that OHCA could use as a guide. 
In 2003, TSET funded the statewide Oklahoma Tobacco Helpline, which is provided 
at no cost to all state residents regardless of their insurance status. OHCA, in 
turn, built its capacity in tobacco-dependence treatment issues and subsequently 
moved from providing limited coverage to providing comprehensive coverage that 
includes tobacco-dependence treatment medications. 
To achieve the goal of increasing access to medical coverage for tobacco 
dependence treatment, OHCA reviewed utilization data and model Medicaid 
contract language, coordinated training events, and participated in a tobacco-use 
treatment systems strategy session that was facilitated by a resource staff member 
from CDC’s Ofﬁce on Smoking and Health. Once OHCA’s Drug Utilization Review 
Committee, Medical Advisory Committee, and Board of Directors better understood 
potential utilization of the beneﬁt, they approved a policy to lift a preauthorization 
requirement and covered both prescription and over-the-counter tobacco-use 
treatment medications for Medicaid clients. This policy also allows medications 
for a second quit attempt if the client receives counseling from the Oklahoma 
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Tobacco Helpline or other approved tobacco-use treatment program. Furthermore, 
these medications do not count against the six-prescriptions-per-month limit that 
normally applies to Medicaid clients. 
The administrative rules of this policy were passed on November 13, 2003, and 
the expanded coverage took effect on January 1, 2004. Data show an increase in 
tobacco-use treatment claims in January of approximately 20% to 30% above the 
2003 calendar year averages. In February, when the preauthorization requirement 
was waived for the ﬁrst 90 days of therapy, there was an increase of more than 60% 
over the January claims. Data available for March 2004 indicate that the number 
of paid claims will either increase slightly over February or at least remain relatively 
constant. 
Approximately 40% of the Medicaid population is made up of smokers. By 
removing the prior authorization requirement, Medicaid was able to double the 
percentage of smokers receiving medications, but this continues to be a small 
fraction of tobacco users in the program. 
For the period of July 2003 through June 2004, a total of 732 clients received 
smoking-cessation products through the Medicaid fee-for-service program (due to 
computer problems, Oklahoma is assuming that the data presented below under-
represents demand). 
Product 
(unit) 
# of 
Claims 
Total 
Units 
Total 
Days 
Units/ 
Day Total Cost 
Total 
Clients 
Per 
Diem 
Zyban® 
(ea) 209 12,686 6,783 1.87 $24,129.78 165 $3.56 
Spray (ml) 28 1,325 591 2.24 $4,900.24 15 $8.29 
Inhalers 
(cart) 271 27,734 4,571 6.07 $23,073.65 162 $5.05 
Patches 
(ea) 749 16,774 16,846 1.00 $64,307.65 540 $3.82 
Gum (ea) 15 2,340 267 8.76 $924.87 12 $3.46 
Lozenges 
(ea) 25 2,532 281 9.01 $1,282.96 9 $4.56 
TOTAL 
FY 03 1,297 63,391 29,339 2.16 $118,619.15 732 $4.04 
In summary, 
■ 165 clients received Zyban®. 
■ 540 clients received nicotine replacement patches. 
■ 162 clients received inhalers. 
■ 732 individuals received medications. 
■ The standard course of medication was 90 days. 
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For the period of July 2004 through June 2005, a total of 2,531 clients received 
smoking cessation products through the Medicaid fee-for-service program. 
Product 
(unit) 
# of 
Claims 
Total 
Units 
Total 
Days 
Units/ 
Day Total Cost 
Total 
Clients 
Per 
Diem 
Zyban® 
(ea) 461 26,977 14,381 1.88 $44,893.99 319 $3.12 
Spray (ml) 91 5,860 1,353 4.33 $18,376.53 34 $13.58 
Inhalers 
(cart) 737 120,364 15,965 7.54 $89,288.40 476 $5.59 
Patches 
(ea) 3,341 78,692 77,810 1.01 $300,178.23 2,449 $3.94 
Gum (ea) 57 8,359 1,147 7.29 $3,532.78 47 $3.08 
Lozenges 
(ea) 100 16,160 1,768 9.14 $8,050.70 50 $4.55 
TOTAL 
FY 05 4,787 256,412 112,424 2.28 $464,320.63 2,531** $4.13 
* A claim should be considered a full course of treatment. Only the ﬁrst claim is a 
“free ride.” The second and subsequent claims require a preauthorization and a 
cessation program (helpline or other). 
** Total unduplicated clients for FY05. 
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In summary, 
■	 319 clients received Zyban®. 
■	 2,449 clients received nicotine replacement patches. 
■	 476 clients received inhalers. 
■	 2,531 individuals received medications. 
■	 The standard course of medication was 90 days. 
Lessons Learned: 
■	 Multiple-organization involvement was key in improving coverage under 
Medicaid. 
■	 Medicaid was willing to consider policy change when evidence demonstrated 
that beneﬁt utilization was severely limited by the requirement for prior 
authorization. 
■	 Having an informed public health champion in the Medicaid ofﬁce facilitated 
policy change. 
* A claim should be considered a full course of treatment. Only the ﬁrst claim is a 
“free ride.” The second and subsequent claims require a preauthorization and a 
cessation program (helpline or other). 
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Integrated Statewide Program Provides 
Spectrum of Services to Maine Citizens 
Partnership for a Tobacco-Free Maine 
Objective: 
Support a comprehensive tobacco-control program with a quitline and 
provision of medication as core elements. 
The Partnership for a Tobacco-Free Maine (PTM), a program of the Maine Bureau 
of Health, was created in 1997 with $3.5 million in funding from an increase in 
the state’s tobacco excise tax. In 2000, Master Settlement Agreement monies were 
placed into the Fund for a Healthy Maine, which supports programs to lower health 
risks, including programs to promote tobacco control, dental health, substance 
abuse prevention, and school health clinics, among others. Allocation from this 
fund increased revenues for PTM to $17.25 million in ﬁscal year 2001; however, 
since that time, annual funding has been reduced to about $13 to $15 million. 
The Tobacco Treatment Initiative, launched in 2001 by PTM, focuses on access 
to tobacco-use treatments. The initiative comprises 
■	 The Maine Tobacco HelpLine. 
■	 A medication voucher program. 
■	 Tobacco-treatment training to educate health professionals about tobacco 
use and to train and certify tobacco-control specialists. 
The HelpLine offers a total of four counseling sessions to any resident. HelpLine 
callers who have no insurance or beneﬁts for nicotine replacement therapy 
(NRT) can receive up to an 8-week supply of nicotine gum or patches. Through 
collaboration with a pharmacy beneﬁt manager, the HelpLine electronically 
submits voucher information authorizing callers to obtain NRT products at 
a Maine pharmacy of their choice. The voucher program is also expanding 
access to NRT products for patients of primary care clinics in several Maine 
communities. 
Maine works to integrate statewide tobacco-treatment services with the 
medical community, using an academic detailing model to conduct clinical 
outreach (Swartz et al., 2002). Across the state, practice-based educational 
sessions are provided to engage clinicians, nurses, and other clinical 
and administrative staff in implementing clinical quitlines to improve 
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tobacco-dependence treatment. The target audience includes staff of primary 
care and prenatal clinics, as well as medical specialty, dental, chiropractic, and 
nonallopathic practices. The sessions aim to increase the following: 
■	 Knowledge about tobacco dependence. 
■	 Awareness of the impact of supportive messages from health-care providers. 
■	 Use of PTM treatment resources and knowledge of Medicaid beneﬁts for 
tobacco-use treatment. 
■	 Support for integration and monitoring of evidence-based practice. 
In practices providing prenatal care, outreach consultants also promote the 
Every Mother’s Wish program. This program, which is tailored to pregnant 
smokers, provides self-help materials, a quitline video ﬁlmed in Maine, and 
referral by fax to the Maine Tobacco HelpLine. The HelpLine calls women who 
are referred for services and sends them an Every Mother’s Wish T-shirt. After 
completion of counseling sessions, a silver necklace is mailed to the participating 
expectant mother. 
As a result of conducting extensive clinical outreach, offering medication through 
the HelpLine, and using pharmacies to provide NRT, Maine has seen signiﬁcant 
upward trends in population-based use of its tobacco-treatment services. In the ﬁrst 
2 years, HelpLine use climbed from about 1.5% of adult smokers in Maine to about 
3% (from 3,300 to 6,800 per year). In 2003, 31% of callers reported hearing about 
HelpLine services through a doctor or other health professional. Half of all callers 
who received counseling were given a voucher for nicotine patches or gum. Just 
over half of HelpLine callers either had no insurance or were Medicaid beneﬁciaries. 
Finally, when use of services across geographic regions was examined, the volume 
of calls was found to be proportional to the total number of adult smokers residing 
in each region. 
The Maine Tobacco Treatment Initiative plans to continue focusing on increasing 
treatment capacity across the state. The Center for Tobacco Independence (CTI), 
the Treatment Initiative contractor, will train tobacco specialists each year, and 
the American Lung Association of Maine will oversee their certiﬁcation. CTI, in 
collaboration with the Maine Coalition on Tobacco and Health, will advocate for 
insurers (including public payers) to cover services delivered by certiﬁed tobacco 
specialists. And as previously mentioned, the medication voucher program will 
be expanded to provide access to NRT through public health clinics and other 
community sites. 
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Challenges and Opportunities: 
■	 Only one health insurance company provided medication coverage to Maine 
residents. 
■	 Coordinating with the business community to increase medication coverage so 
that state funding could be reserved for medications for the underinsured and 
uninsured required active HelpLine documentation of callers’ insurance status 
and name of insurance carrier (if any). 
■	 The state health department partnered with the large medical center to develop 
and implement the program. 
■	 Active collaboration between partners was necessary to develop a common 
language to overcome cultural differences among partner organizations. 
Lessons Learned: 
■	 Coordinating with a Pharmacy Beneﬁts Manager (PBM) facilitates the 
distribution of medications in a predominantly rural state. 
■	 Referring pregnant women to the HelpLine via fax provides greater access 
to this population. 
■	 Active data collection and reporting provides ongoing program support. 
■	 A scientiﬁc advisory board provides expertise and support for innovative 
programming. 
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State-Level Tobacco-Control Policy Activity: 
Sometimes a Health Plan Can Help 
Group Health Cooperative, The Center for Health Promotion, Inc. 
Objective: 
Build an effective partnership to ensure allocation of Master Settlement 
Agreement (MSA) funding for tobacco control. 
The Group Health Cooperative (GHC) in Washington State partnered with seven 
other community-based organizations, the Governor’s Ofﬁce, the Ofﬁce of the 
Attorney General, and the Washington State Department of Health to ensure that 
state legislators in Washington appropriated tobacco settlement dollars to fund 
health-care priorities, including tobacco-initiation prevention and tobacco-use 
treatment. Steps involved in securing this funding included developing a strong 
coalition of organizations to advocate for public policy aimed at reducing tobacco 
use. GHC served as a founding member of the coalition. Efforts were also made to 
establish a sound network of tobacco-control advocates at the grassroots level. 
Primary strategies employed in pursuit of public policy support for this funding 
included 
■	 Direct lobbying of members of the legislature. 
■	 Conducting a highly visible media campaign. 
■	 Emphasizing grassroots organizing and advocacy. 
A GHC lobbyist assisted with appeals to the legislature, and more than one-third 
of GHC clinicians signed tailored letters encouraging their legislators to support 
the use of tobacco settlement funds for tobacco control and other public health 
priorities. The health plan also provided funds for the media campaign. In addition, 
GHC representatives served on advisory councils to the attorney general and the 
department of health. 
As a result of these strategies, Washington became the ﬁrst state in the nation 
to commit all funding from the master tobacco settlement to tobacco control 
and other public health priorities. To solidify this commitment, the partnering 
organizations then worked to ensure the continuity of tobacco-control funding 
and increase funding levels by 
■	 Drafting an initiative that would increase the tobacco tax and guarantee more 
than $28 million per year in tobacco-control funding. 
■	 Creating a coalition of voluntary organizations, tobacco-control groups, national 
advocacy organizations, and health groups concerned with the uninsured in 
close communication with the state department of health. 
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■	 Obtaining signatures and conducting an effective campaign in support of 
the tobacco tax initiative. 
GHC remained very active in the coalition and provided signiﬁcant funding for 
lobbying in support of the tobacco tax initiative. The GHC Board of Directors 
formally endorsed this initiative, and its Governmental Affairs Ofﬁce worked to 
support it. Other GHC contributions included 
■	 Providing linkages between groups working on obtaining insurance for the 
uninsured and preventing tobacco use. 
■	 Speaking and writing opinion pieces or editorials in support of the tobacco 
tax initiative. 
■	 Mobilizing member support for the initiative. 
As a result of the coalition members’ efforts, including GHC, the tobacco tax 
initiative was passed in July 2005, receiving more than 60% of votes. 
Lessons Learned: 
■	 Partnerships between health-care systems, clinicians, and state agencies can 
be effective in obtaining funding. 
■	 Using health-care system support to lobby for an initiative can be effective. 
■	 Media campaigns add considerable visibility to the initiative. 
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Achieving Seamless Continuation of 
Tobacco-Use Treatment Services from 
Inpatient to Outpatient Settings 
Massachusetts General Hospital, Quit Smoking Service 
Objective: 
Electronically identify patient smoking status upon hospital admission to 
efﬁciently and effectively meet the needs of inpatient smokers and encourage 
post-discharge tobacco-use treatment. 
Many acute-care hospital patients are admitted because they have a smoking-related 
illness. A hospital admission is an opportunity for a smoker to try to quit. Getting sick 
often motivates patients to reconsider their life choices and motivates smokers to 
think about quitting, making the hospital stay a “teachable moment” for tobacco-use 
treatment. Because a hospital is a smoke-free environment, smokers may undergo 
nicotine withdrawal symptoms during their stay, including anxiety, irritability, 
impatience, restlessness, and difﬁculty concentrating and sleeping. These symptoms 
often go untreated because they are not recognized as nicotine withdrawal 
symptoms. The Joint Commission on Accreditation of Healthcare Organizations 
(JCAHO) standards mandate documentation of inpatient tobacco-use treatment 
counseling for all smokers admitted with myocardial infarction, congestive heart 
failure, and pneumonia. To address this, hospitals have expressed increasing interest 
in implementing system changes to comply with the accreditation standards. 
To meet the needs of inpatient smokers and encourage post-discharge tobacco-
use treatment, Massachusetts General Hospital’s Quit Smoking Service (MGH QSS) 
is working with the admissions department to electronically record each patient’s 
smoking status upon admission to the hospital. The MGH QSS envisions a seamless 
process in which a coordinator identiﬁes a list of inpatient smokers daily and a trained 
QSS counselor offers state-of-the-art counseling and drug treatment. All actions are 
then documented in the patient’s medical record, which helps the hospital improve 
compliance with JCAHO measures. Subsequently, and when appropriate, a referral 
is made to “Quitworks,” the Massachusetts state quitline. This proactive telephone-
based counseling program provides up to ﬁve counseling calls to a patient after 
discharge. Quitworks also provides feedback to the MGH QSS on the status and 
outcome of all referrals. The MGH QSS then contacts the patients’ primary care 
clinicians to provide updated information on the patient’s smoking status. 
Lessons Learned: 
■	 Having speciﬁc systems in place is imperative for a seamless tobacco-treatment 
process from admission to post-discharge. 
■	 Reliable identiﬁcation of a patient’s smoking status upon hospital admission is key 
to reaching the largest number of smokers. 
■	 Once a clinical service is developed, referral to the state quitline supports smoking 
cessation following discharge. 
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Conclusion

Effective treatments can more 
than double a person’s chances 
of successfully quitting smoking 
(Fiore et al., 2000). Smokers 
whose beneﬁts cover tobacco-
use treatment are more likely 
to undergo treatment and to 
quit successfully (Curry et al., 
1998; Cochrane Collaboration, 
2005). Data from businesses 
that have included tobacco-use 
treatment beneﬁts as part of their 
health insurance also show that 
providing this coverage is cost-
effective over time (Fiore et al., 
2000; Wagner et al., 1995; Warner 
et al., 1996). 
In the Clinical Practice Guideline: 
Treating Tobacco Use and Dependence, the U.S. Public Health Service presents 
recommendations aimed at improving access to effective treatment. 
Speciﬁcally, the guidelines recommend that every patient who uses tobacco 
should be offered at least brief treatment. Insurers and purchasers should 
include tobacco-dependence treatments as a beneﬁt so clinicians can be 
reimbursed for providing these services (Fiore et al., 2000). 
A systematic review of published studies on tobacco-use treatment was 
conducted on behalf of the Task Force on Community Preventive Services 
(Hopkins et al., 2001). This review, along with the PHS guidelines, reports 
that approaches used by health-care systems—where clinicians identify 
patients who use tobacco and discuss with them the importance of quitting, 
and where the clinicians receive information to assist them in helping their 
patients understand the risks associated with tobacco use—effectively 
increase both the number of clinicians who address tobacco use with their 
patients and the number of tobacco users who attempt to quit. Based on 
these ﬁndings, the Task Force recommends that interventions to increase 
tobacco-use treatment should include reminder systems for clinicians and 
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clinician education programs in conjunction with systems-change strategies, 
sustained media campaigns, availability of quitlines, reduction of patient 
out-of-pocket costs for treatment, and increases in excise taxes on tobacco 
(Centers for Disease Control and Prevention, 2000). 
To be successful advocates, public health professionals and others who are 
interested in and have opportunities to promote tobacco-use treatment or 
reimbursement for these services must understand what types of treatment 
have proven successful, why reimbursement is such an important issue, 
and how providing this beneﬁt affects the business sector in both the short 
and long term. They must also understand how the various components 
of the health-care system operate, the challenges they face, and their role 
in tobacco-use treatment. Armed with a comfortable level of knowledge 
about tobacco-use treatment and the ever-changing health-care arena, 
they can effectively approach health-care clinicians, health plans, insurers, 
and purchasers to educate them about effective strategies, assist them in 
identifying common goals, and plan a strategy for working successfully 
together to achieve those goals. 
Developing effective relationships between public health and health-care 
systems will require time, effort, and persistence. Providing support and 
assistance for incremental change, with an effective evaluation system, will 
be key components in supporting implementation of effective tobacco-
control initiatives. 
Although the PHS and Community Guide recommendations are not fully 
implemented, nor are desirable levels of service and coverage for tobacco-
use treatment in place, progress is being made, and a foundation has been 
laid. A strong science base exists for the treatment of tobacco dependence, 
and additional efforts are required to more effectively translate research 
into practice. We can now see that the needs and desires of health plans, 
clinicians, purchasers, and consumers—particularly as they relate to quitting 
tobacco—often overlap. As demonstrated in the case studies presented in 
this tool kit, progress often is achieved through collaborative efforts, and 
these efforts are resulting in signiﬁcant achievements in tobacco cessation. 
Implementation of the strategies contained in this guide, along with 
establishing strong partnerships with health-care insurers, purchasers, and 
businesses, will provide opportunities to increase the availability and use of 
effective treatments for tobacco use. Integration of comprehensive treatment 
strategies in health-care settings will result in decreases in the prevalence of 
tobacco use and reduce the public health burden of tobacco-related diseases 
in the United States. 
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Appendixes

Appendix A 
Glossary of Terms 
Academic detailing: Detailing similar to that used by the pharmaceutical 
industry, but it brings a training systems change message to ofﬁce practices. 
Broker: A person who is licensed by the state to sell and service contracts 
for multiple health plans. 
Capitation: A method of payment for health services in which the clinician 
is paid a ﬁxed amount for each patient served regardless of the actual 
number or nature of services provided. 
Copayment: A speciﬁed amount that the insured pays out of pocket at the 
time services are provided or prescription medications are purchased. 
Deductible: An amount the insured pays before insurance plan coverage 
is in effect. 
Earned media: Coverage of a story without paying for media placements. 
Examples include a letter to the editor, op-eds, coverage of press confer-
ences, appearance on talk shows or local news programs, and on-air or 
print interviews. Such coverage is called “earned media” because you 
have to develop materials, work with reporters, and expend resources 
to get it; however, you do not have to pay for the placement of the messages 
in the stories. 
Fee-for-service: A method of payment in which the health-care clinician 
is paid for services rendered instead of receiving a salary or receiving 
capitated payments (see above). In fee-for-service plans, the insurer may 
reimburse the plan member or pay the clinician directly after services have 
been provided. 
Fully insured: A type of coverage in which the insurance company is paid 
a monthly premium to assume complete risk for covered charges after the 
deductible and copayments are satisﬁed. 
Health insurance products: The speciﬁc types of health-care coverage 
that are offered by health plans and insurers and may contain differing 
coverage available for purchase. 
Health plan: An organization that offers a variety of health insurance 
products and may take responsibility for coordinating and improving the 
delivery of care. 
Health Plan Employment Data and Information Set (HEDIS): A 
set of standardized performance measures developed by the National 
Committee on Quality Assurance (NCQA) that is designed to ensure that 
purchasers and consumers have the information they need to reliably 
compare the performance of managed health-care plans. 
Indemnity products: Policies that provide coverage for health-care services 
on a fee-for-service basis. Often referred to as “traditional insurance,” these 
plans typically include a deductible and often also require a co-payment. 
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Integrated delivery system: A health-care service organization provides 
a full range of health-care services, including clinician services, hospital 
services, and outpatient and ancillary services. 
Joint Commission on Accreditation of Healthcare Organizations 
(JCAHO): An independent, not-for-proﬁt organization that sets standards 
and accredits health-care organizations and programs in the United States. 
Managed care: A type of health plan or product that typically involves a 
network of clinicians from whom members can receive care, some limitation 
on beneﬁts to members who choose to use clinicians outside the network, 
and some type of authorization or approval system that must be used when 
securing services. 
National Committee for Quality Assurance: The NCQA is a not-for-
proﬁt managed care accreditation organization that is designed to improve 
patient care and health plan performance in three ways: (1) through 
accreditation achieved through a rigorous, on-site review of key clinical 
and administrative processes that are performed at health plans’ requests; 
(2) through HEDIS, a tool used to measure performance in key areas; and 
(3) through a comprehensive member satisfaction survey. 
Point of service (POS): A type of coverage that allows plan members 
to choose a clinician within the plan’s network or one outside the network 
at the time that the care is needed. Choosing an out-of-network clinician 
usually involves higher costs. 
Preferred provider organizations (PPOs): Companies that arrange for 
lower fees with a network of health-care clinicians, giving policyholders a 
ﬁnancial incentive to seek care within that network. Members pay higher 
rates for services obtained from a clinician who is not part of their network. 
Primary care: General medical care that focuses on preventive care and 
the treatment of routine injuries and illnesses. 
Quality improvement organizations (QIOs): A group of clinicians 
and other health-care experts who are paid by the federal government 
to assess the care given to Medicare patients and to plan improvements. 
QIOs review complaints about the quality of care provided by hospitals 
(inpatient, outpatient, and emergency room care), skilled nursing facilities, 
and ambulatory surgical centers. They also assess services provided by 
home health agencies and private fee-for-service plans. QIOs usually 
serve on a statewide basis and may be valuable partners in monitoring the 
implementation of tobacco-control initiatives. 
Self-insured: A plan in which an employer or other group sponsor, 
rather than the health plan, is ﬁnancially responsible for paying expenses, 
including claims. Most large employers are self-insured, and they select 
a beneﬁts package for their employees. Self-insured companies usually 
contract with a health plan or independent company (known as third-party 
administrators) to process claims and handle other administrative needs. 
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Appendix B 
Essential Elements of an Effective 
Practice-Based Tobacco-Cessation 
System* 
1. Identiﬁcation of All Tobacco Users 
■	 Nursing staff or aides ask all patients with unknown status about 
their tobacco use when patients are placed in the examining room. 
(Children with daily secondhand smoke exposure are also identiﬁed.) 
■	 Charts are labeled to identify current use, recent (past year) use, 

former use, and nonuse.

■	 At subsequent visits, patients identiﬁed as current or recent users of 
tobacco are asked about use. 
2. Clinician Reminders 
■	 Information is provided about current use. 
■	 Prominent ﬂags call attention to this information, for example, using a 
colored identiﬁcation sticker or stamp (current, former, never). 
■	 Electronic medical records can prompt providers to obtain status and 
provide brief advice. 
3. Clinician Message 
Clinicians are reminded to 
■	 Assess patient’s interest in quitting (i.e., ask if ready to make a quit 
attempt now). 
■	 Advise patient of the importance of quitting. 
■	 Negotiate a quit date if interested in quitting. 
■	 Offer assistance and follow-up (medication and counseling). 
■	 Refer to state or National Network of Quitlines access numbers 
(1-800-QUIT NOW). 

They also are reminded that it is very difﬁcult for smokers to quit.

4. Assistance 
Provide 
■	 Counseling resources, preferably on-site or phone-based. 
■	 Medication (unless contraindicated). 
■	 Educational materials. 
5. Follow-up 
■	 Provide follow-up at all ofﬁce visits, based on #1 and #2 above. 
■	 Telephone patient soon after quit date to assess progress and reinforce 
action. 
* Solberg LI. Incentivising, facilitating, and implementing an ofﬁce tobacco cessation 
system. Tobacco Control 2000;9(Suppl 1):i37–i41. 
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Appendix C 
Essential Elements of an Effective 
Pediatric Practice-Based Tobacco-
Control System 
In addition to addressing tobacco-use treatment with adults in primary 
care or specialty settings, it is important to recognize the opportunities to 
intervene in pediatric settings. The pediatric setting provides an opportunity 
to prevent and eliminate tobacco use by young people and adults. Tobacco 
control in pediatric health care has three primary aims: (1) to eliminate 
childhood secondhand smoke (SHS) exposure, (2) to eliminate tobacco 
use by parents and guardians of pediatric patients, and (3) to prevent 
and eliminate tobacco use by pediatric patients. Steps to accomplish 
these goals are 
1. Systematically identify all tobacco users in the household. 
■	 Ask the parents and guardians of all pediatric patients about the 
smoking status of household members; this can be done at the front 
desk, during the recording of vital signs, or during the visit with 
the clinician. 
■	 Conﬁdentially ask all adolescent and pre-adolescent patients about 
their tobacco use. 
2. Systematically document smoking status in the medical record. 
■	 In the child’s medical record, document the smoking status of all 
smokers, including pediatric patients, their parents, and other 
household members. 
3. Inform and prompt child health-care clinicians about the 
child’s SHS exposure or tobacco use. 
■	 Use stickers or other indicators on the problem list or visit note to cue 
clinician inquiry and 5 A’s counseling on tobacco issues. 
■	 Electronic medical records can systematically prompt clinicians to 
inquire and follow up on the tobacco issues of pediatric patients and 
household members. 
4. Intervene directly and indirectly. 
■	 Create a smoke-free ofﬁce that includes posters, brochures, and 

information on enrolling smokers in evidence-based smoking-

cessation counseling, creation of smoke-free environments, and 

preventing smoking initiation.

i. 	 Advise: “I strongly advise that you establish a no-smoking policy 
in your home and car and that you quit smoking yourself. I can 
help you.” 
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ii. Prescribe medications for parent and adolescent tobacco 
dependence if appropriate. 
iii. Link smokers to quitlines and other tobacco-treatment services. 
iv. Provide more extensive ofﬁce counseling if possible. 
5. Follow up. 
■	 Address tobacco use with all smoking members of the household 
at future visits. 
■	 Remind nonsmoking families about smoke-free policies and the 
dangers of initiating tobacco use. 
Citation: Winickoff JP, Berkowitz AB, Brooks K, et al. State-of-the-art interventions for 
ofﬁce-based parental tobacco control. Pediatrics 2005;115(3):750–760. 
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Appendix D 
Making the Business Case 
for Tobacco Control*† 
States may ﬁnd it helpful to develop a fact sheet containing some or all of 
the following elements as a means of having key information in one place 
when beginning to work with health-care systems. 
■	 Provide state-speciﬁc and, if possible, organization-speciﬁc data on 
smoking prevalence. 
■	 Provide state-speciﬁc data on the cost of tobacco use in terms of direct 
and indirect health-care costs. 
■	 Use HEDIS data to estimate the percentage of smokers in a health plan. 
■	 Gather organization-speciﬁc HEDIS data on rates of advice to quit and 
assistance with quitting, and provision of medication (may be available 
from the state insurance ofﬁce). 
■	 Assess JCAHO data on rates of providing tobacco-dependence treatment 
for speciﬁed diagnostic categories (pneumonia, cardiovascular disease, 
lung disease). 
■	 Provide a clear description of the health beneﬁts of tobacco cessation. 
(See consumer materials from the 2004 publication The Health 
Consequences of Smoking: A Report of the Surgeon General at 
www.cdc.gov/tobacco.) 
■	 Describe the effectiveness of available treatments. (See PHS Web site.) 
■	 Describe the cost-effectiveness of available treatments. (See PCHT ﬁnance 
document.) 
■	 Describe short- and long-term costs and cost savings. (See Make It Your 
Business Campaign, www.TOFCO.org, and PACT Employer Document, 
www.endsmoking.org.) 
■	 Describe speciﬁc case examples of similar organizations that have 
adopted tobacco-control policies and programs. 
■	 Encourage self-insured businesses and health plans to use the www. 
businesscaseROI.org Web site for assessing costs for tobacco use and 
beneﬁt implementation. 
■	 Use the CDC document Coverage for Tobacco Use Treatments to supple-
ment the sheet you have developed. Available at www.cdc.gov/tobacco/ 
educational_materials/cessation/ReimbursementBrochureFull.pdf 
* The information in this resource sheet was adapted from: Paciﬁc Center on Health 
and Tobacco. Build a Financial Infrastructure: Health Plan Beneﬁts and Clinician 
Reimbursement. Portland, OR: The Center; 2003. Available at http://www. 
paccenter.org/public/reports_folder/reimbursement_web.pdf. 
†See State Highlights for state-speciﬁc tobacco-control data, www.cdc.gov/tobacco. 
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Appendix E 
For More Information 
Listed below are Web sites where you can ﬁnd the primary sources of 
information cited in this tool kit, as well as other policies and practices 
related to implementing tobacco-use treatment in the health-care setting. 
Guidelines and Key Documents 
■	 Treating Tobacco Use and Dependence is a U.S. Public Health Service 
(PHS)-sponsored clinical practice guideline that contains evidence-
based strategies and recommendations to support effective treatment 
for tobacco use and nicotine addiction. Available at http://www. 
surgeongeneral.gov/tobacco. 
■	 The Guide to Community Preventive Services provides information 
on the effectiveness of community-based interventions in three 
areas of tobacco-use prevention and control: (1) initiation of tobacco 
use, (2) tobacco-use treatment, and (3) reduction of exposure to 
environmental tobacco smoke. Articles, slide sets, and commentaries 
can be found at http://www.thecommunityguide.org/tobacco. 
■	 Crossing the Quality Chasm: A New Health System for the 21st Century is 
one in a series of reports developed by the Institute of Medicine’s Quality 
Initiative, which has focused on assessing and improving the nation’s 
quality of care. This report, which is the second of two published in the 
third phase of the initiative, presents key steps to promote evidence-
based practice and strengthen clinical information systems. Ordering 
information and access to online text is available at http://books.nap. 
edu/catalog/10027.html?onpi_newsdoc030101. 
■	 Surgeon General’s reports related to tobacco are available on the Centers 
for Disease Control and Prevention Web site at http://www.cdc.gov/ 
tobacco/sgrpage.htm. These include the reports cited as sources for 
this document. The PHS guidelines and related consumer and clinician 
materials also can be found at http://www.surgeongeneral.gov/tobacco. 
■	 A National Action Plan for Tobacco Cessation outlines a series of 
science-based action steps to reduce tobacco consumption and promote 
tobacco-use treatment, especially among minority and lower-income 
Americans. This report, sponsored by the American Legacy Foundation, 
the University of Wisconsin Center for Tobacco Research and 
Intervention, and the Journal of American Public Health, is available 
at http://www.ctri.wisc.edu/home/NatActionPlan%2002-04.pdf. 
■	 Preventing 3 million premature deaths and helping 5 million smokers 
quit: a national action plan for tobacco cessation, by Michael C. Fiore and 
colleagues at CDC, was published in the American Journal of Public Health 
in February 2004 (Vol. 94, No. 2, pages 205–210).  
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Data 
■	 Data on tobacco-use prevalence, morbidity, and mortality are available at 
the Centers for Disease Control and Prevention Web site at http://www. 
cdc.gov/tobacco/data.htm and http://www.cdc.gov/nchs. 
■	 Data on insurance status and type (national and by state) from a survey 
conducted jointly by the Bureau of Labor Statistics and the Bureau of 
the Census are available at http://ferret.bls.census.gov/macro/032002/ 
health/toc.htm. 
Pregnancy 
■	 A Cost-Beneﬁt/Cost-Effectiveness Analysis of Smoking Cessation for 
Pregnant Women, by J.S. Marks, J.P. Koplan, C.J.R. Hogue, et al. American 
Journal of Preventive Medicine 1990; 6(5):282–289. 
■	 The Partnership for Smoke-Free Families Program (PSF), which focuses 
on tobacco-use treatment for pregnant women and reducing exposure 
to tobacco smoke for infants and young children, has created a technical 
assistance manual that provides other health-care organizations with 
the information they need to create similar programs in their own 
health-care settings. Included are lessons learned, recommendations 
for program implementation, and samples of program materials. The 
manual is available in PDF format at http://www.smokefreefamilies. 
org/documents/PSFManual.pdf. 
Quality Assurance 
■	 The National Committee on Quality Assurance (NCQA) Web site 
provides information to help consumers, including representatives of 
large employers, make more informed decisions when choosing a health 
plan. The site also provides pages for health-care professionals that detail 
NCQA programs and NCQA publications, including publications on 
HEDIS. Available at http://www.ncqa.org/index.asp. 
■	 Accelerating Quality Improvement in Health Care: Strategies to Speed 
the Diffusion of Evidence-Based Innovations explores the reasons why 
clinicians and systems are slow to adopt many medical and health-care 
innovations, best practices, and ways to speed the diffusion of proven 
treatments and tools that improve the quality of health care. This report, 
commissioned papers, and related conference proceedings are available 
at http://www.nihcm.org. 
Finance and Business 
■	 Build a Financial Infrastructure: Health Plan Beneﬁts and Clinician 
Reimbursement combines evidence-based recommendations and the 
experiences of the Paciﬁc Center on Health and Tobacco (PCHT), a 
consortium of ﬁve western states (California, Oregon, Washington, 
Arizona, and Hawaii) concerning tobacco-cessation beneﬁts and clinician 
reimbursement. The report is designed to guide planning and decision 
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making by states and other groups that are working to implement 
tobacco-cessation programs. Also available are two summaries based 
on this report: (1) Health Insurance Beneﬁts for Treatment of Tobacco 
and (2) Invest in Tobacco Cessation for a Healthy, Productive Workforce 
(see next entry). Visit the PCHT Web site at http://www.paccenter.org. 
■	 Implementing Tobacco Interventions in the Real World of Managed Care, 
by J.F. Hollis, R. Bills, E. Whitlock, et al. Tobacco Control 2000; 9(Suppl I): 
i18-i24. 
■	 Invest in Tobacco Cessation for a Healthy, Productive Workforce is a brochure 
designed to help employers determine the cost of smoking to their 
businesses and estimate the cost of providing a tobacco-use cessation 
beneﬁt for their employees. This brochure, developed by the PCHT, is 
available at http://www.paccenter.org/public/reports_folder/cess_in_ 
wp_web.pdf. 
■	 Employers’ Smoking Cessation Guide: Practical Approaches to a Costly 
Workplace Problem, a guide published by the Professional Assisted 
Tobacco Cessation Therapy (PACT) consortium for large and 
small employers interested in enacting an affordable, effective 
smoking-cessation treatment program, is available at http://www. 
endsmoking.org. 
■	 Reimbursement for Smoking Cessation Therapy: A Health Care Practitioner’s 
Guide, a guide published by the PACT consortium for clinicians on how 
to obtain reimbursement for tobacco-use treatment services that also 
is helpful to employers in the implementation of a tobacco-cessation 
beneﬁt. Available at http://www.endsmoking.org 
■	 A guide to purchasing prevention beneﬁts that was developed for 
employers by North Carolina Prevention Partners contains information 
that may be helpful to employers in other states. The guide can be found 
at http://www.ncpreventionpartners.org/basic/eguide.htm. 
■	 Information on the costs of tobacco use to employers and information 
on smoke-free policies can be found in the publication Making Your 
Workplace Smokefree: A Decisionmaker’s Guide. The entire guide or selected 
chapters are available in PDF format at http://www.cdc.gov/tobacco/ 
research_data/environmental/etsguide.htm. 
■	 Making the Business Case for Smoking Cessation is a Web site that 
assists businesses in calculating the costs of smoking and the beneﬁts 
of cessation in terms meaningful to health-care delivery organizations 
and purchasers. Available at www.ahip.org. 
■	 The Oregon Make It Your Business Campaign encourages businesses 
to voluntarily help employees become tobacco-free and urges health 
insurers to include, as a standard beneﬁt, the medications and programs 
to help people quit smoking or chewing tobacco. The tool kit provides a 
step-by-step guide for businesses that want to “make it their business” 
to ensure a tobacco-free workforce. The tool kit also provides checklists, 
worksheets, and fact sheets. Available at http://www.tobaccofreeoregon. 
org/projects/miyb. 
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■	 www.businesscaseROI.org is a Web-based modeling tool that has been 
developed for managed care organizations to assess their tobacco-related 
disease costs and project potential costs for adding tobacco-dependence 
treatment beneﬁts. 
■	 “Coverage of Smoking Cessation Treatment by Union Health and 
Welfare Funds” (Barbeau E., Li Y., et al., American Journal of Public 
Health 2001;91(9):1412–1415) presents the results of a survey to determine 
the level of insurance coverage for smoking-cessation treatment and 
factors associated with coverage among health and welfare funds 
afﬁliated with a large labor union. Information on purchasing a copy of 
this article is available at http://www.ajph.org/cgi/reprint/91/9/1412. 
Quitlines 
■	 Linking a Network: Integrate Quitlines with Health Care Systems describes 
the role that tobacco quitlines play within health-care systems that 
deliver cessation services. The report combines emerging evidence on 
the efﬁcacy of quitlines with practical experience from case studies 
to provide a view of the value of partnerships between quitlines and 
health-care systems in developing a comprehensive statewide tobacco 
program. This brochure, developed by PCHT, is available at http://www. 
paccenter.org/public/reports_folder/linking_broch_web.pdf. 
■	 The North American Quitline Consortium is a forum designed to 
facilitate communication among leaders representing state and 
provincial health departments, quitline vendors, researchers, and 
national organizations in the United States and Canada in an effort to 
better understand quitline operations, promotion, and effectiveness. 
Information about the Consortium is available at http://ctcinfo.org. 
Medicaid 
■	 Links to data from a study conducted by the Center for Health and 
Public Policy Studies at the University of California, Berkeley, to track 
changes in coverage of tobacco-dependence treatments by state Medicaid 
programs and to publications concerning health insurance policy and 
tobacco control are available in two MMWR issues, January 30, 2004, 
and May 30, 2003. Available at www.cdc.gov/tobacco. 
■	 Medicaid Purchasing Speciﬁcations provide valuable contract language 
that can be used by employers and purchasers to structure beneﬁts 
related to tobacco-use prevention and tobacco-use treatment and 
are included in the sample purchasing speciﬁcations developed by 
CDC in conjunction with George Washington University Center 
for Health Services Research and Policy. Designed to assist states in 
implementing evidence-based tobacco-dependence treatment and 
improve Medicaid contracts, these speciﬁcations are available at 
http://www.gwhealthpolicy.org/newsps/tobacco. 
A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment | 87 
Databases and Information Services 
■	 The Center for Tobacco Cessation (CTC) serves as a source of science-
based information on tobacco-use treatment and works with national 
partners to expand the use of effective tobacco-dependence treatment 
and activities. CTC is jointly funded by the American Cancer Society 
and the Robert Wood Johnson Foundation. For resource tools, policy 
information, helpful links, and publications such as A Quick Reference 
Guide to Effective Tobacco Cessation Treatments and Activities, visit the 
CTC Web site at http://www.ctcinfo.org. 
■	 Information on tobacco-cessation counseling can be found on the 
American Cancer Society Web site located at http://www.cancer.org. 
Type “cancer AND counseling” in the search box located in the upper 
right corner of the home page. 
■	 Information on tobacco cessation and the effects of tobacco use on 
speciﬁc populations can be found on the American Lung Association 
Web site located at http://www.lungusa.org. 
■	 Information on tobacco cessation, including how to access state 
quitlines and patient self-help materials, can be found at http:// 
www.smokefree.gov. 
■	 The ttac exchange is an online newsletter produced by the Tobacco 
Technical Assistance Consortium at the Rollins School of Public Health 
at Emory University. This technical assistance tool is designed to bring 
information, strategies, and other tools to the tobacco-control community 
and to serve as a gateway to resources on current tobacco-control issues. 
For details, go to http://www.ttac.org. 
■	 Reaching Higher Ground: A Guide for Preventing, Preparing for, and 
Transforming Conﬂict for Tobacco Coalitions provides coalition leaders, 
members, and facilitators creative ways to address differences within 
a coalition and work successfully to achieve common goals. The guide 
is available online at http://www.ttac.org/products/pdfs/Higher_ 
Ground.pdf. 
■	 University of Michigan Hospital offers a CD discussing the development 
of smoke-free campuses for hospitals. To order this CD contact: UMHS 
Tobacco Consultation Service, 300 N. Ingalls 2D19/0430, Ann Arbor, MI 
48109-0430, Phone: 734-936-5988, Fax: 734-647-1516, quitsmoking@med. 
umich.edu, http://www.naquitline.org. 
■	 QuitWorks is a free statewide cessation resource program that was 
developed by the Massachusetts Department of Health in collaboration 
with all major health plans in Massachusetts. This guide was developed 
to help hospitals and health centers to integrate the comprehensive 
QuitWorks program into their practices. The document provides an 
overview of the QuitWorks program, the scientiﬁc evidence supporting 
it, and the resources necessary to implement this type of program in 
other states. This document is available at http://www.quitworks.org. 
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Partners 
■	 Centers for Medicare and Medicaid Services. Glossary. Available at 
http://www.cms.hhs.gov/glossary. 
■	 Next Generation California Tobacco Control Alliance. A Statewide Strategy 
for Smoking Cessation in California. Sacramento, CA: The Alliance; 2002. 
Available at http://www.tobaccofreealliance.org/Resources.htm. 
■	 Quality Mapping Solutions Web site. Available at http://qmsonline.com/ 
jcaho.htm. 
Centers for Disease Control and Prevention 
■	 The Centers for Disease Control and Prevention’s Ofﬁce on Smoking and 
Health (OSH) has a Web site for Tobacco Information and Prevention 
Source (TIPS) that contains a wealth of information about tobacco use, 
economic costs, and policies. The TIPS Web site can be found at http:// 
www.cdc.gov/tobacco. 
■	 The Cessation Resource Center Web site contains cessation-focused 
resources developed and tested by state tobacco-control programs, 
OSH partner organizations, and other federal agencies. These cessation 
resources are available to registered state and organizational tobacco-
cessation programs. Available at http://apps.nccd.cdc.gov/crc. 
■	 Designing and Implementing an Effective Tobacco Counter-Marketing 
Campaign. Atlanta, Georgia: U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention, National Center for 
Chronic Disease Prevention and Health Promotion, Ofﬁce on Smoking 
and Health. First Edition October 2003. Available at www.cdc.gov/ 
tobacco. 
■	 Telephone Quitlines: A Resource for Development, Implementation, 
and Evaluation is a guide that discusses the role of quitlines in a 
comprehensive tobacco-control program and provides detailed 
information on quitline needs and resources. Available at http:// 
www.cdc.gov/tobacco/quitlines.htm. 
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Part I: Organization of the Health-Care Delivery System 
Appendix F 
Practice Assessment Document 
This document was adapted for the Smoke-Free Families dissemination 
project and can be further adapted for general adult populations by 
removing the pregnancy references. 
Components 
Support from 
leadership in 
our practice for 
addressing tobacco 
use in pregnancy… 
Score 0 1 2 3 4 5 6 7 8 9 10 11 
Little Support 
…does not exist, or 
there is a little interest. 
Basic Support 
…is reﬂected in 
vision statements 
and business plans, 
but no resources are 
speciﬁcally earmarked 
to execute the work. 
Good Support 
…is reﬂected by senior 
leadership and speciﬁc 
dedicated resources 
(dollars and personnel). 
Full Support 
…is part of the system’s 
long-term planning 
strategy, receives 
necessary resources, 
and speciﬁc people 
are held accountable. 
Organizational goals 
incorporated into 
overall activities 
in our practice for 
addressing tobacco 
use in pregnancy… 
Score 
…do not exist. 
0 1 2 
…exist but are not 
actively reviewed. 
3 4 5 
…are measurable and 
reviewed. 
6 7 8 
…are measurable, 
reviewed routinely, and 
incorporated into plans 
for improvement. 
9 10 11 
Quality improve-
ment strategies for 
addressing tobacco 
use in pregnancy in 
our practice… 
Score 
…are ad hoc and not 
organized or supported 
consistently. 
0 1 2 
…utilize ad hoc 
approaches for targeted 
problems as they 
emerge. 
3 4 5 
…utilize a proven 
improvement strategy 
such as academic 
detailing or systems 
changes for addressing 
targeted problems. 
6 7 8 
…include a proven 
improvement strategy 
and use it proactively in 
meeting organizational 
goals. 
9 10 11 
External (state, 
health plans, etc.) 
ﬁnancial incentives 
for addressing 
tobacco use in 
pregnancy… 
Score 
…are not used to 
inﬂuence clinical 
performance goals. 
0 1 2 
…are used to inﬂuence 
utilization and costs of 
tobacco screening and 
treatment. 
3 4 5 
…are used to support 
patient care goals. 
6 7 8 
…are used to motivate 
and empower providers 
to support patient care 
goals. 
9 10 11 
Senior leaders 
in our practice 
(e.g., CEO, Medical 
Director, Director 
of Operations)… 
Score 
…do not encourage 
enrollment of pregnant 
smokers into smoking 
cessation programs. 
0 1 2 
…do not make 
improvements 
related to smoking in 
pregnancy a priority. 
3 4 5 
…encourage 
improvement efforts in 
addressing smoking in 
pregnancy. 
6 7 8 
…visibly participate in 
improvement efforts in 
addressing smoking in 
pregnancy. 
9 10 11 
Adapted from the MacColl Institute for Healthcare Innovation, Group Health Cooperative © 2000. 
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Part III: Self-Management Support 
Part II: Community Linkage 
Components 
Linking pregnant 
patients who smoke 
to resources outside 
our practice… 
Score 0 1 2 3 4 5 6 7 8 9 10 11 
Little Support 
…is not done 
systematically. 
Basic Support 
…is limited to a list of 
identiﬁed community 
resources in an 
accessible format. 
Good Support 
…is accomplished 
through a designated 
staff person or resource 
responsible for ensuring 
providers and patients 
make maximum use of 
community resources. 
Full Support 
…is accomplished 
through active 
coordination between 
the health system, 
community service 
agencies, and patients. 
Components 
Assessment and 
documentation of 
self-management 
needs and activities 
to help pregnant 
patients who smoke 
avoid tobacco use… 
Score 
Little Support 
…are not done. 
0 1 2 
Basic Support 
…are expected. 
3 4 5 
Good Support 
…are completed in a 
standardized manner. 
6 7 8 
Full Support 
…are regularly assessed 
and recorded in 
standardized form 
linked to a treatment 
plan available to 
practice and patients. 
9 10 11 
Self-management 
support for the 
pregnant woman 
who smokes and is 
interested in 
stopping… 
Score 
…is limited to 
the distribution 
of information 
(pamphlets, booklets). 
0 1 2 
…is available by referral 
to self-management 
classes or educators. 
3 4 5 
…is provided by trained 
clinical educators who 
are designated to 
do self-management 
support, afﬁliated with 
the practice, and see 
patients on referral. 
6 7 8 
…is provided by clinical 
educators afﬁliated with 
the practice, trained in 
patient empowerment 
and problem-solving 
methodologies, and 
see most patients with 
chronic illness. 
9 10 11 
Support and 
addressing concerns 
of patients and 
families regarding 
smoking in 
pregnancy as 
they are raised… 
Score 
…is not consistently 
done. 
0 1 2 
…is provided for 
speciﬁc patients and 
families through 
referral. 
3 4 5 
…is encouraged, 
and peer support, 
groups, and mentoring 
programs are available. 
6 7 8 
…is an integral 
part of care and 
includes systematic 
assessment and routine 
involvement in peer 
support, groups, or 
mentoring programs. 
9 10 11 
Effective behavior 
change interventions 
such as counseling 
and assistance for 
quitting smoking… 
Score 
…are not available. 
0 1 2 
…are limited to 
the distribution of 
pamphlets, booklets, 
or other written 
information. 
3 4 5 
…are available only by 
referral to specialized 
centers staffed by 
trained personnel. 
6 7 8 
…are readily available 
and an integral part of 
routine care. 
9 10 11 
Adapted from the MacColl Institute for Healthcare Innovation, Group Health Cooperative © 2000. 
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Part IV: Decision Support 
Components 
Evidence-based 
guidelines for 
prenatal smoking 
cessation… 
Score 
Little Support 
…are not available. 
0 1 2 
Basic Support 
…are available but are 
not integrated into 
care delivery. 
3 4 5 
Good Support 
…are available and 
supported by provider 
education. 
6 7 8 
Full Support 
…are available, 
supported by pro-
vider education, and 
integrated into care 
through reminders and 
other proven behavior 
change methods. 
9 10 11 
Involvement 
of specialists in 
addressing smoking 
in pregnancy… 
Score 
…is primarily through 
traditional referral. 
0 1 2 
…is achieved through 
specialist leadership to 
enhance the capacity 
of the overall system 
to routinely implement 
guidelines. 
3 4 5 
…includes specialist 
leadership and 
designated specialists 
who provide clinical 
care team training. 
6 7 8 
…includes specialist 
leadership and special-
ist involvement in 
improving the care 
of pregnant patients. 
9 10 11 
Education related to 
effective methods 
to address smoking 
in pregnancy for 
individuals involved 
in providing care 
to patients… 
Score 
…is provided 
sporadically. 
0 1 2 
…is provided 
systematically through 
traditional methods. 
3 4 5 
…is provided using 
optimal methods (e.g., 
academic detailing). 
6 7 8 
…includes training 
all practice teams in 
regard to smoking 
cessation methods such 
as population-based 
management and self-
management support. 
9 10 11 
Informing patients 
about guidelines 
and risks associated 
with smoking in 
pregnancy… 
Score 
…is not done. 
0 1 2 
…happens on request 
or through developed 
protocols. 
3 4 5 
…is done through 
speciﬁc patient 
education materials. 
6 7 8 
…includes speciﬁc 
materials developed for 
patients that describe 
their role in achieving 
guideline adherence. 
9 10 11 
Adapted from the MacColl Institute for Healthcare Innovation, Group Health Cooperative © 2000. 
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Part V: Delivery System Design 
Components 
Our practice 
functioning as a 
team… 
Score 
Little Support 
…is not addressed. 
0 1 2 
Basic Support 
…is addressed by 
assuring the availability 
of individuals with 
appropriate training 
in key elements of 
smoking cessation. 
3 4 5 
Good Support 
…is assured by regular 
team meetings to 
address guidelines, roles 
and accountability, and 
problems in addressing 
smoking in pregnancy. 
6 7 8 
Full Support 
…is assured by teams 
who meet regularly and 
have clearly deﬁned 
roles including patient 
self-management 
education, proactive 
follow-up, and resource 
coordination and 
other skills in smoking 
cessation. 
9 10 11 
Practice team 
leadership… 
Score 
…is not recognized in 
the practice or by the 
system. 
0 1 2 
…is assumed by 
the organization 
to reside in speciﬁc 
organizational roles. 
3 4 5 
…is assured by the 
appointment of a 
team leader, but the 
individual roles in 
smoking cessation are 
not deﬁned. 
6 7 8 
…is guaranteed by 
the appointment of 
a team leader who 
assures that roles and 
responsibilities for 
addressing smoking in 
pregnancy are clearly 
deﬁned. 
9 10 11 
The system we use 
for appointments… 
Score 
…can be used to 
schedule a variety of 
appointment types. 
0 1 2 
…assures scheduled 
follow-up with prenatal 
patients. 
3 4 5 
…is ﬂexible and 
can accommodate 
innovations such as 
customized visit length 
or group visits. 
6 7 8 
…includes organization 
of care that facilitates 
the patient seeing 
multiple providers in a 
single visit. 
9 10 11 
Follow-up treatment 
for pregnant patients 
who smoke… 
Score 
…is scheduled by 
patients or providers in 
an ad hoc fashion. 
0 1 2 
…is scheduled by the 
practice in accordance 
with guidelines. 
3 4 5 
…is assured by the 
practice team by 
monitoring patient 
utilization. 
6 7 8 
…is customized to 
patient needs, varies 
in intensity and 
methodology (phone, 
in person, email), 
and assures guideline 
follow-up. 
9 10 11 
Collaborating with 
other providers the 
patient has regarding 
tobacco cessation… 
Score 
…is not a priority. 
0 1 2 
…depends on written 
communication 
between primary 
care providers 
and specialists, 
case managers, or 
disease management 
companies. 
3 4 5 
…between primary care 
providers and specialists 
and other relevant 
providers is a priority 
but not implemented 
systematically. 
6 7 8 
…is a high priority, 
and smoking cessation 
interventions include 
active coordination 
between primary care, 
specialists, and other 
relevant groups. 
9 10 11 
Adapted from the MacColl Institute for Healthcare Innovation, Group Health Cooperative © 2000. 
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Part VI: Clinical Information Systems 
Components 
A list of patients who 
have been identiﬁed 
as pregnant patients 
who smoke… 
Score 
Little Support 
…is not available. 
0 1 2 
Basic Support 
…includes name, 
diagnosis, contact 
information, and date 
of last contact either on 
paper or in a computer 
database. 
3 4 5 
Good Support 
…allows queries to sort 
sub-populations by 
clinical priorities. 
6 7 8 
Full Support 
…is tied to guidelines 
that provide prompts 
and reminders about 
needed services. 
9 10 11 
Reminders to 
providers (stickers, 
ﬂow sheets, etc.) 
about delivering 
information 
related to smoking 
cessation… 
Score 
…are not available. 
0 1 2 
…include general 
notiﬁcation of smoking 
during pregnancy 
but does not describe 
needed services at time 
of encounter. 
3 4 5 
…include indications 
of needed service for 
populations of patients 
through periodic 
reporting. 
6 7 8 
…include speciﬁc 
information for the 
team about guideline 
adherence at the time 
of individual patient 
encounters. 
9 10 11 
Feedback to your 
team on the status 
of success related 
to approaches 
implemented to 
address smoking 
in pregnancy… 
Score 
…is not available or 
is non-speciﬁc to the 
team. 
0 1 2 
…is provided at 
infrequent intervals 
and is delivered 
impersonally. 
3 4 5 
…occurs at frequent 
enough intervals to 
monitor performance 
and is speciﬁc to the 
team’s population. 
6 7 8 
…is timely, speciﬁc to 
the team, routine, and 
personally delivered 
by a respected opinion 
leader to improve team 
performance. 
9 10 11 
Patient treatment 
plans for pregnant 
women who smoke… 
Score 
…are not expected. 
0 1 2 
…are achieved 
through a standardized 
approach. 
3 4 5 
…are established 
collaboratively 
and include self-
management as 
well as clinical goals. 
6 7 8 
…are an established 
collaborative approach 
that includes self-
management as well as 
clinical management. 
Follow-up occurs and 
guides care at every 
point of service. 
9 10 11 
Process Used: 
Brieﬂy describe the process you used to ﬁll out the form (e.g., reached consensus in a face-to-face meeting; ﬁlled out by the team leader in consultation 
with other team members as needed; each team member ﬁlled out a separate form and the responses were averaged). 
Adapted from the MacColl Institute for Healthcare Innovation, Group Health Cooperative © 2000. 
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Appendix G 
Coverage for Tobacco-Use Cessation Treatments 
COVERAGE FOR TOBACCO
USE CESSATION TREATMENTS 
 
Why Is Health Insurance Coverage for Tobacco Use Treatments So 
Important? 
• Smoking is costly to employers both in terms of smoking-related medical expenses and lost 
productivity. 
– Ten percent of smokers alive today are living with a smoking-related illness.1 
– Men who smoke incur $15,8002 (in 2002 dollars) more in lifetime medical expenses and are 
absent from work 4 days more per year than men who do not smoke.3 
– Women who smoke incur $17,5002 (in 2002 dollars) more in lifetime medical expenses and are 
absent from work 2 days more each year than nonsmoking women.3 
– In 1999, each adult smoker cost employers $1,760 in lost productivity and $1,623 in excess 
medical expenditures.4 
– Smoking causes heart disease, stroke, multiple cancers, respiratory diseases, and other costly ill-
nesses. Secondhand smoke causes lung disease and lung cancer.5, 6 
– Smoking increases costly complications of pregnancy, such as pre-term delivery and low birth-
weight infants.7 
• Smoking is the leading preventable cause of death in the United States.8, 9 Smokers who quit will, 
on average, live longer and have fewer years living with disability.10 
• About 23% of American adults and 28% of teens smoke.11, 12 More than 70% want to quit, but few 
succeed without help.11 Tobacco use treatment doubles quitting success rates.9 
What Treatments Are Available? How Effective Are They? 
Smoking cessation treatments have been found to be safe and effective. These include counseling and 
medications, or a combination of both.9 
• Face-to-face counseling and interactive telephone counseling are more effective than services that 
only provide educational or self-help materials. 9, 16 
• The effectiveness of counseling services increases as their intensity (the number and length of 
sessions) increases.9 
• Smokers are more likely to use telephone counseling than to participate in individual or group 
counseling sessions.16, 17 
Why, 
What, 
and 
How 
Paying for tobacco use cessation treatments is the single most cost-effective 
health insurance benefit for adults that can be provided to employees.13, 14, 15 
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Coverage for Tobacco 
Use Cessation Treatment: 
Why, What, and How 
• The Food and Drug Administration has approved six first-line medications to help smokers quit: 
– Five are nicotine replacement therapies that relieve withdrawal symptoms. They include nicotine 
gum, patch, nasal spray, inhaler, and lozenge.9 
– The sixth medication, bupropion SR (sustained release), is a non-nicotine medication that is 
thought to reduce the urge to smoke by affecting the same chemical messengers in the brain that 
are affected by nicotine.9 
Type Form Common Brand Name(s) Availability 
Nicotine 
Replacement 
Therapy 
Gum Nicorette® Over-the-counter (OTC) 
Patch Nicoderm®, Habitrol®, 
Prostep®, Nicotrol® 
OTC and prescription 
Inhaler Nicotrol® Prescription 
Nasal Spray Nicotrol® Prescription 
Lozenge Commit®** OTC 
Bupropion SR Pill Zyban®, Wellbutrin® Prescription 
Prescription and Over-the-Counter Tobacco Cessation Medications* 
* Approved by the Food and Drug Administration (FDA) and addressed in the 2000 PHS Guidelines. 
** Received FDA approval on October 31, 2002, therefore not addressed in the 2000 PHS Guidelines. 
Scientifically proven treatments can double a person’s chances of quitting smoking.9 
How Should Benefits Be Designed? 
Benefits for proven tobacco-use cessation treatments have been shown to increase treatment use and the 
number of successful quitters; therefore, both the Public Health Service-sponsored Clinical Practice 
Guideline, Treating Tobacco Use and Dependence, and the Community Preventive Services Task Force 
recommend that all insurers provide tobacco cessation benefits that do the following: 
• Pay for counseling and medications, together or separately.9 
– Cover at least four counseling sessions of at least 30 minutes each,9 including proactive telephone 
counseling and individual counseling. While classes are also effective, few smokers attend them.19 
– Cover both prescription and over-the-counter nicotine replacement medication and bupropion 
(see medication table).9 
– Provide counseling and medication coverage for at least two smoking cessation attempts per year.20, 21 
– Eliminate or minimize co-pays or deductibles for counseling and medications, as even small 
copayments reduce the use of proven treatments.18, 19 
What Is the Role of Health Insurance Coverage in Tobacco-Use 
Cessation? 
• Health insurance coverage of medication and counseling increases the use of effective treatments.18 
•	 Although 66% of Americans under the age of 65 are insured through an employer,22 only 24% of

employers offer any coverage for tobacco-use treatment.23

Coverage of tobacco-use cessation treatment increases both use of effective treatment 
and the number of successful quit attempts.18 
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How Much Do Cessation Benefits Cost? Are They Cost-Effective? 
• Tobacco cessation is more cost-effective than other common and covered disease prevention 
interventions, such as the treatment of hypertension and high blood cholesterol.14 
• Cost analyses have shown tobacco cessation benefits to be either cost-saving or cost-neutral.3, 20 
Overall, cost/expenditure to employers equalizes at 3 years; benefits exceed costs by 5 years.3 
• It costs between 10 and 40 cents per member per month to provide a comprehensive tobacco 
cessation benefit (costs vary based on utilization and dependent coverage).19, 24 
• In contrast, the annual cost of tobacco use is about $3,400 per smoker or about $7.18 for each 
pack of cigarettes sold.4 
• Neonatal health care costs related to smoking are equivalent to $704 for each maternal smoker.4 
Randomized controlled trials indicate that a smoking cessation program for pregnant women can 
save as much as $6 for each $1 spent.25 
What Is the Experience of Companies and Health Plans Providing 
This Benefit? 
Businesses that have included a tobacco cessation 
benefit report that this coverage has increased 
the number of smokers willing to undergo 
treatment and increased the percentage that 
successfully quit.24, 26 
• Union Pacific Railroad has experienced a 
decrease smoking prevalence among its 
employees from 40% to 25% in the 7-year 
period that it has offered a cessation benefit as 
part of a comprehensive cessation program.26 
• At the Group Health Cooperative in Seattle, 
enrollees offered full coverage for smoking 
cessation treatments were four times as likely to 
try to quit and four times as likely to succeed.24 
How Do I Get More Information? 
Listed below are Web sites where you can find additional information on tobacco-use cessation or 
reimbursement for cessation treatment. 
Smoking Cessation Treatment Effectiveness 
• Treating Tobacco Use and Dependence is a Public Health Service-sponsored clinical practice 
guideline that contains evidence-based strategies and recommendations to support effective treat-
ment for tobacco use and nicotine addiction. The guideline and related consumer and clinician 
materials also can be found at http://www.surgeongeneral.gov/tobacco/. 
• The Guide to Community Preventive Services provides information on the effectiveness of com-
munity-based interventions in three areas of tobacco-use prevention and control: (1) initiation of 
tobacco use, (2) cessation, and (3) reduction of exposure to environmental tobacco smoke. Articles, 
slide sets, and commentaries can be found at http://www.thecommunityguide.org/tobacco/. 
• Surgeon General’s Reports related to tobacco are available on the Centers for Disease Control and 
Prevention Web site at http://www.cdc.gov/tobacco/sgrpage.htm. 
• Data on tobacco-use prevalence and tobacco-related morbidity and mortality rates can be found 
at two Centers for Disease Control and Prevention Web sites: http://www.cdc.gov/tobacco/data.htm 
and http://www.cdc.gov/nchs/. 
Coverage for Tobacco 
Use Cessation Treatment: 
Why, What, and How 
– Reduced life insurance costs 3, 28 
How Tobacco Cessation Cuts Cost 
• Over time, tobacco-use cessation benefits 
generate financial returns for employers in 
four ways: 
– Reduced health care costs 3, 27 
– Reduced absenteeism 3, 28, 29 
– Increased on-the-job productivity 3, 28, 29 
• Benefits realized more immediately include: 
– Increases in employee productivity 3, 29 
– Reductions in smoking-attributed 
neonatal health care costs 25 
• Employers who provide a smoke-free work-
place may also realize savings on fire insurance 
and costs related to items such as ventilation 
services and property repair and upkeep.3, 28 
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• Sample purchasing specifications, which provide valuable contract language that can be used by 
employers and purchasers to structure benefits related to tobacco-use prevention and cessation, are 
available to assist states in implementing evidence-based tobacco-dependence treatment and 
improve Medicaid contracts. These sample specifications, developed by CDC in conjunction with 
George Washington University Center for Health Services Research and Policy, are available at 
http://www.gwhealthpolicy.org/newsps/tobacco. 
• Build a Financial Infrastructure: Health Plan Benefits and Provider Reimbursement combines 
evidence-based recommendations with the experiences of the Pacific Center on Health and Tobacco 
(PCHT), a consortium of five western states (California, Oregon, Washington, Arizona, and Hawaii) 
concerning tobacco cessation benefits and provider reimbursement. The report is designed to guide 
planning and decision-making by states and other groups that are working to implement tobacco 
cessation programs. Also available are two summaries based on this report: (1) Health Insurance 
Benefits for Treatment of Tobacco Dependence and (2) Invest in Tobacco Cessation for a Healthy, 
Productive Workforce. Visit the PCHT Web site at http://www.paccenter.org. 
• Employers’ Smoking Cessation Guide: Practical Approaches to a Costly Workplace Problem, a 
guide published by the Professional Assisted Cessation Therapy (PACT) consortium for large and 
small employers interested in enacting an affordable, effective smoking cessation program, is avail-
able at http://www.endsmoking.org. 
• Reimbursement for Smoking Cessation Therapy: A Health Care Practitioner’s Guide, published 
by the Professional Assisted Cessation Therapy (PACT) consortium for health care providers on how 
to obtain reimbursement for cessation services can be helpful to employers in the implementation of a 
tobacco cessation benefit. It is available at http://www.endsmoking.org. 
• Data on insurance status and type (national and by state) from a survey conducted jointly by the 
Bureau of Labor Statistics and the Bureau of the Census are located at 
http://ferret.bls.census.gov/macro/032002/health/toc.htm. 
• Coverage of Smoking Cessation Treatment by Union Health and Welfare Funds [Barbeau E, Li 
Y, et al. American Journal of Public Health 2001; 91(9):1412-1415]. This article presents the results 
of a survey to determine the level of insurance coverage for smoking cessation treatment and factors 
associated with coverage among health and welfare funds affiliated with a large labor union. 
Information on purchasing a copy of this article is located at 
http://www.ajph.org/cgi/reprint/91/9/1412. 
• Data concerning changes in coverage of tobacco-dependence treatments by state Medicaid 
programs from a study conducted by the Center for Health and Public Policy Studies at the 
University of California, Berkeley, and links to publications addressing health insurance policy and 
tobacco control are available at http://chpps.berkeley.edu/smoking/index.htm. 
• A guide to purchasing prevention benefits that was developed for employers in North Carolina 
by North Carolina Prevention Partners contains information that may be helpful to employers in 
other states. The guide can be found at http://www.ncpreventionpartners.org/basic/eguide.htm. 
Resources Useful for Employers 
• Making Your Workplace Smokefree: A Decisionmaker’s Guide provides information on the costs 
of tobacco use to employers. The entire guide or selected chapters are available in PDF format at 
http://www.cdc.gov/tobacco/research_data/environmental/etsguide.htm. 
• Quitline Resource Guide, published by CDC’s Office on Smoking and Health, provides 
information on contracting for quitline services and key components of quitline services, such as 
counseling, staffing, quality assurance, promotion, and evaluation. The guide (in press when 
this document was published) will be available at http://www.cdc.gov/tobacco. 
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• Linking a Network: Integrate Quitlines with Health Care Systems, published by the Pacific 
Center on Health and Tobacco, describes the importance of linking state quitlines with health care 
systems and presents case studies describing linkages with health care systems. This resource (in press
when this document was published) will be available at http://www.paccenter.org. 
 
• A Quick Reference Guide to Effective Tobacco Cessation Treatments and Activities and other 
resources are available from the Center for Tobacco Cessation’s (CTC) Web site at 
http://www.CTCinfo.org. CTC, which is jointly funded by the American Cancer Society and 
The Robert Wood Johnson Foundation, serves as a source of science-based information on cessation 
and works with national partners to expand the use of effective tobacco dependence treatment and 
activities. 
• Information on tobacco cessation counseling can be found on the American Cancer Society Web 
site located at http://www.cancer.org. Type “cancer AND counseling” in the search box located in 
the upper right corner of the home page. 
• Information on tobacco cessation and the effects of tobacco use on specific populations can be 
found on the American Lung Association Web site located at http://www.lungusa.org. 
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Reducing the Burden of Smoking on 
Employee Health and Productivity 
A Practical Guide to Working with Health-Care Systems on Tobacco-Use Treatment 
This issue brief summarizes information presented during the fifth in a series of Business Consultations 
sponsored by the Centers for Disease Control and Prevention (CDC). The National Business Group on 
Health and the CDC convened Reducing the Burden of Smoking on Employee Health and 
Productivity, a consultation with business and health leaders, on May 28, 2003, in Washington, DC. 
Statistics and figures that are not annotated with a source were presented by the speakers. 
Why Employers Promote Tobacco Use Cessation 
The human and financial costs associated with tobacco use are enormous. In addition 
to the incalculable physical and emotional distress brought on by tobacco related 
diseases and deaths, tobacco use exacts a high price from employers via greater costs 
for health care and life insurance, increased absenteeism and lower rates of 
presenteeism and productivity. 
Employers can combat the negative health 
and economic effects of tobacco use by 
integrating tobacco cessation treatment 
into their mix of employee benefits. In 
fact, paying for an employee’s tobacco 
cessation treatment provides more return 
on investment than any other adult 
treatment or prevention benefit. 
The National Business Group on Health 
is committed to providing employers with 
practical information about the 
advantages of covering tobacco cessation 
benefits. This issue brief is one such 
resource. Here you will find information 
on the prevalence and health impact of 
smoking, proof of the economic cost of 
tobacco related illnesses, guidelines for designing and implementing the most effective 
tobacco cessation benefits, and examples from several large employers who have 
benefited from offering coverage for tobacco use treatment. 
Calculating the Cost of Smoking 
To calculate the cost of smoking for an individual company, consider the following: 
• The overall prevalence of tobacco use is about 25% of the total population, 
which can be generalized to any workplace population. 
• The CDC estimates that companies spend $3,856 per smoker per year in 
direct medical costs and lost productivity. 
(Number of employees) x (0.25) x ($3,856 per year) = Estimated cost per 
year in excess medical expenditures and lost productivity 
Example: 
• (10,000 employees) x (0.25) = 2,500 employees who use tobacco 
• (2,500) x ($3,856) = $9,640,000 per year in business borne costs 
associated with smoking 
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Smoking costs lives, time and money 
• Smoking claims more than 440,000 lives each year, making it the leading 
preventable cause of death in the United States (see chart below). In fact, 
smoking kills more people each year than AIDS, drugs and alcohol, homicide, 
suicide and motor vehicle accidents combined. 
• Since the 1960s, research has linked more than 50 painful and costly diseases 
and conditions to smoking, and it is estimated that 10 percent of smokers, or 
approximately 8.6 million people, are currently living with one or more of these 
smoking-related illnesses. 
• A significant amount of 
time is lost from business 
due to smoking breaks and 
the illnesses and fatalities 
that are caused by smoking, 
as smokers are more likely 
to suffer a disability, are 
more likely to miss work 
and are less productive than 
nonsmokers. 
• Female smokers incur 
$17,500 more in lifetime 
medical expenses and miss 
an average of two more 
days of work than 
nonsmoking women. 
• Male smokers incur 
$15,800 more in lifetime 
medical expenses and miss 
an average of four more 
days of work than 
nonsmoking men. 
• On average, direct medical expenses and lost productivity resulting from 
premature death for people with smoking-related diseases cost a staggering 
$157 billion each year or $3,856 per smoker per year. 
From CDC. (2002). Annual smoking-attributable mortality, years of potential life 
lost, and economic costs—United States, 1995–1999. MMWR, 51(14), 300–303. 
Annual U.S. Deaths 
Attributable to Cigarette Smoking 
Secondhand Smoke 
38,000 
Other Cancers 
31,000 
Ischemic 
Heart Disease 
82,000 
Stroke 
17,500 
Chronic Lung Disease 
82,000 
Other 
Diagnoses 
82,000 
Lung Cancer 
125,000 
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• Additional costs to the economy include those related to permanent or 
temporary disability, absenteeism, or decreased productivity among living 
employees who smoke. Other business-related costs of smoking include workers 
compensation claims and occupational health awards, indoor air pollution, 
accidents, fires, and cleaning and maintenance. 
Employer Strategies For Promoting 
Tobacco Use Cessation 
Smoking is an addiction that often requires repeated attempts and professional 
intervention to overcome. Because the most successful interventions require medical 
attention, it is necessary for most employees to have these services covered as part of their 
health benefit. For businesses, making an investment in tobacco cessation benefits not 
only improves employee health but also reduces the significant direct and indirect costs 
associated with tobacco use. In fact, paying for tobacco use treatment is regarded as the 
single most cost-effective health insurance benefit for adults and it is also considered the 
benefit with the most positive impact on health. 
• Request or select health plans that cover effective treatment of smoking (see 
“Evaluating Your Health Plan’s Coverage” on p.4). 
• Ensure that health care providers (those in on-site medical clinics and those 
with larger health care plans) adhere to Health Employer Data Information Set 
(HEDIS®) requirements. HEDIS® measures whether providers screen all 
patients for smoking, counsel smokers to quit and recommend FDA approved 
medications. 
• Design benefits to cover a variety of treatments (i.e., counseling and prescription 
as well as over the counter medications) and allow individuals to choose their 
preferred approach. 
• Consider the delivery of telephone counseling, as it is one of the most successful 
and cost-effective forms of cessation counseling (see “Evaluating Telephone 
Counseling Programs” on p.5). 
• Ensure that smoking cessation counseling emphasizes problem-solving and 
social support to enhance the likelihood of abstinence. 
• Remove fees, co-pays, and other restrictions intended to limit use of benefits. 
Programs that offer counseling and medications free of charge are more effective 
than those that require cost sharing. 
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• Communicate to employees the types of cessation benefits that are covered 
under their health plans. 
• Take a long-term approach to smoking cessation and structure benefits to 
support multiple quit attempts. 
• Offer smoking cessation treatment to employees’ spouses and dependents. 
• Promote a healthy workplace that discourages smoking and values the well being 
of all employees. Institute workplace bans on smoking to reduce tobacco use 
and protect nonsmokers from secondhand smoke. 
• Offer incentives to achieve and maintain healthy lifestyles (see “Incentives Add 
Up for Bank One Employees” on p.6). 
• In states that offer telephone counseling “quitlines” or “helplines,” consider 
contracting with the state to provide this service to your employees (many states 
lack sufficient funding to cover smokers who have insurance). If the state does 
not have such a service, consider contracting directly with a quitline vendor to 
provide services to employees. 
Evaluating Your Health Plan’s Coverage 
Performance data is an invaluable tool to help identify high quality health care. Most 
managed care plans have data on HEDIS® measures and will provide the data on request. 
This information is collected through the Consumer Assessments of Health Plans Survey 
(CAHPS), which added questions to its 2003 survey to determine whether providers 
recommended medications to help patients quit smoking and/or offered assistance in 
quitting beyond advice. The results will be published in 2004, but health plans can access 
the data before it is publicly reported. 
The National Business Coalition on Health’s eValue8 initiative also assesses health care 
plans on their efforts to promote smoking cessation. In addition to consulting these 
resources, purchasers should ask prospective health care plans whether their providers 
actively try to identify smokers, what smoking initiatives are in place, and what support is 
provided to former smokers to prevent relapse. 
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The effectiveness of tobacco cessastion counseling services 
increases as the number and length of sessions increases. 
Telephone counseling services vary in the number of contacts 
they provide, the duration of the calls, the type of information 
they offer and the training required of counselors. When 
evaluating these services, the following criteria should 
be considered: 
• Is the counseling consistent with the strategies 
described in the Public Health Service’s Treating 
Tobacco Use and Dependence—Clinical Practice 
Guideline? Visit www.surgeongeneral.gov/tobacco/ for a 
copy of the Public Health Service’s report outlining best 
practices for the treatment of tobacco dependence or 
reference the Quitline Resource Guide, which will be 
available in 2004 at www.cdc.gov/tobacco. 
• Does the service allow more than one contact? 
Multiple contacts are generally more effective than a 
single contact, but there are no data to suggest an 
optimal number of contacts. 
• How long has the service been in business? 
A long history in business does not necessarily equate to 
quality service. However, you can learn a great deal 
about a company by examining its track record, 
including quit rates. 
• How are data collected, evaluated, and provided to 
the purchaser? Reference the Quitline Resource Guide 
at www.cdc.gov/tobacco for criteria. 
• What is the service’s 6-month quit rate? 
12-month quit rate? How is the quit rate calculated? Is 
everyone who has agreed to counseling included? 
counseling is paired with medications, smokers 
experience substantially greater cessation success rates. 
Consider contracting with a service that has experience 
integrating counseling with one or more medications. 
• Does the service offer an option to link counseling 
with medications? Research has shown that when 
• Can the service provide references? As you would 
with a new employee or vendor, always insist on 
references and invest the time in several quality 
telephone calls to check the service’s cessation record 
and customer service. Make sure to ask about the 
service’s record with call hang ups and any issues 
related to the service’s hours of operation. 
• How are telephone counselors trained and 
evaluated? Reference the Quitline Resource Guide at 
www.cdc.gov/tobacco for criteria. 
• How does the service evaluate its own success? 
While there is no system of accreditation for counselors, 
there are quality assurance measures that the service 
should be tracking, including call monitoring, quit rates, 
and numbers of calls managed per hour. 
• Do the counselors seem knowledgeable and helpful? 
Make an unannounced call to the service to test your 
impression of the counselor’s expertise and the utility of 
the service. 
• Do counselors offer clients a “tool kit” to help them 
abstain from tobacco use? Smokers can benefit from 
educational materials including fact sheets and quit tips 
that complement medications and counseling. 
• How can the company help to promote its services? 
Find out if the service can help you to engage employees 
to use the service via advertising or other forms of 
promotion. Ongoing promotion is key to program 
success. 
Evaluating Telephone Counseling Programs 
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Cost benefits of tobacco use cessation programs 
The minor cost of covering tobacco cessation benefits seems insignificant when compared 
to the major financial burden that tobacco use places on businesses. As health care 
costs due to tobacco related illnesses increase, they erode employer profits, which in 
turn creates a cycle of diminished health care coverage, salaries and other benefits 
for employees. 
• Tobacco cessation benefits are more cost-effective than more commonly 
covered disease prevention interventions, such as treatment for hypertension 
and high cholesterol. 
• Cost analyses prove that tobacco cessation benefits are either cost-saving 
or cost-neutral. 
• Comprehensive tobacco cessation benefits cost between $1.20 and $4.80 per 
employee per year. In contrast, the annual cost of tobacco use is about $3,400 
per smoker. 
• Overall, cost/expenditure to 
employers equalizes at three years 
and benefits begin to exceed costs 
by five years. 
• Because smoking cessation efforts 
are relatively inexpensive and yield 
a large, long-term benefit, they 
help to stem the rising cost of 
health care. Measures that keep 
health care costs in check are 
valuable because it is estimated that 
a one percent reduction in health 
care costs could increase retained 
profits by five percent. 
Incentives Add Up for 
Bank One Employees 
Through its 2002 health risk assessments, Bank One 
estimated that 11% of its employees are smokers and that 
the company lost more than $24 million annually to 
smoking. To address this issue, Bank One offers a variety of 
health plans, each with different benefits related to tobacco 
cessation. Smokers now pay $14 more per pay period than 
nonsmokers do for both health and life insurance ($336 
more per year). The additional fees paid by smokers fund 
wellness programs and offset higher health care costs. 
In addition, the company implemented a smoking cessation 
program that consists of four class sessions. Anyone who 
completes the program (regardless of whether they quit 
smoking) is eligible for the nonsmokers’ discount. In 2002, 
Bank One found that about 23% of those who took part in 
the program said they quit smoking for at least a year. 
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Resources on Tobacco Use, Smoking Cessation, 
and Smoking-Related Diseases 
Pitney Bowes addresses health promotion and tobacco 
cessation on multiple fronts, including programs offering: 
• incentives (cash incentives for wellness program 
participation and discounted life insurance premiums 
for nonsmokers), 
• discouragement (no smoking inside the workplace 
since 1991 at any U.S. worksite), and 
• access (on-site medical clinics and prescription drug 
coverage that includes nicotine replacement therapy and 
bupropion). 
The company’s more focused efforts have also yielded highly 
beneficial results: 
• The on-site medical clinic in the Connecticut office 
created a successful smoking cessation program that 
offers nicotine replacement therapy and bupropion (free 
of cost through the clinic) as well as referrals for 
counseling as needed. The program also provides 
American Lung Association materials for education and 
measures lung capacity using a CO monitor to help 
individuals mark their progress. Although the results have 
not been studied scientifically, the program reports a 
50% quit rate after one year. 
• Pitney Bowes contracted with Group Health of Puget 
Sound to offer smoking cessation to all of its U.S. 
employees at no cost. The result was “Free and Clear,” 
a one year intervention that combines telephone 
counseling and educational materials. This program was 
also highly successful: 
— From 1999 to 2000, nearly 400 individuals 
participated. 
— Approximately 21% of participants quit for one year 
and 36% reduced their consumption. 
— Through the Free and Clear program, the company 
estimated a return on investment of 2.6:1. 
Pitney Bowes Meets Federal Health Targets 
Making Your Workplace Smokefree: 
A Decisionmaker’s Guide 
www.cdc.gov/tobacco/research_data/ 
environmental/etsguide.htm. 
Quitline Resource Guide (in press) 
Will be available in 2004 at 
www.cdc.gov/tobacco 
Coverage for Tobacco Use Cessation Treatments 
http://www.cdc.gov/tobacco/educational_ 
materials/cessation/index.html 
Health Insurance Benefits for 
Treatment of Tobacco Dependence 
www.paccenter.org/public/reports_ 
folder/insurance_flier_web.pdf 
Linking a Network: Integrate Quitlines 
with Health Care Systems 
www.paccenter.org 
American Cancer Society 
www.cancer.org 
American Lung Association 
www.lungusa.org 
National Cancer Institute 
www.nci.nih.gov 
National Center for Health Statistics 
www.cdc.gov/nchs 
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About the Center for Prevention and Health Services (CPHS) 
The Center houses the Business Group’s projects and resources that relate to the delivery 
of preventive and other health services through employer-sponsored health plans and worksite 
programs. Through the Center, employers can find practical toolkits to address preventive 
health and health promotion issues at the worksite. Employers will find current information 
and recommendations from federal agencies and professional associations, model programs 
from other employers, and the latest clinical and health services research results. In addition, 
the Center provides opportunities for employer participation in teleconferences and in-person 
solutions workshops. Currently, the Center has initiatives in racial and ethnic disparities in health 
and health care, terrorism and public health emergency preparedness, maternal and child health, 
preventive services, health services research and quality, health and work performance, benefit 
design and wellness programs. 
For more information, visit www.wbgh.org/programs/cphs/ 
or contact Ron Finch, Ed.D., Director, at finch@wbgh.org. 
About the National Business Group on Health 
The National Business Group on Health, formerly the Washington Business Group on Health, 
is the national voice of large employers dedicated to finding innovative and forward-thinking 
solutions to the nation’s most important health care issues. The Business Group represents its 
185 members, primarily Fortune 500 companies and large public sector employers, who provide 
health coverage for more than 40 million U.S. workers, retirees and their families. The Business 
Group fosters the development of a quality health care delivery system and treatments based on 
scientific evidence of effectiveness. The Business Group works with other organizations to pro-
mote patient safety and expand the use of technology assessment to ensure access to superior 
new technology and the elimination of ineffective technology. 
Helen Darling, President 
National Business Group on Health 
50 F Street N.W., Suite 600 • Washington D.C. 20001 
Phone (202) 628-9320 • Fax (202) 628-9244 • www.wbgh.org 
Widmeyer Communications, Inc., Editing and Design 
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Tobacco Quitlines 
Tobacco Quitlines 
at a glance 
What are tobacco quitlines?	
Sporadic availability, geographically and over time

Transportation difficulties

Childcare responsibilities

Financial cost of participating.

This map was produced by 

the Map Design Unit of The 

World Bank. The boundaries, 
colors, denominations and 

any other information shown 

on this map do not imply,  on 
the part of The World Bank 
Group, any judgment on the 
legal status  of any territory, 
o r  any  endorsemen t  or  	
a c c e p t a n c e  o f  s u c h  

boundaries.

TOBACCO QUITLINES - DENMARK	
IBRD 33217 
THE NETHERLANDS	 May 2004 
GLOBAL PICTURE LUXEMBOURG NORWAY

ICELAND FINLAND

SWEDEN ESTONIA

BELGIUM 
CANADA UNITED KINGDOM BELARUS

IRELAND POLAND

Channel Islands CZECH REP.

GERMANY FRANCE SLOVAK REP.

UNITED STATES HUNGARY GEORGIA
PORTUGAL SPAIN ITALY	 BOSNIA AND 
HERZEGOVINA ISLAMIC 
SWITZERLAND CROATIA REP. OF IRAN 
AUSTRIA 
MEXICO MALTA Taiwan 
Hong Kong 
THAILAND 
MALAYSIA 
SINGAPORE 
BRAZIL 
AUSTRALIA

SOUTH

AFRICA

NEW

ZEALAND

COUNTRIES AND AREAS WITH FUNCTIONING QUITLINES

COUNTRIES PLANNING/SETTING UP QUITLINES
Canadian, and U.S. states and provinces have publicly 
financed quitlines. Some employers and private health 
insurers provide quitlines for their employees and members.

Many new quitlines have been set up in recent years, as

evidence of their efficacy has become more solid and as

tobacco control programs worldwide have become more

common. Quitlines vary greatly in scale and sophistication.

Quitlines are telephone-based tobacco cessation services. 
Since the late 1980’s, quitlines have been established in many 
countries, states and provinces. Most are accessed through a 
toll-free telephone number and provide a combination of 
services including educational materials, referral to local 
programs, and individualized telephone counseling.

Counselors answer callers’ questions about the cessation

process and help them develop an effective plan for quitting. Why have quitlines become popular?

Reactive quitlines only respond to incoming calls. Proactive 
quitlines handle incoming calls and also follow up the initial 
contact with additional outbound calls, to help initiate a quit 
attempt or to help prevent relapse. In some cases, as when 
smokers give consent in their doctors’ offices to be called by 
a counselor, the contact is entirely proactive. Proactive

telephone counseling has been shown to have a marked 
effect on callers’ probability of success in quitting and in 
maintaining long-term abstinence from tobacco use,	
comparable to the effects of pharmacotherapies.  	
Easy access. Traditionally, tobacco users have faced

various barriers in accessing cessation services, including: 

Quitlines reduce these barriers by allowing users to access

service from their own homes at a time that is convenient 
for them, and usually at no cost to themselves. Partly for 
these reasons, surveys have shown that tobacco users are 
much more likely to use telephone-based services than face-
to-face programs. 
Where are they available?	
Brazil, Iran, New Zealand, South Africa, many European 
countries, some countries in Asia, and most Australian,	 Benefits of centralization. Because it provides services 
over the telephone, a quitline can serve a large geographic 
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Economies of scale, leading to more efficient utilization of 
counseling resources 
Standardized training 
Better quality control 
Ease of evaluation. 
area from a single, centralized base of operations. So 
unlike traditional cessation programs in which it is common 
for participants to have to wait until a group forms, quitlines 
are able to operate year-round, often with extended hours 
of business and multilingual capabilities.

attempts, and found a strong dose-response relationship

between the level of intended treatment intensity (i.e.,

number of follow-up sessions) and the treatment effect (Zhu

et al. 1996). 

Further research has demonstrated the continued effectiveness 
of the California quitline after it scaled up to statewide 
operation (Zhu et al. 2002). Borland et al. (2001) found 
similar results for a quitline service in Victoria, Australia. 
These studies increase confidence that the efficacy found in 
clinical trials can carry over to “real world” settings. With the 
efficiencies inherent in centralized, telephone-based 
operations, quitlines appear to be a cost-effective way to 
deliver cessation assistance (McAlister et al. 2004). 
The benefits of centralization include: 
Ease of promotion. Most comprehensive tobacco control 
programs include a media component designed to counteract 
the effects of tobacco industry advertising. This key part of 
successful anti-tobacco programs can be very costly, 
necessitating prudent spending decisions. Media programs 
are a convenient way to promote cessation services, since 
advertisements can carry a single telephone number and air 
across a wide area. This is more efficient than promoting an 
array of local programs, each with its own method of 
accessing service. And quitlines can refer callers to local 
programs as appropriate, thus serving both as a direct 
cessation service provider and as a hub of coordinated 
services.	
Quitlines as part of comprehensive
tobacco control programs 
Most quitlines are supported by state or national health 
agencies, through tobacco taxes or other public funds. They 
are often the government’s chief or only contribution to 
providing direct tobacco cessation services, with the rest of 
its tobacco control funding earmarked for other efforts such 
as educating people about the harm caused by tobacco 
use, preventing initiation of tobacco use among young 
people, and reducing exposure to second hand smoke. If 
resources were not available to make progress in these 
areas, it is doubtful that a quitline alone would be a 
worthwhile investment of public health funds. But in the 
context of comprehensive tobacco control efforts, a quitline 
can help to advance larger goals of the program, such as 
normalizing cessation and eliminating disparities in tobacco 
use or access to treatment. 
Strong evidence of quitline efficacy 
Reactive quitlines: Two studies support use of a reactive 
quitline in the context of a comprehensive tobacco control 
program. A California study found that a well-promoted 
quitline providing a single comprehensive counseling session 
of about 50 minutes increased quit attempts and reduced 
relapse, relative to an intervention of self-help materials 
alone (Zhu et al. 1996). Counties in New York State where 
a quitline was promoted had significantly higher quit rates 
than those without such promotion, even though the majority 
of evaluated quitters did not access the service, indicating 
that quitline promotion in itself may increase cessation on a 
population level (Ossip-Klein et al. 1991).	
Practical considerations 
The range of services provided: Quitline callers have 
a wide range of expectations, so most well established 
quitlines offer a wide range of services. Adult smokers 
wanting help to quit are the most common callers, but there 
are also those who are not yet ready to quit, or who have 
already quit. There are smokers of cigarettes, cigars, and 
pipes, and callers who use chewing tobacco or other 
smokeless tobacco. There are callers of all ages, including 
minors, and callers who speak different languages. In all of 
these categories, some want counseling; others just want 
printed information or referral. Some callers have particular 
needs such as learning more about smoking while pregnant, 
or quitting tobacco while managing a psychological 
condition such as bipolar disorder or schizophrenia. There 
are non-tobacco-users calling on behalf of friends and family 
members, and health care professionals or others trying to 
decide whether to refer their patients, students, or neighbors. 
Comprehensive quitlines develop protocols, resources, and 
staff training for each situation. 
Proactive quitlines: The evidence for proactive quitlines 
is more thorough. Several meta-analytical reviews have 
established that proactive telephone counseling is an 
effective intervention for smoking cessation (Lichtenstein et al.	
1996, Fiore et al. 2000, Hopkins et al. 2001, Stead et al. 
2004). The most recent of these examined 13 studies of 
proactive interventions and found that callers who received 
counseling were successful at least 50% more often than 
those who only received self-help materials (odds ratio of 
1.56) (Stead et al. 2004). The U.S. Public Health Clinical 
Practice Guideline and the Guide to Community Preventive 
Services recommend proactive quitlines as a way to help 
smokers quit (Fiore et al. 2000, Hopkins et al. 2001). 
A large randomized, controlled trial (n=3,030) that served 
as the basis for the California Smokers’ Helpline, the first 
publicly supported, statewide quitline, found that telephone 
counseling increased the percentage of smokers making a 
quit attempt and decreased the rate of relapse for those 
Evidence-based structured protocols guide the flow of 
counseling sessions and remind counselors of topics 
considered to affect quitting success. Counselors using 
clinically validated protocols help clients to: 
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Clarify and enhance their motivation to quit 
Boost their self-efficacy for quitting 
Identify situations that will trigger an urge to use tobacco, 
and plan effective strategies for getting through them 
without tobacco 
Identify ways to get the social support they need 
Commit to a quit date, often with counselor follow-up for 
accountability and extra support. 
The psychology of tobacco use and the process of habit 
formation, maintenance, and extinction 
General principles of counseling and motivational 
interviewing 
Effective counseling techniques for behavior modification 
Challenging counseling scenarios, such as crisis calls and 
callers with psychiatric issues 
Multicultural counseling 
Effective case management practices, including use of 
protocols 
Health issues related to tobacco use and cessation 
NRT and other quitting aids. 
What contribution is the quitline making to the overall 
tobacco control program? 
Is it successful in reaching target populations, especially 
high-risk and underserved groups?
Are callers satisfied with services received? 
What percentages of callers make a quit attempt, and 
maintain abstinence (e.g., for 6 months)? 
Are the results comparable to other published outcomes? 
Besides providing training, quitline supervisors and

managers oversee coverage of incoming calls, effective

case management, and productivity. They monitor and

debrief sessions and make sure the services provided are 
helpful, appropriate, and factually accurate. They also 
ensure the program’s compliance with applicable laws and 
ethical guidelines governing the provision of telephone 
counseling. 
Evaluation: Successful and sustainable quitline operation 
requires rigorous evaluation. Baseline data include, at a 
minimum, how callers heard about the quitline, 
demographic variables such as age, ethnicity, and 
education, type of tobacco used and level of consumption. 
Process data include percentage of calls answered live and 
number of callers (especially members of target populations) 
receiving each type of service. Follow-up data include quit 
status, length of abstinence, and satisfaction with quitline 
services. For quitlines serving large numbers of callers, 
following up a randomly selected sample is adequate. 
Staffing: Quitlines are staffed to meet demand, which is 
largely determined by the intensity and timing of promotion. 
Rather than staying open around the clock, most quitlines 
focus their resources on peak daytime and evening hours. 
The staffing plan must take into account both the overall 
demand for service over time, and the demand at any given 
moment, especially during the “bursts” of calls that occur 
when mass media advertisements are aired. For new 
quitlines, the number of staff required may be calculated by 
estimating the likely number of callers, which in turn may be 
done by comparing the promotional plan with similar 
campaigns elsewhere. Most quitlines require between 30 
minutes and two hours of counselor time per caller, 
depending on the intensity and number of counseling 
sessions provided. Maintaining a balance between 
counselors’ productivity and their availability for incoming 
calls is one of the main challenges of quitline operations, but 
one which becomes more manageable as the scale grows. 
It may not be feasible or even desirable for every quitline to 
conduct its own clinical trial to ensure efficacy, but all 
quitline funding should include an allocation for program 
evaluation to address key questions: 
When recruiting counselors, it is helpful to keep in mind 
that most of the evidence for the efficacy of quitlines is 
based on the work of paraprofessional counselors using 
structured protocols, indicating that postgraduate education 
and licensure are not necessary. Instead of graduate 
training, most quitlines look for candidates with natural 
counseling skills such as empathy, reflective listening, and 
the ability to guide clients through a structured problem-
solving process. These skills are crucial to quitline quality 
and effectiveness. 
It is important when citing results to identify clearly any 
characteristics of the population that received service that 
may have had a bearing on their success, and to address 
whether and why any participants were excluded from the 
analysis.
Training and supervision: A quitline’s training program 
is another key to assuring quality in its services. At a 
minimum, a good training program addresses: 
Promotion: Increasing public awareness of quitline 
services can be done in various ways. Mass media 
advertising—television, radio, newspapers, billboards, and 
other media—usually plays a central role in promotion. 
Successful mass media campaigns identify their target 
audience and do thorough marketing research before 
launching ads. Cultural and linguistic appropriateness is 
especially important. Low-cost promotional strategies have 
been successfully used in some countries, such as requiring 
manufacturers to print the quitline telephone number on 
cigarette packages. 
Health care providers are natural partners for quitlines and 
can play a major role in increasing their utilization. 
Providers who ask all patients whether they use tobacco, 
advise quitting, and refer patients to quitlines for 
comprehensive cessation counseling can have a profound 
impact on patient health. Therefore many quitlines make 
special efforts to build linkages with health care providers. 
As with mass media advertising, promoting quitlines 
through health care systems not only generates calls and 
Following up the initial training with a regular program of 
continuing education helps counselors continuously develop 
their skills and ensures that their knowledge of the field is 
up to date. 
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Queue calls and route them to counselors according to

pre-established priorities 
Monitor calls 
Track and report on performance (e.g., percentage of

calls answered live) 
Expand capacity as needed. 
Assess the need for cessation services in the 
population, considering the prevalence of tobacco use 
in various communities and their readiness to respond 
to cessation messaging.

Determine how direct provision of service fits into the 
overall plan for decreasing tobacco use in the 
population. 
Identify a reliable funding source and determine a 
funding level appropriate to the quitline’s intended role 
in the overall tobacco control program. Tobacco taxes, 
where available, are a commonly used resource for 
quitlines.

Determine a budget and strategies for promotion. 
Promotional budgets that are roughly equivalent to

operational budgets are common.

Create a competitive process to select a quitline

operator. A Request for Proposals (RFP) process, in

which the funding agency provides a thorough

description of the quitline services to be provided and 
invites proposals from interested parties, is common. 
Create a similar process for selecting a media 
contractor. Require both contractors to coordinate their 
activities with each other. 
Write contracts with the selected providers that include 
firm deadlines for delivery of service. 
Closely monitor the contracts to ensure adherence to 
standards and deadlines. Perform ongoing evaluation 
to ensure the quitline’s effectiveness and continued 
relevance to the overall tobacco control program.

helps callers quit, but also increases cessation among 
people who do not call the quitline. 
Technology: A robust and scalable telephone system 
greatly facilitates operations by allowing quitlines to: 
Information systems are very important to the smooth 
functioning of proactive quitlines, which over time may 
serve hundreds of thousands of callers, each receiving 
service spread out over several calls, in some cases with 
different counselors. Computer networks and databases 
must be able to store sufficient information on all contacts 
with individual callers to ensure a seamless delivery of 
services. Integration of the communication and information 
systems, using off-the-shelf Computer Telephony Integration 
(CTI) software, can greatly enhance efficiency. Other 
technologies have the potential to expand the range of 
services offered. Interactive Voice Response (IVR) systems,

for example, allow callers to access personalized 
automated messages based on information they provide. 
Other emerging options include web-based interfaces,

integration with email, and sending text messages or even 
images and short films to cell phone users.

Careful planning, an adequate budget, and rigorous

evaluation will help ensure a successful quitline.

Key Resources for More Information

Anderson CM, Zhu SH. The California Smokers’ Helpline: A 
Case Study. Sacramento, CA: California Department of Health

Services; May 2000.

Costs: The costs of establishing and running a quitline 
can vary widely. Communications and information 
systems can be a significant start-up cost, although fairly 
inexpensive options with limited functionality are 
available. The two largest ongoing expenses are usually 
for promotion and staffing. The U.S. Centers for Disease 
Control and Prevention recommend that new quitlines 
spend as much money on promotion in the first couple of 
years as on all other direct costs combined. (Quitline 
promotion, it should be remembered, not only generates 
calls to the quitline but also promotes cessation in the 
general population.) Over time, the cost for promotion 
may stabilize or even decrease as the quitline builds 
referral relationships with organizations and individuals in 
the community. Staffing costs, on the other hand, tend to 
increase steadily over the years.	
Borland R, Segan CJ, Livingston PM, Owen N. The effectiveness

of callback counselling for smoking cessation: a randomized

trial. Addiction. 2001;96:881-889.

Centers for Disease Control and Prevention. Quitline Resource

Guide: Strategies for Effective Development, Implementation,

and Evaluation. Atlanta: U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention, National 
Center for Chronic Disease Prevention and Health Promotion, 
Office on Smoking and Health, 2004. 
European Network of Quitlines: Guide to Best Practice.

Available at www.enqonline.org.

Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ, Boles SM.

Telephone counseling for smoking cessation: rationales and meta-

analytic review of evidence. Health Education Research: Theory

and Practice 1996;1:243-257. 
Stead LF, Lancaster T, Perera R. Telephone counselling for 
smoking cessation (Cochrane Review). In: The Cochrane Library 
Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd. Steps in setting up a quitline	
Zhu SH, Anderson CM, Tedeschi GT, Rosbrook B, Johnson CE, 
Byrd M, Gutiérrez-Terrell E. Evidence of real-world effectiveness 
of a telephone quitline for smokers. New England Journal of 
Medicine 2002;347(14):1087-1093.

Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce 
JP. Telephone counseling for smoking cessation: effects of single-
session and multiple-session intervention. Journal of Consulting 
and Clinical Psychology 1996;64:202-211. 
Expanded versions of the “at a glance” series, with e-linkages to resources and more information, are available on the 
World Bank Health-Nutrition-Population web site: www.worldbank.org/hnp 
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QuitWorks
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Minimal Data Set Intake Questions 
Approved February 2005 MDS Questions - FINAL

Phoenix, Arizona Updated July 19, 2005

MINIMAL DATA SET 
INTAKE QUESTIONS 
A. REASON FOR CALLING AND AWARENESS OF QUITLINE 
1. How can I help you? (Reason for Calling) 
Want help / information about quitting 
Want help / information about staying quit 
Want to refer someone for help 
Want general information or materials about quitline service 
Other___________________________________ 
2a. Are you: 
Calling for yourself (SKIP TO Q3) 
Calling on behalf of or to help someone else (CONTINUE TO Q2b) 
2b. Are you: 
A health professional 
A friend or family member 
A community organization, worksite, insurance 
Other___________________________________ 
3.	 How did you hear about the Quitline? (Do NOT read. CHECK ALL RESPONSES) 
(Optional 
North American Quitline Consortium	 Page 1 of 10 
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CANADA: Do you currently smoke cigarettes daily, occasionally, or not at all? 
(CHECK ONE) 
Daily 
Occasionally (if less than 7 days per week or less than 1 cigarette per day) 
Optional if respond “Occasionally”:  How many days did you smoke 
in the last 30 days? _____ 
Not at all 
When was the last time you smoked a cigarette, even a puff? -- / -- / ----
(if day is unknown, code as 15th of month.) dd/mm/yyyy 
(IF RESPONSE IS “NOT AT ALL” SKIP TO Q7) 
Approved February 2005 MDS Questions - FINAL 
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4. 	 Is this your first call to the quitline in the past year? 
Yes 
No Optional: How many times did you call the quitline in the past year? _____ 
(# of times) 
B. TOBACCO BEHAVIOURS 
5a. USA: Do you currently smoke cigarettes every day, some days, or not at all? 
(CHECK ONE) 
Everyday 
Some days (if less than 7 days per week or less than 1 cigarette per day) 
Optional if respond “Some Days”:  How many days did you smoke in the last 30 
days? _____ 
Not at all 
When was the last time you smoked a cigarette, even a puff?  -- / -- / ----
(if day is unknown, code as 15th of month.) dd/mm/yyyy 
(IF RESPONSE IS “NOT AT ALL” SKIP TO Q7) 
5b. How many cigarettes do you smoke per day on the days that you smoke? 
Cigarettes per day __ __ __ (If caller says over 100, confirm. 100 cpd = 5 packs 
per day; If caller says less than one per day, code 5a as Some Days/Occasionally) 
6.	 Cigarette smokers only: 
How soon after you wake up do you smoke your first cigarette? (DO NOT READ) 
within five minutes 
6 to 30 minutes 
31 to 60 minutes 
more than 60 minutes 
don’t know 
refused 
North American Quitline Consortium	 Page 2 of 10 
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7. 	 Do you currently use other tobacco products such as… (check all that apply) 
Cigars 
Pipes 
Chewing Tobacco or Snuff 
Other Tobacco Products (e.g. Bidis) Optional: (specify)___________________ 
     (IF Q5a = EVERYDAY/DAILY OR SOME DAYS/OCCASIONALLY AND Q7 =

NO OTHER TOBACCO, SKIP TO Q9) 

(IF Q5a = NOT AT ALL AND Q7 = NO OTHER TOBACCO, SKIP TO Q10) 

 
8.	 How much tobacco do you use per week? 
____ cigars (number per week) 
____ pipe bowls (number per week) 
____ chewing tobacco or snuff (number of pouches / tins per week) 
____ Other tobacco (amount per week) 
All current tobacco users (smokers and other tobacco users) 
9. Do you intend to quit within the next 30 days? (DO NOT READ) 
Yes 
No 
Don’t know 
Refused to answer 
10. Optional At what age did you start smoking regularly? ______ age in years 
C. CALLER CHARACTERISTICS (Ask of all eligible* callers) 
(* eligible is defined by each quitline and should be clearly described) 
11. First I need to verify are you male or female? 
Male 
Female 
Refused 
12. What year were you born? _ _ _ _ 
Refused 
Optional What is your date of birth? _ _/_ _ _ _ 

Mo./year

13. What is your zip code? (Canada = postal code) _ _ _ _ _ 
14. Optional: Do you have any health insurance? USA only 
Yes 
No 
Don’t know 
Refused 
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15. What is the highest level of education you have completed? (DO NOT READ) 
USA Canada 
Less than grade 9 Less than high school 
Grade 9 to 11, no degree 
GED 
High school degree  High school diploma 
some college or university 
 (includes any post-high school education,
 including technical or trade school, but not
 a degree.) 
Technical or trade school
college or university degree College or university degree 
(includes AA, BA, Masters, Ph.D.) 
16. USA  Are you Hispanic or Latino? 
Yes (Hispanic or Latino) 
No (Not Hispanic or Latino) 
Refused 
Not ascertained (OPTIONAL) Reason: ______(include “don’t know” here) 
17. USA  Which of these groups would you say best describes you? (READ) 
White1 
Black or African American2 
Asian3 
Optional if respond Asian: Which specific ethnicity or race do you identify with 
the most? (Do not read responses; code answer) 
Asian Indian 
Cambodian 
Chinese (except Taiwanese) 
Filipino 
Hmong 
Japanese 
Korean 
Laotian 
Pakistani 
Thai 
Taiwanese 
Vietnamese 
Other Asian (specify):___________________ 
don’t know/not sure 
Refused 
1 A person having origins in any of the original peoples of Europe, the Middle East, or North Africa.

2 A person having origins in any of the black racial groups of Africa. Terms like Haitian or Negro can also

be used.

3 A person having origins in any of the original peoples of the Far East, Southeast Asian, or the Indian

subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the

Philippine islands, Thailand, and Vietnam.

North American Quitline Consortium Page 4 of 10 
118 | Appendixes 
Approved February 2005 MDS Questions - FINAL 
Phoenix, Arizona Updated July 19, 2005 
Native Hawaiian or other pacific islander4 
Optional if respond Native Hawaiian or other pacific islander: Which specific 
ethnicity or race do you identify with the most? (Do not read responses; code 
answer) 
Native Hawaiian 
Samoan 
Tongan 
Tahitian 
Maori 
Guamanian or Chamorro 
Other Micronesian (e.g. Marshallese, Palauan, Pohnpeian, Chuukese, 
Yapese, Saipanese, Kosraean) 
Fijian 
Other (specify):_____________________ 
Don’t know/not sure 
Refused 
American Indian or Alaska native5 
DO NOT READ THE REST: 
THIS IS THE END OF THE INTAKE QUESTIONS REQUIRED BY THE MINIMAL 
DATA SET. 
4 A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. 
5 A person having origins in any of the original peoples of North, Central, or South America, and who 
maintain tribal affiliation or community attachment. 
North American Quitline Consortium Page 5 of 10 
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Other (specify)_____________ 
Don’t know 
Refused 
Canada To which of the following ethnic or cultural groups did your ancestors belong? 
(ancestor = great grandparents or further back) (READ; CAN CHECK MORE THAN 
ONE)
 Canadian (English or French Canadian) 
Aboriginal (Native Indian, Metis, Inuit) 
British (English, Irish, Scottish, Welsh) 
European (specify country __________________) 
Asian (specify country ___________________) 
Other (specify)_______________ (DON’T READ) 
None of the above (DON’T READ) 
Don’t know (DON’T READ) 
Refused (DON’T READ) 
      
Approved February 2005 MDS Questions - FINAL
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INTAKE ADMINISTRATIVE DATA

Counselor ID (Optional) 
Caller ID 
Date of First Contact with Quitline _ /_ _ / _ _ _ _ 
day mo yr 
Intervention Provided to Caller (Check All That Apply) 
Basic information 
Literature and/or self-help materials 
Reactive counseling (one counseling session) 
Proactive counseling (more than one counseling session) 
Medications 
Referral 
Other 
North American Quitline Consortium Page 6 of 10 
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MINIMAL DATA SET 
SEVEN MONTH FOLLOW-UP QUESTIONS 
7 MONTH FOLLOW-UP ADMINISTRATIVE DATA 
Evaluator ID 
Caller ID 
Date of First Contact with Quitline  _ _ /_ _ / _ _ _ _ 
dd /mm/yyyy 
Date of Evaluation Interview: seven months after date of first contact with quitline 
_ _ /_ _ / _ _ _ _ 
dd/mm/yyyy 
. 
A. CALLER SATISFACTION 
1. Overall, how satisfied were you with the service you received from the Quitline? 
(READ ALL, CHECK ONE ONLY) 
very satisfied

mostly satisfied 

somewhat satisfied 

not at all satisfied

don’t know

refused

B. TOBACCO BEHAVIOURS 
2a. USA: Do you currently smoke cigarettes every day, some days, or not at all? 
(CHECK ONE) 
Everyday 
Some days (if less than 7 days per week or less than 1 cigarette per day) 
Optional if respond “Some Days”:  How many days did you smoke in the last 30 
days? _____ 
Not at all 
When was the last time you smoked cigarettes daily? -- / -- / ----

(if day is unknown, code as 15th of month.) dd/mm/yyyy 

IF RESPONSE IS “NOT AT ALL” SKIP TO Q4 
North American Quitline Consortium Page 7 of 10 
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CANADA: Do you currently smoke cigarettes daily, occasionally, or not at all? 
(CHECK ONE) 
Daily 
Occasionally (if less than 7 days per week or less than 1 cigarette per day) 
Optional if respond “Occasionally”:  How many days did you smoke 
in the last 30 days? _____ 
Not at all 
When was the last time you smoked cigarettes daily? -- / -- / ----
(if day is unknown, code as 15th of month.) dd/mm/yyyy 
(IF RESPONSE IS “NOT AT ALL” SKIP TO Q4) 
 pipe bowls (number per week) 
 Other tobacco (amount per week) Optional: (specify)___________________ 
Approved February 2005 MDS Questions - FINAL

Phoenix, Arizona Updated July 19, 2005

2b. How many cigarettes do you smoke per day on the days that you smoke? 
Cigarettes per day __ __ __ (If caller says over 100, confirm. 100 cpd = 5 packs 
per day; If caller says less than one per day, code as Some Days) 
3.	 Cigarette smokers only: 
How soon after you wake up do you smoke your first cigarette? (DO NOT READ) 
within five minutes 
6 to 30 minutes 
31 to 60 minutes 
more than 60 minutes 
don’t know 
refused 
4. 	 Do you currently use other tobacco products such as… (check all that apply) 
Cigars 
Pipes 
Chewing Tobacco or Snuff 
Other Tobacco Products (e.g. Bidis) 

      (IF Q2a = EVERYDAY/DAILY OR SOME DAYS/OCCASIONALLY AND Q4 =

NO OTHER TOBACCO, SKIP TO Q6) 

(IF Q2a = NOT AT ALL AND Q4 = NO OTHER TOBACCO, SKIP TO Q8) 

5.	 How much tobacco do you use per week? 
____ cigars (number per week) 
____ 
____  chewing tobacco or snuff (number of pouches / tins per week) 
____ 
North American Quitline Consortium	 Page 8 of 10 
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 Approved February 2005 MDS Questions - FINAL 
Phoenix, Arizona Updated July 19, 2005 
All current tobacco users (smokers and other tobacco users) 
6. 	 Do you intend to quit within the next 30 days? (DO NOT READ) 
Yes 
No 
Don’t know 
Refused to answer 
7. 	 Since you first called the Quitline on (Date of first contact), seven months ago, did 
you quit using tobacco for 24 hours or longer? (DO NOT READ, CHECK ONE 
ONLY) (Note: collect number of intentional quit attempts only) 
Yes

No

Don’t know

Refused to answer 

Optional: How many times did you quit using tobacco for 24 hours or longer?  ____ 
(Note: collect number of intentional quit attempts only) 
8. When was the last time you smoked a cigarette, even a puff?  -- / -- / ----
(if day unknown, code as 15th of month) dd/mm/yyyy 
Don’t know 
Refused to answer 
9. 	 Have you smoked any cigarettes or used other tobacco, even a puff, in the last 7 days? 
Yes 
No 
Don’t know 
Refused 
10. Have you smoked any cigarettes or used other tobacco, even a puff, in the last 30 
days? 
Yes 
No 
Don’t know 
Refused 
11. Since your call to the quitline on (Date of first contact), seven months ago, have you 
used anything to help you quit?  For example, nicotine replacement (gum or patch), 
pills (Zyban), group cessation, advice from a health professional, self-help materials? 
Yes

No

Don’t know

Refused

North American Quitline Consortium	 Page 9 of 10 
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Approved February 2005 MDS Questions - FINAL 
Phoenix, Arizona Updated July 19, 2005 
12. Optional What kind of treatments or health professionals? 

(Check all that apply – do not read) (Quitlines can expand these categories as necessary)

Medication Zyban 
NRT patches 
NRT gum 
NRT lozenges 
other medications as desired 
Advice from Physician 
Pharamacist 
Nurse 
Group cessation program 
Self-help materials 
Other ______________ 
THIS IS THE END OF THE 7 MONTH FOLLOW-UP QUESTIONS REQUIRED BY 
THE MINIMAL DATA SET. 
North American Quitline Consortium Page 10 of 10 
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Appendix L 
Medicaid Model Language 
A Summary of the Sample Purchasing Speciﬁcations 
Related to Tobacco-Use Prevention and Cessation 
Medicaid populations have been shown to have smoking rates of 36% 
(almost double that of the population as a whole) (MMWR 11/9/01). 
Tobacco use is the most preventable cause of death and disability in the 
United States (McGuinnis). Tobacco use results in $92 billion in excess 
health-care costs annually (MMWR 2005). 
To address this considerable health-care cost and to promote the provision 
of tobacco-dependence treatment for this population, the Centers for 
Disease Control and Prevention’s Ofﬁce on Smoking and Health has 
coordinated with the Center for Health Services Research and Policy 
at the George Washington University School of Public Health to develop 
sample “Purchasing Speciﬁcations Related to Tobacco-Use Prevention 
and Cessation.” 
These draft speciﬁcations are in the form of proposed contract language 
and are designed to be used by state Medicaid agencies as they develop 
their Medicaid managed care contracts. Ideally this language would be 
incorporated in an RFP or contract between the state and HMOs covering 
Medicaid enrollees. 
Several state Medicaid agencies and health departments have reviewed the 
Speciﬁcations and provided input to ensure applicability. The document has 
also been through a vetting process with selected state Medicaid directors. 
This process is part of a larger initiative to assist states in standardizing 
contract language around the most common chronic diseases, such as 
asthma, hypertension, and cardiovascular disease management. 
The Public Health Service (PHS) Clinical Practice Guideline, Treating 
Tobacco Use and Dependence, summarizes a literature review and, along 
with the Community Preventive Services Task Force, makes a strong case 
for implementation of effective tobacco-control treatment and provision of 
comprehensive coverage (Fiore, Hopkins). The Partnership for Prevention 
has ranked tobacco-dependence treatment second overall (and ﬁrst among 
adults) among proven preventive treatments (based on cost, 
cost effectiveness, and impact) (Cofﬁeld). 
Lack of access to tobacco-use treatment and the costs of treatment are major 
barriers for low-income people trying to quit smoking. At present only 3 
states provide comprehensive tobacco treatment coverage under Medicaid, 
36 states and the District of Columbia provide a range of partial coverage 
for counseling and pharmacotherapy, and 15 states provide no coverage 
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(MMWR 1/30/04). The speciﬁcations were developed to improve the level 
of care available to this vulnerable population and create a higher level of 
uniformity among services available to the Medicaid population. 
The speciﬁcations attempt to translate the PHS guideline ﬁndings into 
contract language to support the process. The speciﬁcations address 
■	 Systems components to support the treatment process. 
■	 The scope of the beneﬁt. 
■	 Diagnostic and Treatment Services for enrollees who use tobacco or have 
recently quit, including 
•	 Pharmacotherapy. 
•	 Counseling. 
■	 Services for pregnant women. 
■	 Services for adolescents and pre-teens. 
■	 Tobacco use treatment under chronic disease management programs. 
■	 Guidelines. 
■	 Coverage determination standards and procedures. 
■	 Relationship with state (or local) public health agency. 
Quality measurement, quality improvement, and data reporting 
Quality measures (such as implementation of the HEDIS measure) and 
regular reporting on sample chart audits, prescription drug monitoring, and 
interface with telephone counseling services, if available, are suggested to 
ensure effective implementation. 
Medicaid Model Language Summary 8/05 
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Appendix M 
Promotion of Tobacco Cessation 
in the Health-Care System: 
Suggested Strategies 
The following was created by the Veterans Administration (VA) and the 
Department of Defense for their Tobacco Use Cessation Clinical Practice 
Guideline. It was not used for the actual guideline, but is being reprinted 
with permission from the VA author of the document. 
Objective 
■	 Increase to 100 percent any beneﬁciary’s access to evidence-based 
tobacco use and dependence treatment services in the DoD/VA system. 
■	 Remove barriers to providers, staff, clinical settings, and administrators 
from the DoD/VA system, so as to increase provision and utilization of 
tobacco use and dependence treatment services. 
Background 
In the health care system, treatment for tobacco use and dependence often 
begins with brief advice provided by a health care provider that advises 
the patient to quit, followed by possible interaction with counseling and 
pharmacotherapy. Considerable research shows that many evidence-
based tobacco use and dependence treatments are effective in addition 
to health care provider advice and follow-up (Levy & Friend, 2002). With 
this evidence, the DoD/VA health care system administrators must ensure 
changes in the DoD/VA systems that develop, support, and sustain a range 
of evidence-based tobacco use and dependence treatment services. Based on 
system changes that remove barriers to evidence-based treatment services, 
the greater the access that DoD/VA beneﬁciaries have to this range of 
services, the greater the potential to increase treatment use and quit rates. 
Smoking cessation is the “gold-standard” for cost-effectiveness among 
medical/preventive interventions. Smoking cessation has been called 
the “gold standard of health care cost effectiveness” (Eddy, 1992). Few 
interventions, with the exception of vaccinations for children and older 
adults, offer better value. Compared with other routine preventive 
interventions, smoking cessation is extremely cost-effective, comparing 
favorable with other health care interventions such as screening for 
hypertension and yearly mammography. Coronary bypass graft surgery 
costs roughly 10 times as much per quality-adjusted year of life saved 
(Cromwell et al. 1997). A return on the investment made on smoking 
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cessation can be made relatively quickly. A study by the Group Health 
Cooperative suggests that 4 years after quitting, smokers who quit have 
signiﬁcantly lower health care utilization than smokers who continue 
(Wagner et al. 1995). 
In a systematic assessment of the value of clinical preventive services 
recommended by the US Preventive Services Task Force, smoking cessation 
services for adults was one of the highest ranked services (in terms of 
disease burden and cost-effectiveness) with one of the lowest delivery 
rates of all preventive services (Cofﬁeld et al. 2001). These and other 
ﬁndings would suggest that despite knowledge of the health beneﬁts of 
tobacco use cessation and availability of cost-effective treatments, many 
health care providers and health care systems still fail to treat tobacco 
use adequately. 
Recommendations 
Main recommendations – “Top 10 system changes” 
Changes at the organization level 
1. National and local leadership should fully endorse and support the 
goal of reducing tobacco use and make it an organizational and 
institutional priority. 
2. Tobacco use cessation treatment (both counseling and pharmacotherapy) 
should be provided as a covered beneﬁt with no co-payment. 
3. Clinical sites should dedicate staff to provide tobacco dependence 
treatment and assess the delivery of this treatment in staff performance 
evaluations. 
4. The Veterans Health Administration and Department of Defense should 
each implement standardized data collection to allow tracking and 
management of tobacco users. 
5. The Veterans Health Administration and Department of Defense 
should establish national Quitlines for smoking cessation, which 
include provision of smoking cessation medications. Mechanisms 
should be developed to facilitate provider referral to Quitlines. 
Changes at the clinic level 
6. Treatment and referral for smoking cessation, (as well as their 
documentation) should be as convenient as possible, since it increases 
the likelihood that patients will receive appropriate treatment. 
7. Every clinic should implement a tobacco-user identiﬁcation system 
(e.g., use nicotine dependence ICD code). 
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8. The Veterans Health Administration and Department of Defense should 
each use clinical reminders (electronic, if possible) that are tailored to the 
speciﬁc treatment setting. 
Changes at the provider level 
9. Every facility should develop and adopt strategies to increase provider’s 
adherence to the guideline (e.g., academic detailing, provider proﬁling, 
education outreach). 
10.All providers and other health care team members should be trained 
in providing smoking cessation treatment, as patients who see trained 
providers are more likely to receive appropriate treatment. 
Additional recommendations 
Changes at the organization level 
11. The Veterans Health Administration and Department of Defense should 
establish an Internet-based smoking cessation web site, to provide 
broader access to treatment for smokers and a central resource location 
for staff. 
12.The Veterans Health Administration and Department of Defense should 
make all installations and campuses smoke-free. 
13.Each institution’s policies should support and promote the provision of 
tobacco use cessation services. 
14.All facilities should initiate environmental and policy changes that 
discourage tobacco use among staff personnel, as staff who use tobacco 
are less likely to assist patients in quitting. 
Changes at the clinic level 
15.Tobacco users should be offered treatment at all clinical settings, as 
repeated advice from multiple providers increases the likelihood that 
they will quit. 
16.Barriers to receiving smoking cessation treatment should be eliminated, 
so that patients can access treatment at any time and place. 
Changes at the provider level 
17.The Veterans Health Administration and Department of Defense should 
develop methods to reward clinicians and specialists for delivery of 
effective tobacco dependence treatments. 
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Discussion 
System changes are one of the most important aspects of tobacco control. 
Health care providers and staff universally acknowledge the importance 
of tobacco use cessation, but often fail to advise tobacco users to quit and 
assist them in quitting. This is in part due to the many competing demands 
placed on providers (Chernof et al., 1999) and health care institutions. 
System changes help to reduce barriers, increase knowledge and skills, 
and modify attitudes with respect to smoking cessation, which in turn 
increases the provision of effective tobacco cessation services. The 
changes are broken down into three levels for convenience and clarity 
(the organization, the clinic, and the provider), although many of the 
recommendations act at multiple levels. 
Organization Level Changes 
Changes at the organization level focus on modifying the culture with 
respect to tobacco use cessation and providing services or resources that 
are too large or complex for one facility to develop. Making tobacco use 
cessation a top organizational priority is one of the most important changes, 
as that makes all other changes much easier to effect. Tobacco use cessation 
treatment (both counseling and pharmacotherapy) should be a covered 
beneﬁt, as it dramatically increases the rate of provision of these services 
(Curry et al., 1998; Fiore et al., 2000). Co-payments for treatment should be 
eliminated. Curry and colleagues found that elimination of all co-payments 
led to higher total costs but also to an increased number of non-smokers, 
through much higher levels of provision of tobacco use cessation treatments. 
Despite some people’s concerns, having smoking cessation treatment 
available as a covered beneﬁt did not lead to proﬂigate use. When cost-
free access of up to four 30-day trials of NRT was provided for over a 
year, 73 percent used this beneﬁt once, 20 percent used it twice, and only 
3 percent and 5 percent used it three and four times, respectively (Harris 
et al., 2001). On a separate note, telephone Quitlines should be available 
to all tobacco users, as these are effective and greatly increase access 
to treatment. 
While there is not yet evidence that Internet-based smoking cessation 
programs are effective, several studies are currently examining this issue. 
In the absence of data, these programs provide a reasonable and efﬁcient 
way to support patients who have Internet access. In addition, the 
Internet provides an efﬁcient way to allow providers to access up-to-
date information, including guidelines, handouts, and other materials. 
Clinic-Level Changes 
Changes at the clinic level focus on making it as easy as possible to provide 
tobacco use cessation treatment to patients. Providers have many other 
competing obligations and demands on their time (Chernof et al., 1999), 
and the more difﬁcult it is to help tobacco users quit, the less likely it is 
that it will happen. Therefore, clinics should review the entire process for 
tobacco use cessation, with an eye to making it as simple and easy 
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as possible. Patients often say that the provider’s advice is a particularly 
important motivating factor in helping them quit (Fiore et al., 2000). Clinics 
should therefore ensure there is a system for helping remind the provider 
to advise the patient to quit and then for assisting the provider in assisting 
the patient to quit. As an example, a typical set-up might include tobacco 
use status as part of the vital signs, with a reminder (electronic or paper) 
for the provider if the patient uses tobacco. After the provider advises the 
patient to quit, another staff member (e.g., nurse, pharmacist) might provide 
more detailed instructions on medication use and cessation tips, along with 
one or more follow-up contacts. Speciﬁc tasks that a clinic should think 
about in this regard are: 1) identiﬁcation of tobacco users in a systematic 
way, 2) provision of detailed information about cessation, 3) ongoing 
management of tobacco cessation pharmacotherapy, and 4) follow-up 
counseling. 
Provider Level Changes 
At the provider level, changes focus on training and encouraging the 
provider and making tobacco use cessation treatment the standard of 
care. Therefore, systems should ensure that all health care providers 
receive adequate training in counseling tobacco users and providing 
pharmacotherapy. Training includes both initial training (which focuses 
on improving everyone’s knowledge and skills) and ongoing, follow-up 
training (which focuses on reﬁning skills and removing barriers). Several 
ongoing studies are examining the use of provider proﬁling, whereby the 
performance of individual providers is audited and providers are given 
individual feedback. Additional studies are examining the effectiveness 
of educational outreach (also known as academic detailing). In a typical 
implementation of this approach, a respected local peer (an opinion leader) 
might brieﬂy “detail” providers with speciﬁc information about tobacco use 
cessation. Not only does this efﬁciently give providers helpful information, 
it also sends the unspoken message that someone they know believes in 
tobacco use cessation and practices it with their own patients (thereby 
targeting cultural norms for providers). No studies have examined the use 
of incentives (either positive or negative) as a way to modify providers’ 
behavior with respect to tobacco use cessation, and studies examining 
their use in other areas (e.g., increasing immunization rates) have had 
mixed results (Giuffrida et al., 2000). 
[Additional data on strategies for designing the health care system 
to promote tobacco use cessation can be found in Evidence Report 
Question #18] 
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